













This thesis has been submitted in fulfilment of the requirements for a postgraduate degree 
(e.g. PhD, MPhil, DClinPsychol) at the University of Edinburgh. Please note the following 
terms and conditions of use: 
 
This work is protected by copyright and other intellectual property rights, which are 
retained by the thesis author, unless otherwise stated. 
A copy can be downloaded for personal non-commercial research or study, without 
prior permission or charge. 
This thesis cannot be reproduced or quoted extensively from without first obtaining 
permission in writing from the author. 
The content must not be changed in any way or sold commercially in any format or 
medium without the formal permission of the author. 
When referring to this work, full bibliographic details including the author, title, 
awarding institution and date of the thesis must be given. 
 
   
 
 
High Spectral Resolution Mass Spectrometry 
Imaging of Three-Dimensional Cell Culture 
 















The University of Edinburgh 
2019
 
   i 
Declaration 
I declare that this thesis has been composed solely by myself and that it has not 
been submitted, in whole or in part, in any previous application for a degree. Except 
where states otherwise by reference or acknowledgment, the work presented is 
entirely my own.  
 
Lulu H. Tucker  
 
   ii 
Abstract 
Three-dimensional (3D) cell culture combines the simplicity of two-dimensional (2D) 
cell culture systems with the complex interplay of factors resembling the 
multifaceted physiology of tissues in vivo. These microscale spherical cell clusters – 
known as multicellular tumour spheroids (MTS) – replicate the oxygen, nutrient, and 
waste gradients observed within tumours, and provide useful model systems to 
improve our understanding of cancer biology. 
Matrix-assisted laser desorption/ionisation (MALDI) mass spectrometry imaging 
(MSI) is an analytical technique that permits broad spectral and label-free analysis 
to observe the distribution of compounds without requiring any significant prior 
knowledge. MALDI-MSI can be used as a global untargeted approach to elucidate 
the various microenvironments within MTS at high spatial resolution.  
Here, method development for MALDI-MSI of MTS will be reported. Breast cancer 
(MCF-7) and prostate cancer (PC3) spheroids were grown to diameters of 
approximately 500 µm using the hanging drop method. For MALDI imaging, the 
spheroids were embedded in gelatin, cryosectioned, and coated with a matrix. Using 
the optimised protocol, up to eight spheroids were embedded in a gelatin block, and 
up to 100 spheroid sections were mounted onto a slide.  
To discern the ionisable metabolome of an MCF-7 spheroid, MALDI mass 
spectrometry (MS) analysis was employed to compile a list of tentative metabolite 
identifications. Using various matrices in both polarities, over 760 tentative formulae 
were assigned at sub-ppm errors. 
A targeted MALDI-MSI approach suggested that adenosine triphosphate (ATP), 
adenosine diphosphate (ADP), and glutathione can be used as metabolite markers 
to indicate regions of increased oxidative stress and hypoxia. ATP was found to be 
primarily localised to the outer region, whereas ADP was more uniformly distributed, 
suggesting there is a decreasing oxygen gradient through the spheroid.  
Subsequently, an untargeted approach of discriminatory analysis tentatively 
identified the metabolites that colocalised to these areas. The assignments were 
used to investigate the regional flux through specific metabolic branch pathways. 
The hexosamine biosynthetic pathway (HBP) was found to be upregulated in the 
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regions of the spheroid with greater access to oxygen, whereas there was greater 
glycolytic flux within the regions limited by hypoxia. 
MALDI-MSI is useful for elucidating the absorption, distribution, metabolism, and 
excretion (ADME) of drugs within MTS. Therefore, the developed protocol was 
employed to observe the time-dependent distribution of the hypoxia marker 
pimonidazole within PC3 spheroids. Due to the low signal-to-noise (S/N) of 
pimonidazole and its metabolites, continual accumulation of ions (CASI) was used 
to effectively lower the limit of detection and increase the signal intensities. Over 24 
hours, pimonidazole was distributed throughout the spheroid and underwent 
reduction. Furthermore, its reduction derivatives showed a central localisation 
throughout the time course, suggestive of a hypoxic core. 
Finally, a 3D printer and other parts commonly found in an analytical chemistry lab 
were employed as a low-cost alternative to commercial sprayers for matrix 
deposition. Using printed rhodamine B microarrays and fluorescence imaging, 
matrix application conditions were optimised to effectively reduce delocalisation 
from 403% to 9.4%. Subsequently, MALDI-MSI of MTS was used to compare the 
optimised conditions of the home-built sprayer to a commercially available matrix 
application platform. Using this system, robust and reproducible distributions of 
endogenous metabolite distributions with a high spatial resolution were observed.  
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Lay Summary 
Oxygen is required to produce the energy that drives many processes within every 
cell in our bodies. Sometimes, cells can divide uncontrollably and cause cancer. 
These cancer cells grow and divide so quickly that the tumour is unable to obtain 
sufficient oxygen. Whilst this would cause our ‘healthy’ cells to run out of energy and 
die, cancer cells have found methods enabling them to adapt, survive, and continue 
to divide. 
Many anti-cancer drugs are developed to specifically target these adaptations. 
Initially, during drug development, a potential drug is tested on cells that are grown 
on a flat surface. However, these carefully controlled conditions are unable to 
accurately mimic the complicated environments within our body. This over-
simplification within the drug discovery pipeline necessitates the development of 
alternative, more representative models. Three-dimensional (3D) cell cultures 
involve growing cells in the absence of a surface, causing the cells to attach to each 
other and produce spherical structures up to 1 mm in diameter. 
The work presented here focuses on a specific 3D cell culture known as 
multicellular tumour spheroids (MTS). As a result of their size, these clusters of 
cancer cells experience the same environments that are observed in a tumour within 
the body. By using spheroids as models of tumours, we can improve our 
understanding of how cancer cells adapt and survive under otherwise lethal 
conditions. Furthermore, by treating the spheroids with drugs, we are able to better 
understand how the drug will affect a tumour, thus reducing the need for animal 
models during drug discovery. 
This work employs a technique called mass spectrometry imaging (MSI) to elucidate 
the structures of these spheroids. In a single experiment, MSI is able to detect a 
variety of important biological molecules without the requirement for additional 
labels. Furthermore, as an imaging technique, MSI enables us to observe the 
distributions of these molecules and drugs, contributing towards improving our 
understanding of how drugs interact with a tumour. 
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1.1 Mass spectrometry 
Mass Spectrometry (MS) is a key contributor to the ‘omics’ era; an analytical method 
that enables the comprehensive profiling of small molecules (metabolomics) and 
proteins (proteomics).1,2 It is advantageous for global untargeted analysis as a result 
of its speed, sensitivity, and wide dynamic range.3 The fundamental principle of MS 
involves three stages: ionisation of the sample into the gas phase, separation of the 
ions based on their mass-to-charge ratios (m/z), and subsequent detection of the 
ions. 
1.1.1 Ionisation  
The principal aim of ionisation is to introduce the analytes of interest to into the gas-
phase and impart a fixed charge. Soft ionisation methods such as electrospray 
ionisation (ESI) and matrix-assisted laser desorption/ionisation (MALDI) produce 
gas-phase ions without fragmentation, enabling the formation of intact molecular 
ions. In 2002, Koichi Tanaka and John Fenn were awarded the Nobel prize in 
Chemistry for their work on MALDI4 and ESI5 and their applications to biological MS. 
Whilst ESI is primarily used for solution-phase samples, MALDI uses a laser to 
analyse a sample’s surface. Alternative surface ionisation methods include 
secondary ion mass spectrometry (SIMS),6 desorption electrospray ionisation 
(DESI),7 and liquid extraction surface analysis (LESA).8 
1.1.1.1 Matrix-assisted laser desorption/ionisation (MALDI) 
MALDI ionises molecules across a wide mass range in a single polarity by laser 
ablation of a matrix-coated sample. Initially, the sample is co-crystallised with a 
matrix compound. These matrices are commonly small, aromatic, volatile acids that 
have a strong optical absorption at the wavelength of the laser.9 The most common 
matrices for low molecular weight analyses are α-cyano-4-hydroxycinnamic acid 
(CHCA) and 2,5-dihydroxybenzoic acid (DHB) for positive mode MS, 9-
aminoacridine (9AA) and DHB for negative mode MS, and sinapinic acid (SA) is 
commonly used for larger proteins (figure 1.1).9,10 Typically, matrices are applied in 
a saturated solution consisting of a mixture of water and an organic solvent, and the 
combination of matrix and matrix solvent can be optimised for the ionisation of 
specific analytes of interest.11  
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Figure 1.1. Structures of common MALDI matrices. (A) α-cyano-4-hydroxycinnamic 
acid, (B) 2,5-dihydroxybenzoic acid (C) 9-aminoacridine and (D) sinapinic acid. 
MALDI works by pulsing a laser at a distinct location on the matrix-coated sample. 
The matrix absorbs this energy, causing rapid volatilisation of the crystal with its 
associated compounds.2,12 The detailed mechanism of MALDI is still debated.13,14 
However, evidence suggests that the matrix acts as a proton donor to the analyte, 
producing [M+H]+ ions, or accepts a proton to produce [M-H]- ions; where M is the 
mass of the analyte (figure 1.2).15,16 Subsequent desolvation of the charged analyte 
occurs as gas phase ions are accelerated by an electrostatic field towards the mass 
analyser.11 
 
Figure 1.2. Schematic of MALDI. The sample is co-crystallised with a small 
photoactive matrix which absorbs energy at a wavelength similar to the laser. 
Ionisation of the matrix and analyte leads to proton transfer from the matrix to the 
analyte, producing singly charged ions. 
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A primary limitation of MALDI is the requirement of a matrix, as the presence of 
matrix peaks in the spectrum can suppress low abundance analytes.17,18 
Additionally, native tissue samples often have high concentrations of sodium and 
potassium ions, which can cluster with matrix ions and produce numerous peaks for 
each molecular species.17 
1.1.1.2 Secondary ion mass spectrometry (SIMS) 
SIMS utilises a primary ion beam to analyse the composition of solid surfaces.19 
Under ultra-high vacuum conditions, a high-energy primary beam of ions is focused 
onto a sample surface to initiate a collision cascade. The interaction of the ion beam 
with the sample provides sufficient collisional energy to overcome the surface 
binding energy and ejects ionic and neutral atoms, molecular fragments, and intact 
molecules (figure 1.3).20 More than 90% of the emitted particles are neutral, and 
only the ionised particles – known as secondary ions – are used for analysis. 
Ionisation is suggested to occur by the bond-breaking model, whereby the 
heterolytic cleavage of a bond in the target emits an ion from the surface of the 
sample.20 Alternatively, after emission, sputtered particles can release an Auger 
electron and ionise.20 The composition of the ion beam determines the polarity of 
the secondary ions produced. Primary beams of positively charged ions favour the 
production of negative secondary ions, whereas negatively charged primary beams 
enhance the generation of positively charged secondary ions. The yield of 
secondary ions is strongly influenced by the components of the sample and the 
nature of the local chemical environment of the material being analysed.19 
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Figure 1.3. Schematic of SIMS. A primary ion beam is focused onto the surface of a 
sample, initiating a collision cascade leading to the emission of secondary ions. 
More specifically, static SIMS employs a low energy primary ion beam to analyse 
the top atomic monolayer of a sample, whereas dynamic SIMS uses a much higher 
energy primary ion beam to erode the sample surface (figure 1.4). The secondary 
ions generated can be used to characterise the composition of the surface to a 
depth of 1 to 2 nm.6 
 
Figure 1.4. Schematic of (A) static SIMS and (B) dynamic SIMS. Static SIMS utilises 
a low energy primary ion beam to analyse the top atomic layer of a sample. 
Dynamic SIMS produces a depth profile of the sample through serial ablation of 
layers with the primary ion beam. 
1.1.1.3 Electrospray ionisation (ESI) 
ESI directly samples an analyte from solution and provides a sensitive tool for 
studying micro-litre sample volumes of non-volatile molecules that are not amenable 
to analysis by other conventional techniques.21 After aspiration of the solution 
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containing the analyte into a capillary, charged droplets are formed at the tip which 
is held at a high potential. The presence of an electric field causes a partial 
separation of charges in the solution in the capillary tip, and the charges are 
attracted to the oppositely charged electrode, forming a Taylor cone.22 Small 
droplets containing the charged particles break off the Taylor cone, producing a fine 
spray of charged droplets. A heated counter flow or drying gas causes the 
evaporation of the solvent in the charged droplet, increasing the density of the 
charged ions. At the Rayleigh limit of charge density, the Coulombic repulsion 
between these charges overcomes the surface tension holding the droplet together. 
Coulomb fissions occurs forming successively smaller droplets until the analyte is 
ionised, producing multiply-charged gas-phase ions (figure 1.5).21  
 
Figure 1.5. Schematic of ESI. The high potential difference between the capillary 
and the inlet causes the analyte solution to undergo charge separation to produce a 
Taylor cone. Charged droplets are ejected and reduce in size through solvent 
evaporation.  
Two ionisation models for the production of multiply charged gas-phase ions have 
been proposed (figure 1.6). The ion evaporation model (IEM) suggests that droplets 
reduce in size through evaporation.23 Once a droplet reaches a certain radius, the 
surface field strength becomes sufficient that solvated ions are expelled from the 
droplet.23 Alternatively, the charge residue model (CRM) suggests that the droplets 
undergo successive evaporation and fission, eventually producing droplets 
containing one analyte or less. Gas-phase ions are produced after the remaining 
solvent evaporates, leaving the analyte carrying the charges that were initially in the 
droplet. Evidence suggests that small molecules utilise the IEM, whereas larger ions 
such as proteins employ CRM.24,25 A third model – known as the chain ejection 
model (CEM) – has been proposed to account for protein ESI behaviour under non-
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native conditions.26 This model suggests that hydrophobic interactions and 
electrostatic factors drive unfolded or disordered proteins to the droplet surface, 
where they are ejected and the droplets carry extended protein tails. 
 
Figure 1.6. Ionisation theories for ESI. (A) Charge residue model uses even or 
uneven fissioning to produce analytes that carry the solvent charge. (B) Ion 
evaporation model expels the charged analyte as a result of evaporation and 
desorption. 
1.1.1.4 Liquid extraction surface analysis (LESA) ionisation 
Initially developed to extract small molecules from thin layer chromatography (TLC) 
plates for MS analysis,27 LESA employs liquid micro junction sampling and nanoESI 
to analyse the composition of discrete locations on a sample’s surface.8 A robotic 
pipette aspirates a single droplet (a few μL) from a solvent reservoir, and dispenses 
the droplet onto the surface of a sample. The droplet is held in contact between the 
pipette and the surface to produce a wall-less liquid micro junction. As a result, 
soluble analytes are extracted and diffuse into the solvent via passive diffusion. 
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After a few seconds, the sample droplet is re-aspirated and the analyte-solvent 
mixture is directly injected into the mass spectrometer (figure 1.7).8 Ionisation 
utilises the principles of ESI previously discussed.8
Figure 1.7. Schematic of LESA ionisation. A solvent is taken up into a robotic 
spotter. It is then placed onto the sample, whereby the analyte dissolves into the 
solvent via a wall-less liquid micro junction. The spotter is removed, and the solvent-
analyte mixture is put through an electrospray chip for inlet into the mass analyser. 
1.1.1.5 Desorption electrospray ionisation (DESI) 
DESI is a direct probe exposure method based on ESI that can be used on samples 
under ambient conditions.7 A charged solvent stream produced by an ESI source 
sprays charged droplets and solvent ions onto the sample surface. The exact 
mechanism of ionisation is not yet established, but it is suggested that the collision 
of the primary droplets with the surface forms a thin film into which the analyte is 
dissolved.28 Subsequent droplet collisions result in momentum transfer and take-off 
of secondary droplets containing the material extracted from the surface (figure 
1.8).29 Gas phase ions are believed to be produced through similar mechanisms to 
ESI, producing multiply charged species.30 Unlike MALDI, DESI does not require 
application of a matrix, making it useful for investigating samples in their native 
environment, and as a complementary platform for compounds that are not ionised 
by MALDI.31 As desorption relies on localised microextraction, DESI sensitivity is 
strongly dependent upon the optimisation of the solvent content to maximise the 
solubility of the analyte.32 
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Figure 1.8. Schematic of DESI. A fast-flowing solvent is directed at the sample 
surface, causing the ionisation of analytes in the liquid-interface. The production of 
gas phase ions utilises the same mechanism as ESI. The ions produced are 
subsequently taken into the MS inlet for separation. 
1.1.2 Separation and detection 
Separation of ions can be done using any of the common mass analysers based on 
the desired spectral quality and resolution; including time-of-flight (ToF), Orbitrap, or 
Fourier-transform ion cyclotron resonance (FT-ICR).16 Mass analysers are chosen 
based on the reproducibility of data, efficiency of ion separation, and their mass 
accuracy and range.2 Separation by ToF and FT-ICR will be discussed in this 
section. 
1.1.2.1 Time-of-flight (ToF) 
ToF mass analysers separate ions based on the time taken for different species to 
travel to a detector through a drift zone, or field free region.33 Ions are expelled from 
the source in pulses and accelerated towards the flight tube by a difference of 
potential applied between an electrode and the extraction grid, giving the ions equal 
kinetic energies. The ions then enter into a field-free drift region where they are 
separated according to their velocities before reaching the detector at the opposite 
end of the flight tube (figure 1.9).  
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Figure 1.9. A schematic linear ToF mass analyser. Ions are given equal kinetic 
energy in the acceleration region, before being separated by their m/z in the drift 
zone. The ion with a smaller m/z (pink) arrives at the detector before the ion with a 
higher m/z (blue) because of its greater velocity. 
The m/z of analytes are determined by measuring the time that ions take to move 
through the field-free region between the source and the detector. Before it enters 
this region, an ion with mass (!) and total charge (" = $%) is accelerated by 




= "&' = $%&' 
Equation 1.1 
The velocity of the ion leaving the source is given by rearranging equation 1.1 into 




After the initial acceleration, the ion travels in a straight line at a constant velocity 
towards the detector. The time (2) needed to cover the distance (3) before reaching 






Replacing * with its value in equation 1.2 gives 
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Showing that m/z can be calculated from a measurement of 2+ and that the lower 
the mass of the ion, the faster it will reach the detector. 
The major limitation of the linear ToF is its poor mass resolution. Factors such as 
the length of the ion formation pulse and the variation of initial kinetic energy 
produce a distribution of flight times for ions with the same m/z ratio.11 The 
heterogeneous initial energies of the ions prior to acceleration results in ions with 
the same m/z travelling through the field-free drift region at different velocities and 
arriving at the detector at different times. Reflectrons can be added into the drift 
regions of ToF instruments to improve the mass resolution (figure 1.10). The 
reflectron increases the length of the drift region and reverses the direction of ion 
velocities, correcting for variations in the kinetic energies. Ions with greater initial 
kinetic energy penetrate further into the reflectron and therefore take longer to be 
reflected.11 
Figure 1.10. Schematic of a reflectron ToF mass analyser. Ions with a greater initial 
kinetic energy (2) penetrate further into the reflectron, whilst ions with less kinetic 
energy (1) are reflected faster. This improves the mass resolution obtained. 
ToF-MS systems provide high sensitivity and relative fast acquisition of MS data. 
Modern ToF instruments typically have a mass resolving power of up to ~50,000 
and mass accuracies of 1–5 ppm after external calibration.34  
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1.1.2.2 Fourier-transform ion cyclotron resonance (FT-ICR) 
FT-ICR determines the m/z of ions based on the ICR frequency within a fixed 
magnetic field under ultra-high vacuum, producing a higher mass resolution and 
accuracy than any other available mass spectrometer.35,36 A set of trapping plates 
hold the ions inside the analyser cell which is composed of two sets of opposed 
electrodes: the excitation plates and the detection plates (figure 1.11).35 
 
Figure 1.11. Schematic of a FT-ICR mass analyser. Two sets of opposed plates 
form the excitation and detection functions of the cell. Ions enter through an inlet, 
where they are kept in place by front and back trapping plates. 6 shows the 
direction of the magnetic field 
An ion moving in the presence of a spatially uniform magnetic field (6) is subject to 
a force, known as the Lorentz force (equation 1.5).  
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Where mass, velocity and charge are given by !, * and " respectively. If the ion is 
moving in the presence of a directional magnetic field (6), the Lorentz force acts at 
an angle perpendicular to the plane determined by * and	6. Therefore, at a constant 
speed in the absence of collisions, the magnetic field bends the ions path into a 
radius of a circle (9) (figure 1.12). 
 
Figure 1.12. Schematic showing that with a velocity of D, and the acting Lorentz 
force at an angle perpendicular to that of the magnetic field	6, an ion moves in a 
curve. 
By considering the following, that the velocity in the EF	plane (perpendicular to 6)  
*GH = I*G+ + *H+ 
Equation 1.6 
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Making equation 1.8 
789:% = !L+9 = "6KL9 
Equation 1.10 






Showing that all ions of a given m/q have the same ICR frequency independent of 
their velocity. Therefore, by holding the magnetic field (6K) constant, the m/z of the 
ions can be determined by calculating the cyclotron frequency.  
In the absence of a radio frequency (RF), the ions are localised to the centre of the 
cell and their cyclotron orbit is small. The ions are excited by applying a uniform 
electric field oscillating at or near the cyclotron frequency corresponding to a 
particular m/z, accelerating these ions to a larger and detectable radius. A rapid 
frequency sweep is applied across the excitation plates to simultaneously excite all 
the ions within the cell to a higher orbital radius. Ions with similar m/z values move 
into groups of the same radius.16 As these ions approach a detection plate, they 
attract or repel electrons and induce an alternating current as they pass each of the 
detection plates. The ICR signal produced is measured using the voltage difference 
between the two plates as a function of time, and the Fourier-transform of this 
difference produces a frequency spectrum that can be converted to a mass 
spectrum (figure 1.13). 
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Figure 1.13. A schematic of an FT-ICR cell. An electric field is applied across the 
voltage plates (navy), exciting ions into a greater cyclotron resonance. As ions 
approach the detection plates (green), they induce an alternating current and an 
oscillating spectrum of charge as a function of time. By calculating the Fourier-
transform of this difference, a frequency spectrum and subsequent mass spectrum 
can be produced. 
The high mass measurement accuracy obtained with FT-ICR MS is a result of 
inherently accurate frequency measurements. The cyclotron frequency of an ion is 
independent of its kinetic energy. Therefore, unlike ToF analysers, resolution is not 
limited by the spread in the kinetic energy distribution of the ions. This insensitivity 
of cyclotron frequency to kinetic energy is one of the principle reasons why FT-ICR 
MS is able to achieve ultra-high resolution. Increasing the magnetic field increases 
the resolving power by increasing the cyclotron frequency of an ion, thus enabling 
more measurements to be taken within a given timeframe. The difference between 
two cyclotron frequencies is also increased, corresponding to greater resolving 
power.36  
1.1.2.3 Quadrupoles 
MS approaches can be either ‘target mode’ when the m/z of interest is known, or 
‘discovery mode’ when no previous knowledge of the sample is required.15 This is 
especially useful when using MS as a global approach to understand the 
metabolism of a drug in development. This is because an untargeted analysis aims 
to maximise the range of masses investigated; however this can compromise the 
sensitivity and specificity for any particular analyte.37 For targeted analysis where 
High Spectral Resolution Mass Spectrometry Imaging of Three-Dimensional Cell Culture 
 
Chapter 1. Introduction   16 
the m/z of the ion of interest is known, a narrow mass region can be isolated using 
quadrupoles to provide an improved signal-to-noise ratio (S/N) and mass resolution. 
A quadrupole consists of four parallel circular rods which act as two opposing pairs 
of electrodes with a voltage of both a direct and alternating current applied (figure 
1.14).35 Ions are attracted towards the oppositely charged electrodes, but as the 
electrodes switch potential, this results in the ions constantly moving. As ions travel 
through the quadrupole, ions of a certain m/z will have a stable trajectory to facilitate 
transmission through the quadrupole for any given voltages. Ions that don’t possess 
the specific voltages will have unstable trajectories and will collide with the rods, 
thus isolating ions with specific m/z values to be selected from complex mixtures of 
ions.35 
 
Figure 1.14. Schematic of quadrupole set-up in the z plane. (A) Two opposed pair of 
electrodes possess an alternating and direct current. (B) Ions are attracted to the 
oppositely charged electrode, but as the potential switches in these electrodes the 
ions continually move in the xy plane. 
1.2 Mass spectrometry imaging (MSI) 
The primary limitation of conventional MS is its inability to identify heterogeneity 
within a sample.38 This is especially important for elucidating the time-dependent 
spatial distribution of a drug and its metabolites within tissue samples.39 MSI 
combines the principles of MS with spatial information, permitting broad spectral and 
label-free analysis to observe the distribution of compounds without any significant 
prior knowledge.15,40,41 MSI employs the process of ionisation, separation and 
detection at a discrete location on a sample – referred to as a ‘pixel’ – to produce a 
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mass spectrum. This process is repeated across the sample. The spectra within the 
pixels are compiled to produce a profile spectrum from which the distributions of 
each m/z value can be observed using ion density maps (figure 1.15).42 The 
spectrum from each pixel can also be exported from the ion density maps and 
individually analysed. 
 
Figure 1.15. Schematic of MSI. (A) In conventional MS, ionisation, separation and 
detection at an individual ’pixel’ on the sample produces a mass spectrum. (B) In 
MSI, this process is repeated at regular intervals across the sample to produce a 
profile spectrum, from which the distributions of various m/z values can be displayed 
using an ion density map. 
The first publication of applying MS to understand the spatial arrangement of 
elements on the surfaces of biological samples employed SIMS.43 SIMS is 
especially useful for MSI, as dynamic SIMS is capable of producing a three-
dimensional (3D) map of the sample at high spatial resolution.44 Alternative 
ionisation processes have also been applied to MSI, including DESI,45 LESA,46,47 
and MALDI.48 Each of the ionisation methods has unique advantages and limitations 
which are summarised in table 1.1. 
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Whilst the spatial resolution of SIMS is the highest of all MSI techniques, the small 
primary beam diameter used at high resolution reduces the amount of material 
produced during ionisation, thus compromising its sensitivity.49 Conversely, LESA is 
limited by its spatial resolution, as the diameter of the liquid micro junction 
determines the minimum pixel size, but its solvent-based extraction is useful for 
molecules with poor volatility.50 Similarly, the solvent jet in DESI also limits its spatial 
resolution.51 The primary advantage of DESI is its ambient ionisation conditions and 
minimal sample preparation, making it useful for application in clinical settings.52 The 
requirement of a matrix in MALDI involves additional sample preparation, the 
application of which can cause delocalisation of soluble analytes, thus 
compromising the biological validity of the information obtained.40 However, the 
addition of a matrix increases the number of analytes ionised, and alternative 
solvent-free matrix application methods have been developed to reduce this 
phenomenon.53,54 Combining these MSI approaches can produce complementary 
spatial information for molecules covering a range of masses from m/z 20 to 
50,000.6 MALDI-MSI was utilised in the work presented here, so the next section will 
focus on the development of this technique. 
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1.2.1 MALDI-MSI 
MALDI-MSI was first developed in 1997 to observe the distribution of peptides and 
small proteins across tissue samples.55 Serial ablation of sectioned pancreatic and 
pituitary samples followed by ToF separation produced an ordered array of 
complete mass spectra contained in discrete ‘pixels.’ Individual m/z values in each 
spectrum were assembled to produce images showing the distribution of the 
proteins observed. By blotting the tissue onto a C-18 resin surface, interfering peaks 
and salts were removed and over 50 peptides and proteins could be tentatively 
identified, with on-tissue proteolysis supporting the identifications. However, the 
acquisition of these images required over one minute per pixel, resulting in a total 
analysis time of over 15 hours for an image comprising 302 pixels. In 1999, Stoeckli 
developed a new software (Mass Spectrometry Image Tool) enabling the automated 
acquisition of spectra and presentation of the distributions obtained, reducing the 
data acquisition to one second per pixel.56 As a result of improvements in 
instrumentation and throughput, MALDI-MSI offers a promising tool to obtain global 
information on the spatial proteomic composition of samples without the requirement 
of labels and prior information.57 Initial biological applications of this technique 
focused on the identification of tumour-specific protein markers for cancers including 
brain,58,59 colon,60 and prostate,61 as well as markers for neurodegenerative 
diseases.62,63 Through consecutive imaging of serial sections, it became possible to 
map the distributions of these proteins across a reconstructed 3D sample.64 
Despite its principal use in protein analysis, MALDI has the propensity for some low 
molecular mass molecules to ionise through the formation of radicals, ions, or by 
proton transfer.6 This enabled the simultaneous spatial analysis of a wider range of 
masses; from drugs and metabolites, to small proteins. MALDI with a quadrupole 
ion trap mass spectrometer was used in 1999 to detect pharmaceutical compounds 
within intact tissue.65 Spectra were recorded at various locations of the tumour to 
analyse the drug’s distribution, and MS fragmentation (MS/MS) was used to confirm 
the identity of the drug at trace levels in human ovarian tumours.17 Simultaneously 
mapping the distributions of a drug and its metabolites using MALDI-MSI was first 
employed in 2001, whereby clozapine – an antipsychotic drug – was shown to 
localise to the cerebral cortex and striatum, but was absent in the corpus callosum.6 
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Later work observed a bronchodilator drug in rat lungs and used serial dilutions to 
produce a calibration curve for quantification.66 
MALDI-MSI has been employed to map the distributions of drugs and proteins in a 
range of samples sizes, from cells67 and tissues,68 to whole organisms.48 As a result 
of its ability to produce global, label-free spatial information, MALDI-MSI provides a 
promising tool for elucidating the efficacy of a drug’s absorption, distribution, 
metabolism and excretion (ADME), and plays an important role in drug discovery.39  
As well as its application in drug discovery, MALDI-MSI of small molecules has been 
applied to quantify neurotransmitters in brain sections,69 detect drugs within hair 
samples,70 identify biocontrol agents for plants diseases,71 and classify markers for 
patient survival prognosis.72 Its application to solve biological problems has 
significantly increased since its initial development, and MSI is regularly combined 
with other analytical techniques including histology markers,73 magnetic resonance 
imaging,74 and Raman spectroscopy75 to produce complementary informative data 
on biological samples (figure 1.16).  
 
Figure 1.16. Web of Science search for articles containing the subject MALDI mass 
spectrometry imaging between 1997 and 2018. Data correct as of December 2018. 
Since the first application of MALDI-MSI in 1997, delocalisation of molecules has 
been a major limitation of the technique.55 Early MALDI imaging data produced an 
imaging resolution down to 50 µm, but recent publications have achieved a spatial 
resolution of 1.4 µm, making the reduction of delocalisation more important than 
ever.42,76 The majority of delocalisation is caused by inconsistent and sub-optimal 
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preparation needs to be carefully considered and optimised to produce high 
resolution and meaningful data.40 For this reason, reproducible sample preparation 
has been a focus in the development of the MALDI-MSI field.9,40 Publications have 
focused on the optimisation of sectioning conditions,77 automation of matrix 
application,78–80 and sample storage conditions.81 The next section will cover the 
methods utilised to prepare a tissue sample for MALDI-MSI.  
1.2.1.1 Sample Preparation 
Tissue sample preparation can be categorised into four stages: sample collection, 
processing, post-sectioning, and ionisation treatment (figure 1.17).40 In order to 
produce biologically relevant results, it is imperative that the spatial distribution and 
abundance of molecules in biological samples remains as close to a native state as 
possible throughout each stage of sample preparation.9 The failure to optimise each 
stage produces an amplified effect on the sensitivity, reproducibility, accuracy, and 
overall quality of the results obtained, thus producing a non-representative 
distribution or abundance of the molecules in the tissue.40 
 
Figure 1.17. Schematic of MALDI-MSI preparation workflow for tissues. (A) The 
tissue or sample of interest is (B) sectioned using a cryostat and (C) thaw-mounted 
onto a conductive slide. (D) This slide is coated in matrix and (E) teach points are 
added for calibration of the area to be imaged. 
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1.2.1.1.1 Sample collection 
As soon as a tissue sample is removed from the in vivo environment, a cascade of 
biological processes commences that will alter the abundance of important 
molecules within the cells.40 Therefore, efficient and consistent collection protocols 
are important to prevent the rapid delocalisation and degradation of target 
compounds. Histological samples can be preserved using formalin fixation and 
paraffin embedding (FFPE), but the covalent cross-linking and degradation of some 
lipids limits the use of these samples for MSI.78 Furthermore, the sample preparation 
for FFPE can cause delocalisation of some small molecules.40 Alternatively, 
immediately freezing the sample in liquid nitrogen and storing it at -80 °C preserves 
the integrity of the tissue’s structure and protects the biological compounds from 
degradation. However, once the temperature increases, the degradation and 
proteolytic activity will resume.9,40 Storage of a mouse brain at sub-zero 
temperatures for seven months exhibited no significant lipid degradation, though 
there was no analysis carried out for proteins or other small molecules.81 Moreover, 
it has been shown that upon returning sectioned tissue to room temperature, the 
abundance of low molecular weight compounds changes in a tissue-specific manner 
in as little as 30 seconds.82 
Small and fragile samples are often embedded in compounds including binding 
agar,55 carboxymethylcellulose (CMC),83 ice,48 gelatin,84 and optimal cutting 
temperature (OCT).85 However the latter can contaminate the sample because it 
readily ionises and causes ion suppression of less abundant species.  
1.2.1.1.2 Sample processing 
Once the sample is prepared, it undergoes sectioning to expose the contents of the 
cells.40 Initial work used a manual microtome blade,55 but modern cryostats ensure 
accurate sectioning with minimal contamination by keeping the sample frozen during 
this stage of the process.9 Thicker sections are easier to manipulate, but take longer 
to dry and may not be electrically conductive once in the spectrometer.9 Thinner 
sections increase the number of signals detected, but are difficult to manipulate and 
can tear easily.77 Whilst molecules are detected as deep as 40 µm, sections are 
typically between 10 to 20 µm as a compromise between tissue fragility and ion 
abundance, as well as being approximately the diameter of a mammalian cell.9,86  
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Once a section is taken, it is mounted onto a flat, conductive surface. Early 
conduction plates used metal55 or adhesive tape,6 but the majority of work now 
employs conductive indium-tin oxide (ITO) coated slides.64 Samples are most 
commonly transferred through thaw-mounting, whereby the slide is cooled prior to 
the sample being added, and once the sample is on the slide, the two are both 
heated simultaneously.9 Thaw-mounting prevents the loss of water-soluble proteins, 
as any ice crystals produced are transferred onto the plate alongside the section, 
but differing levels of heating can cause inter-sample variation.9,87  
To ensure all water is removed from the slides before matrix coating and to reduce 
delocalisation, the samples are often dried using a stream of nitrogen gas.88 Some 
samples are washed with an organic solvent to remove the salts responsible for ion 
suppression, but this process affects the analyte composition and is avoided if small 
molecules such as drugs or metabolites are the target of interest.40 Mounted 
samples are stored at -80 °C before being placed in a desiccator prior to matrix 
application, although this freeze-thaw cycle can result in increased analyte 
diffusion.89 To reduce inter-sample variability, comparable sections are mounted on 
the same slide to enable normalisation and identical processing.40  
To improve the sensitivity of detecting low abundance proteins, early studies 
employed sample blotting. This involves blotting the tissue sample onto specially 
prepared targets containing an adsorbent material.55 This method maximises 
sensitivity by removing interfering lipids and salt peaks while maintaining the spatial 
arrangements of molecules in the sample.55 
1.2.1.1.3 Post-sectioning processing 
MALDI-MSI requires the addition of a matrix for ionisation. The principal aim of the 
matrix is to co-crystallise with molecules in the tissue sample and extract the 
analytes for ionisation.2 Subtle changes in matrix application rate, drying times, 
matrix composition and thickness all affect the ionisation efficiency, the propensity to 
detect low abundance compounds, and the reproducibility of the results obtained.40 
The Einstein-Smoluchowski relation (equation 1.12) shows the effect of matrix 
application on the diffusion of molecules in the absence of convection.86 If a matrix 
takes longer to dry, it has the benefit of extracting more molecules from deeper 
within the tissue slice, but has the disadvantage of lateral diffusion.86 
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τ = d+/2D 
Equation 1.12 
Where d is the average distance travelled by a molecule in interval τ, and D is the 
diffusion coefficient for a given molecule; a value that is increased by the solvent 
content of the matrix solution.86 
Analyte diffusion is the major concern during matrix application, as the spatial 
resolution in MALDI-MSI is limited to the size of the matrix crystals.90 Therefore, the 
selection of the most appropriate matrix and optimisation of its application 
parameters is required to obtain high quality and biologically relevant spectra 
directly from tissue samples.9,40 Whilst insufficient matrix application can lead to 
unstable ion signals, excessive wetting augments analyte migration, altering the true 
biological distribution of compounds within the tissue.65 
Matrix can be applied discretely as spots or continuously as a coating, either 
manually or using an automated system.9 Early MALDI-MSI matrix application 
utilised airbrushes,6 droplet spotting,65 or even immersion,55 however, these manual 
methods produced results that were inconsistent between researchers. Now, fully 
automated matrix application is routine and has improved inter user reproducibility.90 
Key tuning parameters are wetting, droplet size, incubation time and drying time, 
which together determine both the sensitivity and spatial resolution of the image 
obtained. 
Depositing discrete spots of matrix is reproducible with minimal delocalisation, but 
the image resolution is limited to the size and spacing of the spots.78,91 The matrix-
solvent mixture diffuses below the tissue surface to produce signals that are more 
intense than those observed using continuous coatings.86,92 Notwithstanding, due to 
the heterogeneity of any given tissue, adjacent spots produce varying levels of 
ionisation propensity, producing hotspots for detectable molecules.78 Droplet 
deposition can be done using a capillary that makes contact with the sample, 
however there is a greater chance of cross-contamination compared to non-contact 
methods, as well as less control over the size and placement of each droplet.78 
Typically the volume deposited using this method is between 200–300 nL, whilst 
automated methods deposit significantly smaller volumes, improving the potential 
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resolution of the image produced.86 Alternatively, increasing the solvent percentage 
decreases the droplet volume, dispensing a drier matrix with less spreading.78 
Samples can be washed with ethanol to improve the distinction between spots, but 
this washes off low molecular weight compounds and so cannot be used for 
analytes in a low mass range.91  
Continuous application can be done in a number of ways, but can be prone to 
analyte delocalisation if the application is too wet.40 The sample is held 20 to 30 cm 
from the nozzle of the sprayer and coated using repetitive cycles of matrix 
application. In each cycle, small volumes of matrix solution are deposited to produce 
a dense matrix coat whilst minimising the time the sample remains wet.9 The most 
common manual spray techniques use an airbrush or electrospray to deposit the 
matrix solution directly onto the tissue.78 Manual matrix application permits a user-
defined velocity and homogeneity, but is often not reproducible.93,94 Inadequate 
coverage of the tissue sample can result in unstable analyte ion signals, whereas an 
excessively wet application can lead to soluble analyte migration and large crystal 
formation.95 Furthermore, if the temperature or the solvent concentration is too high 
during matrix application, the crystals will form in transit to the slide, minimising the 
incorporation of molecules into the crystals and thus reducing the ionisation 
efficiency.9 
Automated sprayers remove the variability between users and significantly increase 
the number of metabolites detected by robotically controlling the temperature, flow 
rate, velocity of the spraying nozzle and the number of passes.95 A number of 
automated systems are available, including the Bruker ImagePrep, the Shimadzu 
CHIP-1000, and the HTX-TM-Sprayer.95 In order to increase access to automated 
matrix applications, a number of alternative cheaper methods have been developed, 
such as a converted inkjet printer.79  
A combination of the two applications, known as the spray-droplet method, 
improved both the crystal density and homogeneity, resulting in an improved 
sensitivity and S/N compared to the droplet method alone.92 The application of this 
method on tissue samples produced a 9.4 fold improved S/N with approximately 90 
uniquely identified peaks that were not observed in the droplet method. However, 
the slide became wet during matrix deposition and required a five-minute interval 
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between each coat, which would have caused delocalisation in an imaging run with 
a spatial resolution below 100 µm. A large disadvantage to both the spray and spot 
deposition methods is the potential of blocking the capillary or nozzle as a result of 
solvent volatility combined with a saturated matrix concentration.78  
An alternative ‘dry’ application using a 20 µm sieve to finely distribute matrix over 
the tissue controls both the crystal size and reduces the variability between different 
operators.53 The application of this method to detect drugs in a mouse brain 
produced fewer signals above m/z 1000 than traditional ‘wet’ methods, but also 
uniquely identified marker ions that were not identified using the spray application.88 
By simplifying the sample preparation and avoiding the use of an organic solvent, 
there are fewer conditions to optimise.53 
Alternatively, sublimation deposition uses a simple set up, and has been shown to 
produce high spatial resolution down to 10 µm, an improved lipid intensity, and a 
reduced laser spot-to-spot variation.96,97 During sublimation, it is common to place 
the slide into a humidity chamber for 45 minutes to increase the number of signals 
observed at higher m/z values, however this can result in analyte diffusion of smaller 
molecules.94  
MALDI’s primary limitations are that the signal efficiency varies heavily in a tissue-
dependent manner, abundant species can suppress other signals, and overlapping 
peaks can lead to ambiguous molecular identification.17,18 Furthermore, tissue 
sections often have high concentrations of sodium and potassium ions, which can 
cluster with matrix ions, producing numerous peaks for each molecular species.17  
1.2.1.2 Spatial resolution  
The spatial resolution of the MSI image refers to the distance between the centre of 
adjacent spots.18 The resolution of the image is a function of both the size of the 
crystals produced during matrix application and laser diameter.9,40 Once the crystal 
size becomes smaller than the diameter of the laser, the laser beam becomes the 
limiting factor in imaging resolution.9 The laser diameter is selected during 
experimental set-up by varying the laser spot size and step increment. Improving 
the spatial resolution enables more discrete localisation patterns to be observed 
throughout a tissue. However, since improving spatial resolution decreases the area 
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of tissue ionised, there is a trade-off between spatial resolution and sensitivity. 
Furthermore, with increasing resolution, data processing becomes more difficult as 
a result of the exponentially larger file sizes.49  
Several strategies have been developed to increase the spatial resolution 
achievable using MALDI-MSI. Laser ablation of a sample produces a Gaussian 
distribution pattern, with incomplete ionisation around the outside of the pixel. 
Oversampling uses a raster increment smaller than the diameter of the laser beam 
coupled with complete matrix ablation to produce an image with a resolution smaller 
than the diameter of the laser (figure 1.18).98 Alternatively, adjusting the geometry of 
the ionisation source can further reduce the laser size applied. For example, 
Spengler and co-workers reported a lateral spatial resolution of 1.4 μm on an 
atmospheric pressure MALDI, allowing for the visualisation of subcellular 
distributions of lipids, metabolites, and peptides.76 Meanwhile, on a vacuum 
pressure MALDI, a spatial resolution of 5 μm has been reported.99 
 
Figure 1.18. (A) Under-sampling leaves gaps between adjacent laser spots whereas 
(B) over-sampling produces overlapping spots that are smaller than the diameter of 
the laser to increase the resolution with a larger laser size. 
1.2.1.3 Data analysis  
Ongoing instrumental developments and improved spatial resolution are causing an 
exponential growth in data file sizes.49 To address this challenge and ensure that 
analyses remain possible without the loss of valuable information, important 
advancements in software have been developed.  
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The most important information obtained from an imaging experiment is the 
visualisation of the distribution of analytes throughout the tissue. Early imaging 
experiments required over one minute per pixel,55 however the development of 
automated software continues to effectively reduce the acquisition and processing 
time.56 Each pixel of an imaging experiment contains an entire mass spectrum, so 
special software is required to handle the multi-dimensional information held within 
the datasets. FlexImaging and SCiLS are commercially available platforms, whereas 
the development of open access platforms such as MSiReader100 and 
SpectralAnalysis101 have widened the accessibility of MSI. 
Data sizes can be reduced to simplify handling and distribution. Several 
compression strategies including binning mass spectra and compression based on 
region of interest (ROI) have been implemented to reduce the size of data while still 
retaining the important information.49 Further processing of the data can be utilised 
to reduce experimental variance, extract relevant information, and improve the 
accuracy of subsequent statistical analysis.49 
Manual analysis involves selecting an m/z value unique to the ROI and generating 
an image of its distribution. However, a number of software programmes are 
capable of further analysis, including colocalisation analyses, spatial segmentation, 
and classification model calculations.101 Statistical analyses can be applied to 
determine differences that exist between regions within a sample or between two 
samples. One example of this is principal component analysis (PCA), which reduces 
the dimensionality of the data set by plotting the two components that cause the 
greatest variation on the x and y-axis to induce groupings of related pixels in the 
data sets.102 It can also be used to remove noise and any signals which are poorly 
connected with variability between groups.101 Alternatively, partial least-squares 
(PLS) regression is similar to PCA, but classes of data are annotated with known 
labels. 
Data storage and sharing of the final results across laboratories is important for the 
standardisation of MSI as a technique. Imaging depositories such as 
METASPACE103 are being developed to enable inter-laboratory comparison of 
results. 
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1.2.1.4 Quantification  
The signal intensity of an ion irradiated from any point is assumed to be proportional 
to the concentration of the target analyte.6,104 However, this view is over simplistic, 
as heterogeneity across a tissue influences the ionisation efficiency of the 
analytes.83,105 The comparison of relative ion intensities using the 2D ion density 
maps can be utilised as a semi-quantitative tool. However, this provides a relative 
intensity and not an absolute quantification, thus MSI is currently considered a 
qualitative technique.106 Notwithstanding, the correct procedure, processing, and 
software enables quantitative information to be extracted, although the degree of 
accuracy remains under close scrutiny.  
Normalisation can be used to rationalise the signal intensity and enable some sort of 
quantification of the compound of interest.105 Total ion count (TIC) normalisation is 
commonly applied to convert the spectra into the same intensity ranges and to 
compare the intensities of different ions. This process is based on the assumption 
that there is a comparable number of signals in each spectrum, and ensures that all 
spectra have the same integrated area.107 Alternatively, normalisation can be 
completed using: endogenous molecules that are consistently expressed throughout 
the whole tissue, an external standard applied during matrix application, or reporter 
ions.108 In the latter case, when the standard is ionised by the laser, it fragments into 
distinct reporter ions; the ratios of which are compared to other molecules to 
calculate their relative abundance.109 
Whilst relative quantification is useful, calculating the true concentration of a 
molecule is highly desirable for drug distribution studies. However, as a result of 
sample heterogeneity and ion suppression, using an external spotted calibration 
curve adjacent to the sample yields inaccurate concentrations. Alternatively, an on-
tissue calibration curve can be used to calculate the tissue-specific ionisation 
efficiency, and each signal intensity can be scaled to compensate for suppression 
(figure 1.19).66,83,105 Other work has utilised a labelled form of the compound of 
interest; either using a compound with similar ionisation properties,91 or a deuterated 
standard combined with matrix.54  
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Figure 1.19. Representative diagram showing how a serial dilution of a drug or 
standard can be placed onto the tissue of interest to create a calibration curve. 
Using this curve, the intensity of the compound can be compared and quantified. 
1.3 Three-dimensional cell culture 
Currently, more than half of all drugs fail in Phase II and Phase III clinical trials.110 
One of the most promising areas expected to improve the success rates in drug 
development is the availability of new preclinical models that better recapitulate in 
vivo biology and microenvironmental factors. Conventionally, initial drug 
development is tested on cells grown in two-dimensional (2D) culture under carefully 
controlled conditions with supplemented medium to aid growth.111 Whilst these 
homogeneous conditions provide effective experimental consistency, in vivo tissue 
microenvironments are not typically composed of a homogenous cell population, but 
are complex structures with intricate relationships.112,113 3D cell culture combines the 
simplicity of cell culture systems with the interplay of factors resembling the 
multifaceted physiology of tissues in vivo.84,114 Unlike conventional culture formats, 
3D cell culture is capable of mimicking the various cell-cell and cell-matrix 
interactions that make up the complex architecture in vivo.112,115  
A number of cancer cell lines form microscale spherical cell clusters, known as 
multicellular tumour spheroids (MTS), which self-assemble spontaneously in the 
absence of attachment to another surface.113,116 The layered structure of MTS 
commonly exhibits an increased resistance to radiotherapy and drug treatments, 
making them an effective ex vivo model of cancer, and useful in the development of 
potential treatments.117 
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1.3.1 Spheroid formation 
A number of methods are available for MTS generation, including using either 
spinner flasks or rotary vessels to prevent the cells settling. Spheroids produced 
using these methods vary in size and rely on specialist equipment.115 An alternative, 
more labour intensive method relies on gravity to induce the formation of uniformly 
sized aggregates from a suspension of cells, known as the hanging drop method.115 
Developed by Kelm et al, this method involves the placement of an aliquot of cell 
suspension onto the lid of a petri dish. The lid is subsequently inverted, and the 
droplet is held in place by surface tension.118 By varying the number of cells seeded 
into the droplet, the size of the spheroid produced can be varied up to a diameter of 
approximately 1 mm.111 Cells accumulate at the liquid-air interface and proliferate to 
produce highly organised, tissue-like spheroids with their own extracellular matrix 
(ECM) (figure 1.20).119 However, the volume of the drop is the limiting factor with 
this method, as above 50 µL the surface tension no longer holds the drop in 
place.118  
 
Figure 1.20. Formation of spheroids using the hanging drop method. The lack of 
interactions between the cells and a surface causes the cells attach to one another 
and produce a spheroid.  
The formation of spheroids is a three-staged process (figure 1.21). Initially, cell-
surface integrins and long-chain ECM fibres with multiple arginine-glycine-aspartate 
(RGD)-containing binding sites organise cells into loose aggregates with high 
permeability.120 Subsequently, there is a delay phase during which cadherin 
expression is upregulated to increase the intercellular interactions, after which 
homophilic cadherin-cadherin interactions augment cell cohesion between two 
adjacent cells.121 In some cell lines, the outer compacted cells then differentiate into 
smooth tightly packed, polarised cells.120 Whilst the process remains relatively 
conserved across spheroids, the ECM fibres and cadherins vary between cell 
types.120 
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Figure 1.21. Formation of spheroids. (A) Integrins bind to ECM via RGD binding 
motifs producing (B) loose aggregates with high permeability. After a delay period, 
upregulated cadherin expression leads to (C) homophilic cadherin binding and 
subsequent compaction. This produces (D) differentiated and polarised outer cells.  
Each cell line reacts differently when cultured using the same method, and not all 
cell lines are capable of producing spheroids.111 Furthermore, the MTS currently 
available omit the vascularisation aspect of tumour development, which is a hugely 
significant part of tumorigenesis.111 Co-culturing multiple cell-types and incorporating 
cultivation methods that enable the angiogenesis process could more accurately 
mimic tumours and provide a better representation of the in vivo environment.115 
1.3.2 MTS structure 
Due to the rapid proliferative properties and poor vasculature observed in tumours, 
cells furthest from the blood supply experience gradients of oxygen, nutrients, and 
waste.122 Similarly, with a radius greater than ca. 200 µm, MTS display these same 
diffusional limits. Above this threshold, the centre of the spheroid experiences 
hypoxic conditions and forms a concentric three-layered structure (figure 1.22).84,115 
At the centre is a necrotic core, surrounded by a layer of quiescent cells, and at the 
spheroid periphery is a rim of proliferating cells.84,116 The thickness of each layer is 
dependent on the cell type and the growth conditions. For example, increasing the 
concentration of oxygen and glucose increases the thickness of the outer 
proliferating layer.123,124 It has also been suggested that the central hypoxic cells can 
adapt their metabolism to the environment and maintain intracellular homeostasis 
until shortly before cell death. With an increasing size, Freyer and co-workers found 
that the levels of high-energy phosphates and intracellular pH remained constant, 
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suggesting that the quiescent cells adapt their metabolism under the environmental 
conditions until the point of cell death.125 
 
Figure 1.22. Spheroids experience a three-layered structure. At the centre is a 
necrotic core, surrounded by a layer of quiescent cells. At the periphery, the cells 
have access to oxygen and nutrients, so can rapidly divide.  
The primary limitation of MTS is their upper size limit of 1 mm, limiting the range of 
tumour sizes that can be investigated. Tumour explants have been developed that 
bypass the current size limitations of some small-growing spheroids, and are useful 
for cancer cell lines which do not form spheroids.126 Additionally, the development of 
organoids has the potential to provide a more accurate model than current 
spheroids. Organoids are self-organising, self-renewing 3D cell cultures derived 
from primary tissue, embryonic stem cells, or induced pluripotent stem cells.127 
Organoid cultures have a similar functionality to the tissue from which the cells 
originate, and have been described for normal and disease models of the digestive 
tract, prostate, lung, kidney, and brain.127,128 
1.4 MSI of MTS 
Early investigations of the structure of MTS employed serial trypsinisation and 
subsequent LC-MS/MS for identification of each spheroid layer.129 More recently, 
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imaging techniques such as confocal Raman microscopy (CRM)75 and MSI84 have 
been utilised. MSI was first applied to MTS in 2011 to examine the distribution of 
biological molecules in human carcinoma (HCT-116) spheroids.84 There are now a 
total of 20 papers published including the subject ‘MALDI mass spectrometry 
imaging’ and ‘spheroids;’ with the number of publications steadily increasing over 
the last four years (figure 1.23).  
 
Figure 1.23. Web of science search of subjects containing MALDI mass 
spectrometry imaging and spheroids over the past 10 years. A total of 20 
publications have been produced. Data correct as of January 2019.  
In 2011, Li and co-workers developed a method for MALDI-MSI of MTS to observe 
how the cellular proteome responded to the formation of these molecular 
gradients.84 They observed the distribution of a limited number of intact proteins 
which localised to the central necrotic region. To complement this MSI study, nano 
liquid chromatography (LC) MS/MS was used to identify cytochrome C and histone 
H4, both of which distributed uniformly across the spheroid.84 Later work applied 
multivariate statistical analyses including PCA, k means clustering and linear 
discriminant analysis (LDA) to visualise the differences in protein expression levels 
across HCT-116 MTS.130 They were able to identify a number of m/z values that 
uniquely localised to the central hypoxic and proliferative outer regions, however the 
values were not identified.  
As well as elucidating how the proteome is affected by gradients of oxygen and 
waste, MSI has been used to characterise the endogenous lipids in HCT-116 
spheroids, and compare these distributions to both monolayer culture and tumour 
tissue.131 Using MALDI-ToF in both positive and negative mode, Hiraide and co-
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workers identified an arachidonic-containing phosphatidylinositol that localised to 
the periphery of the spheroids and at the stromal interface of the tumour. However, 
the lipid species was absent in the monolayer culture, suggesting that 3D cell 
culture provides a more accurate model for tumour biology.131  
MALDI-MSI of MTS is most commonly employed for observing the time-dependent 
penetration of drugs as an ex vivo model of cancer.38 This application was first 
developed in 2013 whereby HCT-116 spheroids were sectioned at 60 µm intervals 
and MSI was used to observe the time-dependent penetration of the 
chemotherapeutic drug irinotecan and its metabolites at 75 µm resolution.132 
Irinotecan was shown to distribute evenly across the spheroid after 24 hours, and 
using LC-MS/MS, 10 metabolites were observed after 72 hours of incubation.132 
This work was later repeated on patient-derived colorectal tumour organoids (CTOs) 
to predict the therapeutic response of individual patients.133 Unlike in the 
homogenously populated HCT-116 spheroids, the heterogeneous CTOs showed 
that the active metabolite had a localisation unique from the parent drug and 
inactive metabolites.  
However, the static dosing method employed in these drug penetration studies 
involves a single exchange of media at the beginning of the time course. This 
method provides a poor mimic of in vivo drug studies as it lacks the flow component 
of nutrients and waste products. LaBonia employed a 3D printed fluidic device to 
dynamically dose HCT-116 spheroids with irinotecan over 24 hours. They identified 
that whilst irinotecan distributed throughout the spheroid, its active metabolite was 
localised to the outer rim of proliferating cells.134 From these results, they suggested 
that dynamic dosing gives a more realistic representation of the ADME of an in vivo 
system because it allows for nutrient exchange and the diffusion of toxic metabolites 
and waste products away from the spheroid.134  
Whilst irinotecan has been widely used for drug studies in MTS, other drugs have 
been investigated, including comparing the distribution of liposomal-encased 
doxorubicin and free doxorubicin over 72 hours of treatment.135 Both forms of the 
chemotherapeutic drug distributed throughout the HCT-116 spheroid after 12 hours 
of treatment, suggesting that liposomal encasement did not severely affect the rate 
of drug diffusion into spheroids. However, the free drug was at its highest intensity in 
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the outer region of the cells after six hours compared to 12 hours in the liposomal 
time course. This delay in permeation of the encased drug was proposed to have 
been caused by the time it took to bind the liposome to the lipid bilayer and release 
the drug into the cells.  
A number of drugs are not detectable by MALDI, and so derivatisation can be used 
to improve the sensitivity of the analysis. In 2016, colorectal spheroids were dosed 
with the platinum-based anti-cancer drug oxaliplatin and imaged using MALDI-ToF 
MSI.136 The derivatisation reagent diethyldithiocarbamate (DDTC) was incubated 
with the sectioned spheroids to extract and chelate the platinum to form a dimer or a 
trimer, which is detectable by MALDI-ToF. In the absence of DDTC, they identified 
the presence of an inactive metabolite but were unable to detect the parent drug. 
However, with derivatisation they identified that after 90 minutes exposure, 
oxaliplatin is present in the outer and intermediate regions of the MTS, suggesting 
the necrotic core has limited penetration. Furthermore, they identified that a reaction 
with methionine produces an inactive metabolite in the necrotic core. 
MALDI-MSI has been combined with other proteomic analysis methods to obtain 
complementary information about MTS. This has been used to further elucidate the 
structure of MTS,75 and examine the effects of therapeutic drugs on post-
translational modifications129 and the proteome.137  
MSI and CRM were used to obtain complementary information on the layered 
structure of MTS.75 CRM revealed differences in cellular integrity and protein 
secretion, whilst MSI was used to observe the distributions of small molecules. 
Using these techniques, Ahlf and co-workers employed PCA to identify the most 
chemically informative elements and suggested that these primarily localised to the 
necrotic core of the HCT-116 spheroids.  
Feist et al analysed HCT-116 spheroids by both MSI and nanoLC-MS/MS to 
observe the epigenetic response to UNC1999; a drug that inhibits the methylation of 
histone H3 lysine 27 (H3K27).129 After 72 hours, MSI showed that UNC1999 
distributed throughout the spheroid and serial trypsinisation followed by nanoLC-
MS/MS on a parallel spheroid identified and quantified 258 differentially modified 
histone peptides. This included a reduction of methylated H3K27, which caused a 
decreased diameter of the MTS. Furthermore, most of the epigenetic and proteomic 
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changes observed were localised to the outer and intermediate regions, consistent 
with the concept that the central necrotic core has reduced enzymatic activity. 
MSI is currently a qualitative tool, however quantification can be completed using 
complementary information from isobaric tag for relative and absolute quantitation 
(iTRAQ). iTRAQ records reporter ion intensities for each peptide via MS/MS. This 
method allows for protein identification along with fold-change quantification 
between samples. This technique was used in conjunction with MSI to evaluate the 
synergistic effects of chemotherapy in tandem with glucose restriction and 
autophagy inhibition in HCT-116 spheroids.138 MALDI ToF MSI showed that the 
chemotherapeutic compound (irinotecan) and the autophagy inhibition compound 
(chloroquine) distributed uniformly throughout the spheroid under both normal and 
nutrient-restricted conditions. Using iTRAQ, significant changes to proteins involved 
in autophagy and metabolism were quantified, as well as an upregulation of various 
tumour suppression proteins. Furthermore, when glucose restriction was combined 
with autophagy inhibition and chemotherapy, all of the phenotypic results were 
intensified, suggesting that chemotherapy in combination with nutrient restriction is 
more effective than chemotherapy alone.  
Later work employed a similar method to observe the distribution of a combination 
of chemotherapy drugs using dynamic dosing. Folinic acid, 5-fluorouracil, and 
irinotecan (FOLFIRI) were dynamically dosed over 24 hours, and iTRAQ was used 
to quantify the proteomic changes.137 After 24 hours, folinic acid and irinotecan were 
localised to the necrotic core, however the active metabolite of folinic acid localised 
to the outer proliferative region. 5-fluorouracil was not detectable by MS. Using 
iTRAQ, over 5400 proteins were identified and quantified. After 24 hours, 171 
unique proteins with roles in histone regulation and protein synthesis were 
differentially regulated with a fold change of more than two, and 269 proteins after 
48 hours. The Eukaryotic Initiation Factor 2 (eIF2) signalling pathway was the most 
significantly downregulated pathway, including several ribosomal proteins with roles 
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2.1 Project aims 
When MTS are grown to a radius greater than 200 µm, they display gradients of 
oxygen, nutrients, and waste. These gradients produce a three-layered structure 
comprised of a necrotic centre, an intermediate quiescent region, and an outer layer 
of rapidly proliferating cells. MALDI-MSI provides a global untargeted approach for 
investigating how these gradients influence the proteome and metabolome across 
the spheroid. This project aims to use high spatial resolution MALDI-MSI to 
elucidate the biological environments within MTS. 
The most widely employed protocol for MALDI-MSI of MTS was developed by the 
Hummon group in 2011. Using agarose-coated well plates, human carcinoma (HCT-
116) spheroids were grown to diameters of approximately 1 mm over 14–20 days. 
For imaging, gelatin was used to embed up to six spheroids in a well of a 24-well 
microtiter plate. Sectioning of the gelatin block produced up to 16 spheroid sections 
per slide. This project aims to optimise a method for MALDI-MSI of breast cancer 
(MCF-7) and prostate cancer (PC3) spheroids grown using the hanging drop 
method to a diameter of approximately 500 µm. By exploring the use of different 
embedding procedures, this project aims to simplify sample preparation and 
increase the number of sections that can be mounted onto a slide. 
The high spectral resolution of FT-ICR MS affords sufficient mass accuracy and 
resolution to assign elemental formulae from accurate mass measurements. 
Therefore, MALDI MS FT-ICR MS in positive and negative polarities will be used to 
compile comprehensive lists of tentative metabolite assignments with sub-ppm 
errors. 
The oxygen, nutrient, and waste gradients experienced across MTS result in the 
formation of various microenvironments. Using a targeted MSI approach, this project 
will use metabolite markers to indicate regions of increased oxidative stress and 
hypoxia within the spheroid. Furthermore, to investigate how the various spheroid 
microenvironments affect the regional flux through specific metabolic branch 
pathways, untargeted discriminatory analysis will be performed to observe 
metabolites that colocalise to these regions. 
Pimonidazole is a widely used immunohistochemical marker of hypoxia. MALDI-MSI 
has been employed to observe the distribution of pimonidazole within tumours, and 
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a number of its metabolites have been found to colocalise with regions of hypoxia. 
This project aims to use MALDI-MSI to observe the localisation of pimonidazole and 
its metabolites within MTS. By treating spheroids with pimonidazole over a time 
course, MALDI-MSI will be used to simultaneously observe the distribution of the 
parent drug and its metabolites at high spatial and spectral resolution. 
Commercially available matrix application platforms are expensive, limiting the 
accessibility into the MALDI-MSI field. Alternative options have been developed, 
including an inkjet printer, but this is prone to blockage and regularly needs 
replacing. This project aims to use a 3D printer and components regularly found in 
an analytical chemistry laboratory to develop a cheaper alternative for matrix 
application. Using rhodamine B microarrays and fluorescence scanning, various 
matrix application conditions will be tested, and the optimised parameters will be 
identified. Using MALDI-MSI, the optimised conditions can be compared to the 
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3.1 Reagents 
Human breast cancer cell line (MCF-7) at passage 52 were obtained in 1 mL 
aliquots from the Queen’s Medical Research Institute (University of Edinburgh, Little 
France, EH16 4UU) and stored in liquid nitrogen. Human prostate cancer cell line 
(PC3) (20 µL) was purchased at passage 6 from Sigma-Aldrich. Phosphate buffered 
saline (PBS) was acquired from Thermo-Fisher Scientific. For cell culture, Roswell 
Park Memorial Institute (RPMI) medium (Thermo-Fisher) or Dulbecco Modified 
Eagle’s Medium (DMEM) (Thermo-Fisher) was supplemented with fetal bovine 
serum (FBS) (Sigma-Aldrich) and penicillin (Thermo-Fisher). Trypsin was acquired 
from Sigma-Aldrich. Dimethyl sulfoxide (DMSO) (Sigma-Aldrich) was used to 
solubilise pimonidazole (Sigma-Aldrich). ITO-coated slides were purchased directly 
from Bruker (Bremen, Germany). Trifluoroacetic acid (TFA), CHCA, DHB and 9AA 
for the imaging data were purchased from Sigma-Aldrich. HPLC-grade solvents 
were provided by Sigma-Aldrich. Haematoxylin, eosin and acid alcohol for 
histological staining were purchased from Sigma-Aldrich. 
3.2 Cell culture 
3.2.1 MCF-7 cells 
Both monolayer cells and spheroids were grown in DMEM media supplemented with 
FBS (10% v/v) and Penicillin-Streptomycin (10000 units penicillin/mL, 10 mg 
streptomycin/mL, 3 mL). Monolayer cells were routinely seeded every four days at 
approximately 80% confluence in a 75 cm3 flask. For seeding the cells, the media 
was poured off, cells were washed twice with PBS (10 mL) and incubated with 
trypsin (5 minutes). Supplemented media (10 mL) was added to arrest trypsin 
activity, and the contents of the flask was transferred into a falcon tube (50 mL) and 
centrifuged (2.0 rpm, 4 minutes). The media was poured off and the cells re-
suspended in fresh supplemented DMEM media (10 mL). Re-suspended cells (2 
mL) were placed into a new 75 cm3 flask with fresh supplemented DMEM media (8 
mL). The media was replaced every 48 hours. 
3.2.2 PC3 cells  
Both monolayer cells and spheroids were grown in RPMI media supplemented with 
FBS (10% v/v) and Penicillin-Streptomycin (10000 units penicillin/mL, 10 mg 
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streptomycin/mL, 3 mL). Monolayer cells were routinely seeded every four days at 
approximately 80% confluence in a 75 cm3 flask. The process of seeding is the 
same as section 3.2.1. The media was replaced every 48 hours.  
3.2.3 Spheroid preparation 
Spheroids were obtained using the hanging drop method.139 Approximately 6000 
cells were seeded into droplets (20 µL) that were then suspended from the lid of a 
petri dish. A reservoir of fresh media (10 mL) was placed in the bottom of the dish. 
Media (15 µL) was removed and fresh media (15 µL) was added every 72 hours. 
Spheroids were incubated at 36.5 °C, 5% CO2 and 95% humidity for up to 14 days 
before imaging. 
3.2.3.1 Spheroid dosing with pimonidazole 
For dosing the spheroids, media (15 µL) was removed from the droplets. For control 
spheroids, fresh supplemented RPMI media (20 µL) was added for the equivalent 
time course. For the dosed spheroids, a stock of pimonidazole (4 mM) in DMSO 
was diluted into fresh supplemented media to a final concentration of 200 µM and 
was added to the spheroids (20 µL). Spheroids were then incubated under the same 
conditions as previously stated for various time points over 24 hours. 
3.3 MSI sample preparation 
3.3.1 Embedding 
Media (20 µL) was removed, and spheroids were washed with ammonium formate 
(20 µL, 50 mM). Each spheroid was picked up using a 100 µL pipette and placed 
into a droplet from which the maximum amount of liquid was removed. To aid 
spheroid detection during sectioning, gelatin (3 mL, 17.5% (w/v)) was prepared 
using blue food colouring (2.5 mL water, 0.5 mL Sainsbury’s food colouring) at 37.5 
°C using a heated stirrer plate. 20 µL was initially placed onto the spheroids using a 
P100 pipette. A second layer (20 µL) was added, and the gelatin-embedded 
spheroids were frozen on isopentane and dry ice (-78 °C, 2 minutes). The gelatin 
blocks were then snap frozen in liquid nitrogen and stored (-80 °C) until sectioning.  
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3.3.2 Sectioning 
Sectioning was performed using a cryostat (-21 oC) (Leica CM 1900 (Leica 
Biosystems, Nussloch, Germany). Water (ca. 1.5 mL) was frozen onto a chuck (3 
minutes) and faced off to provide a flat surface. Then, gelatin-embedded spheroids 
were frozen onto the chuck using water (ca. 500 µL, 30 seconds). Sections (15 µm) 
were cut and thaw mounted onto conductive ITO-coated glass slides. Consecutive 
sections were taken for haematoxylin and eosin (HE) staining (see section 3.3.4). 
The slides were then placed into a slide adapter and the image scanned (4800 dpi). 
3.3.3 Matrix application 
3.3.3.1 CHCA 
For matrix application of CHCA (5 mg/mL, 70% acetonitrile (ACN), 0.1% TFA) a TM-
sprayerTM (HTX Technologies, LLC, NC, USA) was used to apply eight coats of 
matrix at a flow rate of 0.1 mL/minute at 80 °C with a gas pressure of 10 psi and a 
velocity of 1100 mm/minute. These parameters took approximately 20 minutes to 
coat a slide and resulted in a matrix density of 0.22 mg/cm2. 
3.3.3.2 DHB 
For matrix application of DHB (10 mg/mL, 80% ACN), a TM-sprayerTM was used to 
apply eight coats of matrix at a flow rate of 0.1 mL/minute at 80 °C with a gas 
pressure of 10 psi and a velocity of 1100 mm/minute. These parameters took 
approximately 20 minutes to coat a slide and resulted in a matrix density of 0.15 
mg/cm2. 
3.3.3.3 9AA 
For matrix application of 9AA (5 mg/mL 70% ACN), a TM-sprayerTM was used to 
apply eight coats of matrix at a flow rate of 0.1 mL/minute at 80 °C with a gas 
pressure of 10 psi and a velocity of 1100 mm/minute. These parameters took 
approximately 20 minutes to coat a slide and resulted in a matrix area density of 
0.11 mg/cm2. 
9AA matrix was also applied using a converted 3D printer. The optimised conditions 
consisted of eight coats of matrix (5 mg/mL, 70% ACN) at a flow rate of 0.1 
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mL/minute at 40 °C with a gas pressure of 50 psi and a z height of 30 mm. The 
velocity was set within the G-code as F1000, which resulted in a velocity of 1100 
mm/minute. These parameters took approximately 15 minutes to coat a slide and 
resulted in a matrix area density of 0.11 mg/cm2 (for further details, see chapter 7). 
3.3.4 H&E staining 
Alternate spheroid sections were thaw-mounted onto a glass slide and stored in a 
vacuum desiccator (room temperature, 18 hours). Sections were covered with 
haematoxylin (3 minutes) and washed with running water. The slide was coated with 
tap water (1 minute), then acid alcohol (20 seconds) and then washed using water. 
Eosin was added (1 minute) and then washed with water. The stained cells were 
then air dried before being imaged under the 40x objective on an inverted AE2000 
(Motic, Hong Kong) microscope.  
3.4 MALDI MS 
3.4.1 Steel plate MALDI MS 
For MALDI MS of pimonidazole, the UltraFlex MS equipped with a MALDI ionisation 
source (Bruker Daltonics) was used. Mass spectra were acquired in reflectron 
positive-ion mode with 500 laser shots per spot. Spectra were acquired across a 
mass range of m/z 100–1000 using a laser spot size of 35 μm with a SmartWalk 
raster of 50 μm. A sampling frequency of 2 kHz was used, and the laser intensity 
was set at 65% for CHCA and 47% for DHB. 100 µM pimonidazole was mixed with 
either DHB (70% ACN, 0.1% TFA) or CHCA (50% ACN, 0.1% TFA) and 15 spectra 
were averaged. Calibration was carried out using red phosphorus. 
3.4.2 MALDI MS of spheroids 
For MALDI MS analysis, a 12T SolariX FT-ICR MS equipped with an infinity ICR cell 
and a MALDI ionisation SmartBeam II UV laser (Bruker Daltonics, Bremen, 
Germany) was used. Spectra were acquired in positive-ion mode (using CHCA and 
DHB matrices) and negative-ion mode (using DHB and 9AA matrices). Typically, an 
m/z range of 98-1500 was acquired in broadband mode with a Time Domain for 
Acquisition of 2 MWord. 300 shots were accumulated across 20 scans with 15%, 
9%, and 7% laser power for CHCA, 9AA, and DHB matrices respectively. 
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3.4.2.1 Accurate mass assignment 
The resulting mass spectra were internally calibrated using five known species for 
each matrix and confirmed using the DataAnalysis SmartFormula tool (tables 3.1 – 
3.4). A mass list for each matrix was produced using FTMS peak detection with a 
S/N > 3 in DataAnalysis 4.4. The calibrated m/z values were then identified using 
the Human Metabolome Database (HMDB) using an error tolerance of 1 ppm 
(http://www.hmdb.ca/spectra/ms/search) and LipidMaps using an error tolerance of 
0.001 m/z (http://www.lipidmaps.org/tools/ms/lm_mass_form.php). This was 
subsequently manually filtered to errors within 1 ppm. For positive-ion mode, 
formulae were assigned with the adducts [M+H]+, [M+Na]+ and [M+K]+. For negative-
ion mode, formulae were assigned with the adducts [M-H]-, [M+Na-2H]- and [M+K-
2H]-. 
Table 3.1. Calibration list for CHCA in positive mode. 
m/z Neutral formula Adduct 
190.04987 C10H7NO3 [M+H]+ 
379.09246 C10H7NO3 [2M+H]+ 
666.48330 C36H70NO6P [M+Na]+ 
725.55680 C39H79N2O6P [M+Na]+ 
851.64028 C47H93N2O6P [M+K]+ 
Table 3.2. Calibration list for DHB in positive mode. 
m/z Neutral formula Adduct 
155.03389 C7H6O4 [M+H]+ 
283.01894 C6H13O9P [M+Na]+ 
348.07036 C10H14N5O7P [M+H]+ 
428.03669 C10H15N5O10P2 [M+H]+ 
703.57485 C39H79N2O6P [M+H]+ 
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Table 3.3. Calibration list for DHB in negative mode. 
m/z Neutral formula Adduct 
153.01933 C7H6O4 [M-H]- 
241.01188 C6H11O8P [M-H]- 
402.99492 C9H14N2O12P2 [M-H]- 
505.98847 C10H16N5O13P3 [M-H]- 
834.52906 C46H78NO10P [M-H]- 
 
Table 3.4. Calibration list for 9AA in negative mode. 
m/z Neutral formula Adduct 
193.07712 C13H10N2 [M-H]- 
346.05581 C10H14N5O7P [M-H]- 
426.02214 C10H15N5O10P2 [M-H]- 
611.14469 C20H32N6O12S2 [M-H]- 
885.549985 C47H83O13P [M-H]- 
 
3.4.3 Continual accumulation of selected ions (CASI) 
CASI was used for negative mode MS with a CASI window of m/z 30 and a Q1 
mass of m/z 506, 426 and 346 for adenosine triphosphate (ATP), adenosine 
diphosphate (ADP), and adenosine monophosphate (AMP) respectively. 300 shots 
were accumulated across 20 scans using the 12T SolariX FT-ICR MS in negative-
ion mode with a 7% laser power. A Time Domain for Acquisition of 2 MWord and an 
ICR transient length of 0.5 seconds in broadband mode was used. 
For MS of pimonidazole, a Q1 mass of m/z 240 and an isolation window of m/z 40 
was used. 300 shots were accumulated across 20 scans in positive-ion mode with 
15% laser power, an ICR transient length of 0.5 seconds, and a Time Domain for 
Acquisition of 2 MWord. 
3.5 MALDI-MSI 
3.5.1 ToF MSI 
ToF MSI experiments were performed on an UltraFlex MS equipped with a MALDI 
ionisation source (Bruker Daltonics, Germany). Mass spectra were acquired in 
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reflectron positive-ion mode with 500 laser shots per spot. Mass spectra were 
acquired in a mass range of m/z 100–1000 using a laser spot size of 35 μm and a 
SmartWalk raster of 50 μm. A sampling frequency of 2 kHz was used, and the laser 
intensity was set at 65% for CHCA and 47% for DHB. Quadratic calibration was 
completed prior to the imaging run using red phosphorus and resulting images were 
further calibrated using internal DHB and CHCA matrix peaks (tables 3.5 and 3.6). 
Images were processed with FlexImaging 4.1 and SCiLS version 2019a (Bruker 
Daltonics, Bremen, Germany) with TIC normalisation to generate ion maps. 
Table 3.5. DHB calibration list for ToF data. 
m/z Neutral formula Adduct 
137.02332 C7H4O3 [M+H]+ 
155.03389 C7H6O4 [M+H]+ 
273.03936 C14H8O6 [M+H]+ 
409.05541 C21H12O9 [M+H]+ 
545.07145 C28H16O12 [M+H]+ 
681.08750 C35H20O15 [M+H]+ 
817.10354 C42H24O18 [M+H]+ 
 
Table 3.6. CHCA calibration list for ToF data. 
m/z Neutral formula Adduct 
190.04987 C10H7NO3 [M+H]+ 
379.09246 C10H7NO3 [2M+H]+ 
401.07441 C10H7NO3 [2M+Na]+ 
417.04834 C10H7NO3 [2M+K]+ 
568.13506 C10H7NO3 [3M+H]+ 
3.5.2 FT-ICR MSI 
FT-ICR experiments were performed on a 12T SolariX FT-ICR MS equipped with an 
infinity ICR cell and a MALDI SmartBeam II UV laser (Bruker Daltonics, Bremen, 
Germany). Spectra were acquired in positive-ion mode (using CHCA and DHB 
matrices) and negative-ion mode (using DHB and 9AA matrices). An m/z range of 
98-1500 was acquired in broadband mode with a Time Domain for Acquisition of 
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2 MWord. Ions were accumulated across 300 laser shots for each mass analysis. 
The method settings were as follows: 100 V offset, 280 V defector plate, 18% sweep 
excitation power, 100 sweep frequency density, 10 s sweep time. The laser was set 
to minimum spot size (laser diameter of ca. 15 µm), 1000 Hz laser frequency, 
minimum laser focus, and a 50 µm Smart Walk for each matrix. The dwell time per 
pixel was 1000-1500 ms, which resulted in a total data acquisition time of ca. 20 
minutes per spheroid section. Images were processed using FlexImaging 4.1 and 
SCiLS version 2019a software with TIC normalisation to generate ion maps. Pixels 
were exported to DataAnalysis 4.4 and quadratic calibration was carried out using a 
pre-determined list of internal calibrants for each matrix (tables 3.1 – 3.4). 
3.5.2.1 CASI MSI 
CASI imaging was performed using the 12T SolariX FT-ICR mass spectrometer. For 
pimonidazole, a Q1 mass of m/z 240 and an isolation window of m/z 40 was used. 
300 shots were accumulated across 20 scans in positive-ion mode with 15% laser 
power. An ICR transient length of 0.5 seconds in broadband mode with a Time 
Domain for Acquisition of 2 MWord was used. The laser raster increment was set to 
40 µm along both the x and y axis with a smart walk of 50 µm. Laser focus was set 
to minimum, with a frequency of 1000 Hz. Ions were accumulated across 300 laser 
shots for each mass analysis.  
3.6 Discriminatory analysis 
.mis files were imported into SCiLS version 2019a and the raw data was converted 
into the .ibd SCiLS format without baseline removal. TIC normalisation was applied 
to the data once it was imported. The spheroids were segregated into the ‘outer’ and 
‘central’ region based on 50% of the radius. For automatically finding m/z values 
discriminating the outer and central regions, the receiver operating characteristic 
(ROC) tool was employed and the area under the ROC curve (AUC) was calculated. 
A threshold was set for the top five discriminatory m/z values. Using a 
representative pixel from either region, the calibrated m/z values were then 
assigned formulae using HMDB with an error tolerance of 1 ppm for the [M-H]- ion. 
For comparison of the ion abundances of individual species between regions of 
spheroids, ion abundance distributions were represented as box and whisker plots 
using SCiLS software.  
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3.7 Production and imaging of rhodamine microarrays 
45 spots containing 50 droplets of 350 pL 0.01% rhodamine (w/v) in water (Sigma 
Aldrich) was dispensed. A microarray printer (SciFLEXARRAYER S5 (Scienion AG)) 
equipped with a Piezo Dispense Capillary (PDC 80) with a 50 µm nozzle aperture 
was used to print onto a SuperFrostTM glass slide. The fluorescence was measured 
using a BioAnalyzer 4F/4S (LaVision BioTec) fluorescence scanner at 70 ms 
exposure time and a Cy5 filter. The area of observed fluorescence was measured 
using ImageJ before and after matrix application. 9AA (5 mg/mL, 70% ACN) was 
used as the matrix. 
3.8 Scanning electron microscopy 
Matrix-coated rhodamine B slides were mounted on aluminium stubs with carbon 
tabs attached and sputter coated with 20 nm gold palladium (Emscope). The 
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4.1 Introduction 
MSI was first applied to MTS in 2011 to examine the distribution of biological 
molecules in human carcinoma (HCT 116) spheroids.84 In this report, by Li et al., 
HCT-116 spheroids were grown over 14–20 days to approximately 1 mm in 
diameter, embedded in gelatin (350 mg/mL) and sectioned. This workflow 
embedded up to five spheroids and produced up to 16 spheroid sections on each 
slide. Using MALDI ToF MSI in positive mode with 75 µm resolution, Li and co-
workers observed the distribution of a limited number of intact proteins that localised 
to the central necrotic region. To complement this MSI study, nanoLC MS/MS was 
used to identify cytochrome C and histone H4, both of which distributed uniformly 
across the spheroid. Since this first report, several other studies have applied a 
similar workflow to investigate MTS in a spatially-resolved manner. These include 
observing the distribution of lipids,131 metabolites,80 and the time-dependent 
penetration of drugs.129,132,136,140  
Although several reports have demonstrated the feasibility of MSI analysis of 
spheroids, no standardised sample preparation protocol has been universally 
adopted. Therefore, our initial work focused on the development of a robust, reliable 
and reproducible protocol for the sample preparation, MSI data collection, and data 
processing of MTS cultures.  
Specifically, we have optimised a method for MALDI ToF and FT-ICR MSI of breast 
cancer (MCF-7) spheroids. Initial MALDI MS analysis was used to create peak lists 
in positive and negative polarities, and formulae were tentatively assigned with sub-
ppm errors. These mass lists were subsequently employed to assign formulae to 
exported spectra from an imaging run. Metabolites that displayed localised 
distributions to specific regions – in this case outer and centre – were assigned 
based on accurate mass and metabolome database searches. 
4.2 Results and discussion 
4.2.1 Method development for MALDI MS of MTS  
For all work carried out, the spheroids were produced using the hanging drop 
method.113 20 µL containing approximately 6000 cells were placed onto the lid of a 
petri dish (figure 4.1). The droplets were suspended over a reservoir containing 
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fresh media (10 mL) supplemented with FBS (10% v/v) and Penicillin-Streptomycin 
(10000 units penicillin/mL, 10 mg streptomycin/mL, 3 mL). 15 µL of media was 
removed and replaced every third day over a total of seven to 21 days of culture. 
Above 21 days, spheroids became fragile and easily damaged during sample 
preparation, as shown by H&E staining (figure 4.2). 
 
Figure 4.1. Spheroids were produced using the hanging drop method. This involved 
placing 20 µL of approximately 6000 cells onto the lid of a petri dish. The lid was 
then inverted, and a reservoir of 10 mL of media was placed in the bottom of the 
petri dish.  
 
Figure 4.2. H&E staining of embedded and sectioned MCF-7 spheroids after 
culturing for seven, 14, and 21 days. 
After seven days, the spheroids reached an approximate diameter of 500 µm. They 
were prepared for imaging by removing the media and washing the spheroids twice 
with PBS (20 µL). During this stage, spheroids are very fragile and likely to be 
damaged, and so extra care is required when washing the spheroids. Gelatin (3 mL, 
17.5% (w/v)) was used as the embedding medium. It was prepared using a stirrer 
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plate at 37 °C to reduce heat damage to the spheroids, and a Sainsbury’s own 
brand blue food colouring dye (0.5 mL) was added in order to visualise the 
spheroids during sectioning. Embedding was initially carried out using moulds, 
including a silica well plate and a 3D printed block with a lid to make individual wells 
(figure 4.3). However, both of these methods prevented visualisation of the 
spheroids within the mould during embedding, and the gelatin block was regularly 
damaged during removal. A simplified protocol was developed using the petri dish 
lid on which the spheroids were grown. After the second wash with PBS, spheroids 
were picked up with a 100 µL pipette tip and placed into a single droplet from which 
maximal liquid was removed. Blue gelatin (20 µL) was then added to the spheroids. 
An additional ‘blanket’ layer of gelatin (20 µL) was added on top once the first layer 
had set to ensure the spheroids were fully embedded. Up to eight spheroids were 
embedded in each droplet. 
 
Figure 4.3. Schematic of moulds used for initial MALDI-MSI of spheroids. (A) Silica 
mould containing individual wells for spheroids. (B) 3D-printed plastic mould 
containing four wells for spheroids. (C) Gelatin droplets were placed directly onto the 
petri dish where the spheroid was cultured. 
To prevent degradation of biological molecules, embedded spheroids were 
immediately frozen. To reduce the size of the water crystals in the gelatin, spheroids 
were frozen on dry ice with isopentane, then snap-frozen in liquid nitrogen and 
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stored at -80 °C until use. Sectioning thickness is commonly between 10 and 20 µm 
as a compromise between minimising tissue fragility and maximising ion 
abundance.9,86 Therefore, the embedded spheroids were sectioned at 15 µm 
thickness using the cryostat (-21 °C) and thaw mounted onto ITO-coated glass 
slides. Cryostat temperatures above -10 °C resulted in unsuccessful sectioning due 
to thawing of the edges of the gelatin. 
During sectioning, alternate sections were taken for H&E staining to confirm the 
structural integrity of the spheroid sections. Using this method, a single slide could 
mount up to 24 gelatin sections. Therefore, depending on the number of spheroids 
per section, up to 100 spheroid sections were mounted onto one slide. The slide 
was then scanned at 4800 dpi and this image was used to calibrate the imaging run 
and identify the locations of the spheroids (figure 4.4). Slides were scanned prior to 
matrix coating to improve the visibility of the sectioned spheroids.  
 
Figure 4.4. Scanned image of (A) a slide with gelatin-embedded spheroids mounted. 
(B) A single gelatin section with spheroids identified by the dotted white lines. 
Additional marks are the result of air bubbles in the gelatin. 
Each spheroid-mounted slide was coated in a matrix for MALDI ionisation. 
Depending on the polarity of ionisation and the analyte of interest, a number of 
matrices were used; including DHB, CHCA and 9AA. A TM-sprayerTM was used for 
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matrix application, and the solvent composition, number of passes, temperature, 
spray velocity, and gas pressure were all optimised (figure 4.5). For each condition, 
the quality of the matrix coverage was observed using glass slides without a sample 
mounted to observe how changing each parameter affected the quality of matrix 
deposition. The optimised conditions for the TM-sprayerTM were identified as 80 °C, 
0.1 mL/minute flow rate, 10 psi gas pressure, and a velocity of 1100 mm/minute. 
These conditions took approximately 20 minutes to coat a slide and resulted in a 
matrix density of 0.22 mg/cm2 for CHCA, 0.15 mg/cm2 for DHB, and 0.11 mg/cm2 for 
9AA (figure 4.6). 
 
Figure 4.5. Optimisation of matrix application conditions for 9AA matrix application. 
(A) 50 °C produced an inhomogeneous coverage of large crystals. (B) 80 °C 
produced a dense homogeneous coverage of small crystals. (C) 90°C produced an 
uneven coverage, and the nozzle became blocked during application. All conditions 
shown used 10 psi gas pressure, 0.1 mL/minute flow rate, and a velocity of 1100 
mm/minute. 
 
Figure 4.6. Representative image of a MALDI slide holder with two spheroid-
mounted ITO slides. The slide was coated in a variety of matrices (DHB, CHCA, and 
9AA), placed into a slide holder and stored in a desiccator until use on the same 
day. 
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Once the spheroids were coated, FlexImaging 4.4 was used to calibrate the 
scanned image with the slide to align the laser with the spheroids. Spheroid sections 
had a diameter of approximately 500 µm, so a minimum laser size (ca. 15 µm) with 
a step size of 40 µm was employed. For each instrument and each matrix, the 
number of accumulated shots and laser power were optimised to produce an 
intense signal for the analytes of interest. For FT-ICR MS, this was identified as 
15%, 9%, and 7% laser power for CHCA, 9AA, and DHB matrices respectively. For 
ToF MS, this was identified as 65%, 50%, and 47% laser power for CHCA, 9AA, and 
DHB matrices respectively. All conditions fully ablated the sample. The ToF 
instrument was quadratically calibrated using red phosphorus prior to analysis, and 
re-calibrated using internal matrix peaks after acquisition. FT-ICR spectra were 
calibrated after acquisition. For FT-ICR imaging runs, a representative pixel was 
exported from the ion density map and calibrated using internal peaks (see methods 
section 3.4.1). 
4.2.2 MALDI MS global metabolite analysis of MTS 
This high spectral resolution of the FT-ICR affords sufficient mass accuracy and 
resolution to assign elemental formulae from accurate mass measurements. These 
elemental formulae can then be searched against metabolite databases in order to 
propose potential metabolite assignments. Therefore, FT-ICR MS can be used to 
produce a mass list of the ionisable metabolome of a spheroid.  
However, during an MSI experiment, only a single spectrum is acquired per pixel, 
thus low intensity ions may not be observed. Consequently, in order to gain a more 
comprehensive picture of the ionisable metabolome in MTS, a MALDI MS method 
was employed. During MALDI MS data acquisition, multiple spectra are 
accumulated and averaged, increasing the signal of the less abundant metabolites 
and as a result more peaks can be assigned.  
For MALDI MS analysis, eight-day-old MCF-7 spheroids were prepared using the 
previously outlined method. Sections were taken close to the hemisphere of each 
spheroid to improve the reproducibility. For ionisation, CHCA and DHB matrices 
were employed for positive-ion mode, and DHB and 9AA matrices were used for 
negative-ion mode. All experiments were completed in triplicate. For each matrix, a 
single spheroid was used to sum and average 20 spectra between m/z 100 and 
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1500. This enabled ionisation of metabolites from the entire area of the sectioned 
spheroid and produced a final spectrum containing a representative snapshot of the 
ionisable metabolome of an eight-day-old MCF-7 spheroid. By summing multiple 
spectra, a greater S/N for each metabolite is obtained, and therefore more formulae 
can be tentatively identified. However, the limitation of this method is the lack of 
spatial information. This could result in some low abundance localised species 
within the spheroid to be below the S/N threshold required for assignment. 
For each matrix, a mass resolution above 100000 was achieved and over 1000 
peaks were observed with S/N >3. After internal calibration, the obtained peak lists 
could be searched against metabolite and lipid databases (HMDB and Lipidmaps) to 
produce potential metabolite assignments based on accurate mass alone (figure 
4.7). 
 
Figure 4.7. (A) MALDI FT-ICR MS analysis of sectioned MCF-7 spheroids. 
Accumulation of 20 shots manually acquired across a spheroid between m/z 100–
1500 using various MALDI matrices. (i) CHCA positive mode, (ii) DHB positive 
mode, (iii) DHB negative mode (iv) 9AA negative mode. (B) Venn diagrams showing 
the identification of metabolites in (top) positive and (bottom) negative mode. Blue 
corresponds to DHB, yellow corresponds to CHCA and pink corresponds to 9AA. 
For each matrix, the mass resolution was greater than 102000 at m/z 300. 
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Using positive mode ionisation, 279 and 390 metabolites formulae were tentatively 
assigned with sub-ppm error using CHCA and DHB as matrices respectively. In 
negative mode using DHB, 89 metabolites were assigned, and 220 assignments 
were made using 9AA as a matrix. Considering all matrices used, overall, 471 
different species were assigned putative metabolite identities in positive mode, and 
291 metabolites were assigned in negative mode (see appendix for tentative 
metabolite formulae assignments). Of the metabolites assigned, 198 formulae were 
reproducibly assigned for both matrices in positive mode and 18 were reproducibly 
assigned in negative mode.  
In some cases, for a single peak, the online databases identified multiple different 
formulae within the pre-determined error tolerance. Therefore, for each of these 
assignments, the biological relevance of the assigned metabolite was used to select 
the most likely formula. For example, if the formula corresponded to a metabolite 
uniquely identified in fruit, this would be an unlikely metabolite to be observed within 
a spheroid. In order to increase the confidence of these assignments, MS/MS is 
required to analyse neutral mass losses for each assignment observed. 
4.2.3 FT-ICR and ToF MSI of MTS  
In an imaging experiment, the spatial distributions of hundreds to thousands of 
metabolites are mapped simultaneously.141 MCF-7 spheroids were imaged at 40 µm 
spatial resolution in positive mode using ToF and FT-ICR MSI. Each spheroid 
section imaged took approximately 10 minutes using the ToF and 20 minutes using 
the FT-ICR. The profile spectrum produced from each spheroid was highly complex, 
and the distributions of various m/z values could be observed (figure 4.8). 
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Figure 4.8. Profile spectrum and ion density maps of various m/z values from ToF 
MSI of MCF-7 spheroids in positive mode with CHCA as the matrix at 40 µm spatial 
resolution. The resolution obtained was 20000 at m/z 300. 
ToF mass analysers have a mass resolving power of up to 50000, whereas FT-ICR 
instruments have a mass resolving power of up to 1 million.34 By exporting a 
representative pixel from each of the imaging datasets, the improved mass 
resolution of the FT-ICR is shown through its capability to separate overlapping 
peaks (figure 4.9). Using a S/N >3, 232 peaks were picked from the ToF spectrum, 
whereas 1495 peaks were picked from the FT-ICR spectrum. Furthermore, FT-ICR 
data acquired a resolution of over 100000, whereas ToF imaging data produced a 
resolution of 20000 at m/z 300. 
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Figure 4.9. Profile spectrum of an MCF-7 spheroid using CHCA as the matrix for 
(top) ToF and (bottom) FT-ICR MSI. (A) m/z 100–1000 (B) m/z 600–1000 (C) m/z 
700–760 and (D) m/z 749–754. 
The high mass resolution of FT-ICR enables the assignment of elemental formulae 
without the requirement for targeted MS/MS approaches.142 To observe the benefits 
of the high spectral resolution of FT-ICR imaging, formula assignments of the peaks 
between m/z 772 and 775 were carried out using online databases (figure 4.10). 
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The FT-ICR peak list assigned C43H76NO7P (m/z 772.52516) and C43H82NO8P (m/z 
772.58509) with 0.254 and 0.210 ppm errors respectively. In contrast, the data 
collected by ToF was unable to resolve these two species and single feature is 
observed at m/z 772.529; consequently, neither can be assigned with confidence. 
Database searching based on this signal feature matches C43H76NO7P with a 4.984 
ppm error and C43H82NO8P with an error of 72.587 ppm. This demonstrates that the 
high spectral resolution of the FT-ICR is required for global analysis as it is capable 
of assigning elemental formulae from accurate m/z measurements, whereas ToF 
MSI lacks the resolving power required. Furthermore, the two mass analysers 
display unique distribution patterns for the m/z value imaged, however the reason 
for this is unknown. 
 
Figure 4.10 (A) Spectra of exported pixel from (top) ToF and (bottom) FT-ICR MSI of 
MTS at 40 µm resolution in positive mode with CHCA as the matrix. (B) Ion density 
maps from (top) ToF and (bottom) FT-ICR showing the distribution of the identified 
lipids. Overlaid spectra show the (red) C43H76NO7P [M+Na]+ and the (blue) 
C43H82NO8P [M+H]+ adduct. 
4.2.3.1 Elucidating spheroid microenvironments 
To elucidate how the various microenvironments across a spheroid influence its 
metabolome, MCF-7 3D cell cultures were grown over eight days to form spheroids 
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of approximately 500 µm in diameter and prepared for MSI as previously discussed. 
Spheroid sections were coated in 9AA matrix and subjected to MALDI FT-ICR MSI 
at 40 µm spatial resolution between m/z 98–1500 in negative mode. This matrix was 
selected to preferentially ionise metabolites including nucleotides and 
phosphates,143 as these are important in understanding the biology of cancer.144 
Figure 4.11 highlights the differences in the profile mass spectra produced from 
areas across the diameter of the spheroid (in this case, the central and outer 
regions). By inspection of an exported representative pixel from the outer and centre 
region, it is clear that spectra from the spheroid are highly complex, and significant 
differences in the profile mass spectra are apparent in the two regions (Figure 
4.11A). Across the entire spectrum, formulae were assigned to each peak with sub-
ppm error and database searches offered tentative metabolite identifications. A 
narrow region of each spectrum is shown in Figure 4.11B, highlighting the variation 
in abundance of species between the outer and centre region of the spheroid. The 
intensities of these peaks are consistent across the spheroid as shown by the ion 
density maps (Figure 4.11C).  
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Figure 4.11. (A) A representative H&E stained section of the MCF-7 spheroids used 
in this study. An FT-ICR mass spectrum from a representative pixel in the outer and 
centre regions of the MCF-7 spheroid is shown. (B) Representative pixels from the 
(top) outer and (bottom) centre region of an MCF-7 spheroid imaged at 40 µm 
resolution. Using HMDB, each peak could be assigned with sub-ppm error and the 
relative intensity compared between the regions. The errors identified were 0.0719, 
0.3816, 0.2375 and 0.1174 ppm for each assigned formula respectively. (C) The ion 
density maps for each of the formulae assigned. 
By exporting and calibrating a representative spectrum from the outer and centre 
region (see section 3.4.1 in materials and methods for detailed description of 
calibration process), peaks with a S/N >3 were assigned formulae with sub-ppm 
errors using online databases HMDB and LipidMaps. In total, 100 peaks were 
assigned using the imaging data from both pixels. Furthermore, of the peaks 
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assigned, four peaks were unique to the outer region and eight peaks were unique 
to the centre region (figure 4.12). Based on the formulae assigned to the unique 
peaks, tentative metabolite identifications were made (tables 4.1 and 4.2). 
 
Figure 4.12. Venn diagram showing the identified molecules in the (blue) outer and 
(pink) centre of the spheroid. Of the 100 formulae assigned, four were unique to an 
outer pixel and eight were unique to a centre pixel of the eight-day-old spheroid. 
Table 4.1. m/z values assigned uniquely to a pixel in the outer region of a spheroid 
with sub-ppm error using HMDB and LipidMaps. Tentative metabolite identifications 









Adduct Tentative identity 





481.97734 481.97724 -0.21578 C9H16N3O14P3 [M-H]- 
Cytidine 
triphosphate 
558.06435 558.06440 0.08422 C15H23N5O14P2 [M-H]- 
Adenosine 
diphosphate ribose 
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Table 4.2. m/z values assigned uniquely to a pixel in the centre region of a spheroid 
with sub-ppm error using HMDB and LipidMaps. Tentative metabolite identifications 
were made based on the accurate masses and formulae. PA, Phosphatidic acid, 









Adduct Tentative identity 
214.04859 214.04860 0.03270 C5H14NO6P [M-H]- 
Glycerylphosphoryle
thanolamine 
253.05000 253.04998 -0.07508 C7H14N2O6S [M-H]- 
5-L-Glutamyl-
taurine 
304.03403 304.03401 -0.06578 C9H12N3O7P [M-H]- 
Cytidine 2',3'-cyclic 
phosphate 
334.07143 334.07144 0.04191 C11H17N3O7S [M-H]- S-Formylglutathione 











613.13971 613.13999 0.45667 C20H31N4O16P [M-H]- CMP-NeuNAc 
669.45021 669.45008 -0.19568 C37H67O8P [M-H]- 
PA(20:2(11Z,14Z)/1
4:1(9Z)) 
An advantage of MSI over MALDI MS is the spatial information provided within the 
data. The initial assignment of formulae from an exported pixel can be 
complemented by observing the spatial distribution of each assignment across the 
spheroids. Of the metabolites uniquely assigned in the outer pixel, all of the 
assignments involved nucleotides, two of which are uridine phosphates. The ion 
density maps show that both uridine diphosphate (UDP) (m/z 424.97684) and UDP-
N-Acetylglucosamine (UDP-GlcNAc) (m/z 628.05599) display higher intensities in 
the outer region of the spheroid, which agrees with the pixel assignments (figure 
4.13). Furthermore, both of these metabolites are associated with the hexosamine 
biosynthetic pathway (HBP), which has been shown to be downregulated in hypoxic 
conditions.145,146 ADP ribose (m/z 628.05599) also displays a clear distribution to 
the outer region of the spheroid. This metabolite is suggested to play an important 
role in DNA repair,147 which could explain its absence from the hypoxic central 
regions of the spheroid. 
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Figure 4.13. Ion density maps showing metabolites that were uniquely assigned 
from a representative exported pixel from the outer region of the eight-day-old MCF-
7 spheroid. The white line denotes the outer and centre regions of the spheroid. 
From left to right, tentative identifications are UDP, CTP, ADP ribose and UDP-
GlcNAc. 
Despite the unique assignment of cytidine triphosphate (CTP) (m/z 481.97734) in 
the exported spectrum from an outer region, the ion density map suggests that it has 
a uniform distribution across the spheroid. CTP is present at a low intensity 
throughout the spheroid, and the exported pixel did not contain the peak 
corresponding to CTP, resulting in a false positive assignment of this nucleotide to 
the outer region (figure 4.14). This shows the limitations of using a representative 
pixel from the ion density map, whereby a single pixel is not representative of the 
heterogeneous distributions of metabolites. 
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Figure 4.14. Exported pixels shows that the peak corresponding to CTP (m/z 
481.97734) in the (top) outer and (bottom) centre of the spheroid produced a false 
positive result for the discriminatory distribution of this analyte to the outer region. 
The predicted isotope pattern is plotted as a scatter plot over the data. 
In the centre of the spheroid, four of the eight metabolites assigned are nucleotides, 
two of which are cytidine phosphates (figure 4.15). Based on the ion density maps, 
seven of the metabolites identified display distinctly localised distributions towards 
the centre of the spheroid. However, phosphatidic acid (PA) (m/z 669.45021) 
displays a consistent distribution across the structure. Comparably to the pixel 
analysis of the outer region, this false positive is the result of the exported pixel 
possessing a S/N <3 (figure 4.16). These results suggest that whilst pixel analysis is 
effective in identifying unique distributions of metabolites, a threshold of S/N >3 is 
not consistently low enough to identify low abundance peaks. 
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Figure 4.15. Ion density map showing the distribution of the metabolites that were 
assigned uniquely in the centre region using pixel analysis. The white line denotes 
the outer and centre regions of the spheroid. From left to right top row 
Glycerylphosphorylethanolamine, 5-L-Glutamyl-taurine, Cytidine 2',3'-cyclic 
phosphate, S-Formylglutathione. Bottom row LysoPA (0:0/18:2(9Z,12Z)), Riboflavin 
cyclic-4',5'-phosphate, CMP, N-acetylneuraminic acid, PA (20:2(11Z,14Z)/14:1(9Z)). 
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Figure 4.16. Exported pixels shows that the peak corresponding to PA (m/z 
669.45021) in the (top) outer and (bottom) centre of the spheroid produced a false 
positive result for the discriminatory distribution of this analyte to the centre region. 
The predicted isotope pattern is plotted as a scatter plot over the data. 
4.3 Conclusions  
Here we have shown the method development for MALDI-MSI of MTS. Using a 
simplified gelatin-embedding process, the handling of spheroids is effectively 
minimised to prevent damage. The conditions of matrix composition and matrix 
application were effectively optimised to enable successful MSI at high spatial 
resolution using both FT-ICR and ToF MSI. Using MALDI MS analysis, tentative 
formulae assignment lists were compiled. These were used to assign metabolites 
from representative pixels of an imaged spheroid, and metabolites that uniquely 
localised to different regions of the spheroid – in this case the outer and centre – 
were observed. However, the primary limitation of this method is the low S/N of a 
number of metabolites, resulting in identification of false positives during peak 
selection. 
 










Chapter 5.  
Untargeted metabolite mapping in 3D cell culture models using high spectral 
resolution Fourier-transform ion cyclotron resonance mass spectrometry 
imaging
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5.1. Introduction 
Despite the recent advances in MSI of spheroids, the majority of the work has been 
carried out using ToF MS.38 Whilst ToF-MS instruments provide high sensitivity and 
relatively fast acquisition of MSI data, they typically have a mass resolving power of 
up to ~50000 and mass accuracies of 1–5 ppm after external calibration.34 As a 
result, these instruments lack the resolving power and mass accuracy required for 
definitive determination of elemental formulae. In contrast, FT-ICR MS can achieve 
a mass resolution above 300000 and mass accuracies between 0.1–1 ppm, which is 
sufficient to assign elemental formulae from accurate mass measurements.148 For 
this reason, FT-ICR MS is widely used for characterisation of unknown metabolites 
and biomarkers.149,150 The high spectral resolution can be combined with spatial 
information using MSI to observe the distribution of known metabolites without 
employing targeted MS/MS techniques.151  
In this chapter, the high spectral resolution of the 12T FT-ICR is combined with high 
spatial resolution imaging for the analysis of metabolites within MCF-7 spheroids. 
Initially, a targeted approach was used to indicate regions of increased hypoxia and 
oxidative stress within spheroids. Subsequently, an untargeted approach of 
discriminatory analysis was employed to identify metabolites that colocalise to these 
areas. Finally, the tentative assignments were used to investigate the regional flux 
through specific biochemical pathways.  
5.2 Results and discussion 
5.2.1 MS imaging highlights redox and energy gradients across MTS 
During MSI, the signal abundance of an ion irradiated from any point is assumed to 
be proportional to the concentration of the targeted analyte. However, this view is 
over simplistic, as the analytes present could be ionised to varying extents as a 
result of ion suppression and sample heterogeneity.40 Alternatively, the proportional 
abundance of individual ions can be used to compare how their ratios change in 
different locations across the tissue.16 Using this approach, a targeted method can 
be used to compare the distributions of known metabolites within MTS. The 
distributions of oxidised/reduced glutathione and high energy adenosine phosphates 
were analysed, as these are thought to be affected by the nutrient and oxygen 
gradients within MTS.113 This study was performed with MCF-7 3D cell cultures 
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grown over eight days to form spheroids of approximately 500 µm in diameter and 
prepared for MSI as previously discussed. Spheroid sections were coated in 9AA 
matrix and subjected to MALDI FT-ICR MSI. 
5.2.1.1 An increased distribution of ATP in the outer region of the spheroid 
indicates a decreasing oxygen gradient through the spheroid. 
Almost every cellular process requires energy, converting ATP to ADP and 
phosphate. As a result, one of the fundamental parameters that all living cells must 
maintain is a high ratio of ATP to ADP. Under intracellular conditions, the 
equilibrium ratio of ATP:ADP is around 10-7:1; however, in living cells, this ratio is 
maintained at 10:1; 108 orders of magnitude away from equilibrium.152 This ratio is a 
central control parameter of intracellular energy metabolism that determines the 
free-energy change for ATP hydrolysis and therefore the driving force for many 
reactions.153 For example, in glucose metabolism, the ATP:ADP ratio determines 
whether the reaction flux through phosphoglycerate kinase is in the glycolytic or 
gluconeogenic direction.153 If mitochondrial ATP synthesis becomes compromised 
when the cell is under stress, such as during hypoxia, the ATP:ADP ratio drops 
dramatically. This results in stimulation of glycolysis to generate ATP anaerobically. 
The ATP yield per mole of glucose is much lower for glycolysis compared to 
mitochondrial oxidative phosphorylation (2 moles of ATP vs. ~35 moles of ATP per 
mole of glucose, respectively).154 Interestingly, the total ATP:ADP ratio in spheroids 
is thought to be reduced compared to monolayer cell culture.155 Furthermore, as 
spheroids age and increase in size, the rate of glycolysis increases.155 This 
suggests that whilst monolayer and small spheroids rely primarily on oxidative 
phosphorylation for energy production, larger spheroid’s energy demand is 
predominantly supported by the glycolytic pathway.155 As a result, the ability to 
observe changes in the ATP:ADP ratio can be used to visualise energy changes in 
cells.156 
Ions corresponding to ATP, ADP, and AMP are all seen in the MSI data of MCF-7 
spheroids. The distributions of the [M-H]- m/z value of ATP (m/z 505.98847) 
localised distinctly towards the outer region of the MCF-7 spheroid with 0.140 ppm 
mass error (figure 5.1). In contrast, ADP (m/z 426.02214) and AMP (m/z 
346.05581) are more uniformly localised across the spheroid with 0.167 and 0.179 
ppm errors respectively. This observation suggests that that there is a lower rate of 
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ATP production relative to dephosphorylation in this central region of the spheroid. 
This implies that the cellular environment is energy depleted, and potentially hypoxic 
compared to the outer region of the spheroid. Biological replicates show that all 
three biomolecules displayed consistent gradients across multiple separately 
imaged spheroids (figure 5.2). 
 
Figure 5.1. (A) Ion density map of ATP, ADP and AMP across an MCF-7 spheroid 
imaged at 40 µm resolution using the FT-ICR. (B) Box and whisker plot showing the 
intensity of the peak for each pixel in the allocated outer and centre regions.  
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Figure 5.2. Biological replicates of the distributions of ATP, ADP and AMP across 
individually imaged MCF-7 spheroids. 
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The high spectral resolution obtainable by FT-ICR MALDI MS enables the 
observation of isotopic fine structure (IFS) of the first isotope peak for ATP, ADP, 
and AMP (i.e. the mass discrepancy between 13C and 15N) to increase the 
confidence of the formula assignments (figure 5.3).  
Figure 5.3. The fine structure of the first isotope for ATP, ADP, and AMP observed 
by MALDI MS analysis (left to right). The predicted isotope fine structure is plotted 
over the data as scatter plots. 15 spectra were summed using a CASI window of 
m/z 15 for each nucleotide, For all species the signal for the 13C and 15N stable 
isotope are sufficiently resolved. 
5.2.1.2 An increased ratio of glutathione disulfide to glutathione is indicative 
of hypoxic environment in the central region of the spheroid 
The tripeptide glutathione (GSH) plays an important role in maintaining the cellular 
redox homeostasis through oxidation of its sulfhydryl group to form glutathione 
disulfide (GSSG).157 The overall concentration of GSH varies between organisms, 
however it exists in vivo predominantly in the reduced form to maintain the 
GSH:GSSG ratio and avert oxidative stress and apoptosis.158 Under conditions of 
oxidative stress, GSH is oxidised. This results in an intracellular redox imbalance 
reflected by a decreased GSH:GSSG ratio.159 Thus, the ratio of GSH:GSSG has 
been proposed to be a marker for the oxidative nature of the cellular environment 
and a potential indicator of oxidative stress.  
The distributions of the [M-H]- m/z values of GSSG (m/z 611.14469) and GSH (m/z 
306.07653) were imaged within the MCF-7 spheroid with 0.294 ppm and 0.289 ppm 
errors respectively (figure 5.4). Overall, both GSSG and GSH increase in intensity 
towards the centre of the spheroid (figure 5.4A). However, the observed ratio of ion 
abundance for the GSH:GSSG ions differs in the two regions, with a clear decrease 
of this ratio in the inner region (figure 5.4B). This observation suggests that the 
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oxidised form is present at a higher relative abundance compared to the reduced 
form in the central region of the spheroid. This is consistent with greater oxidative 
stress experienced in this central region. This observation was reproducible across 
independently imaged spheroids (figure 5.5). 
 
Figure 5.4. (A) Ion density map of oxidised (m/z 611.14469) and reduced (m/z 
306.07653) glutathione with overlaid spectra showing with 0.294 ppm and 0.289 
ppm errors respectively. (B) The box and whisker plots correspond to the intensity of 
the m/z value for each pixel allocated to the outer and centre region. The values are 
normalised against the highest peak intensity. 
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Figure 5.5. Biological replicates of the distributions of oxidised (GSSG) and reduced 
(GSH) glutathione across independently imaged MCF-7 spheroids. 
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Taken together, the ratios of ATP:ADP and GSSG:GSH observed using MSI are 
indicative of both oxidative stress and hypoxia occurring within the central region of 
the spheroid. Whilst this may sound paradoxical, the co-occurrence of these 
biological states in the same tissue environment is well documented, as hypoxia is 
known to increase the production of reactive oxygen species (ROS), thereby 
increasing cellular oxidative stress. In fact, ROS signalling is directly responsible for 
stabilisation of the transcription factor hypoxia-inducible factor (HIF-1α); the primary 
transcriptional response to hypoxic stress.160 In turn, HIF-1α has been shown to 
cause a metabolic switch in tumour cells by modulating expression of genes 
including pyruvate dehydrogenase kinase, resulting in an increased flux through the 
glycolytic pathway.161  
5.2.2 Identifying metabolites which display ion abundance gradients within 
MTS 
Discriminatory analysis was performed to identify the metabolites that are most 
affected by the hypoxia-induced oxidative stress produced across the spheroid’s 
diameter. For this analysis, two regions were defined within a spheroid as the ‘outer’ 
and ‘centre’ based on 50% of the radius (figure 5.6). For each m/z value the area 
under the receiver operating characteristic curve (AUC of ROC) was determined 
and the top five discriminatory metabolites in each region were tentatively identified 
based on their m/z using HMDB.  
 
Figure 5.6. Regions were drawn on the SCiLS software corresponding to the ‘outer’ 
and ‘centre’ regions of the spheroid based on 50% of the radius. Using these 
regions, discriminatory analysis was performed. 
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5.2.2.1 High energy uridine phosphates are localised to areas of high oxygen 
availability 
The five molecules that discriminated most strongly towards the outer region were 
identified using the HMDB with a sub-1 ppm error (figure 5.7). Remarkably, all five 
of the discriminatory molecules were identified as uridine phosphates based on their 
m/z values. This is in agreement with recent findings that hypoxia is associated with 
decreased abundance of uridine nucleosides.144,162 
In our data, uridine triphosphate (UTP) (AUC = 0.960), UDP (AUC = 0.992) and 
UDP-N-acetyl hexose isomers, such as UDP-GlcNAc (AUC = 0.887) display 
gradients across the diameter of a spheroid. These distributions were reproducible 
across biological replicates of independently imaged spheroids (figure 5.8) These 
species play central roles in the HBP from which the high energy end product UDP-
GlcNAc is catabolised from glucose, glutamine, acetyl-CoA and UTP.163 UDP-
GlcNAc goes on to play an important role in proliferation by contributing to the 
synthesis of glycosaminoglycans, proteoglycans, and glycolipids, which regulate cell 
signalling and enzyme activity in primary metabolism.164,165 
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Figure 5.7. Discriminatory analysis for the identified five outer discriminatory molecules. Formulae were assigned with a sub-ppm error. For 
each formula identified, the ion density map, ROC, box and whisker plot, and isotope pattern are shown.  Expected isotope pattern is overlaid 
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Figure 5.8. Biological replicates of the distributions of the discriminatory molecules 
identified in the outer region of an MCF-7 spheroid. 
It is thought that under conditions of energetic surplus, 10% of glycolysis flux is 
redirected into the HBP to produce UDP-GlcNAc. However, as a result of 
insufficient oxygen, glucose is re-directed through glycolysis to produce ATP as an 
energy source, reducing the flux through the HBP.145,146 This is supported by the 
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decreased levels of HBP intermediates in the centre of the spheroid. In addition, we 
observed upregulation of assigned glycolysis intermediates in the centre of the 
spheroid. This included C6H13O9P (m/z 259.02244) corresponding to hexose-
monophosphates (e.g. glucose-6-phosphate (G-6-P), galactose-6-phosphate and 
fructose-6-phosphate (F-6-P)), as well as fructose-1,6-bisphosphate (F-1,6-BisP) 
(m/z 338.98877) (figure 5.9). The cleavage of F-1,6-BisP during the next steps of 
glycolysis produces dihydroxyacetone phosphate (DHAP) and glycerol-3-
phosphate, whose distributions were not observed. 
Figure 5.9. The elemental formula of the metabolites assigned can be mapped onto 
the HBP. Note how the HBP is upregulated in the outer region, whereas glycolysis 
intermediates are upregulated in the centre region. Glucosamine-6-phosphate was 
not observed using MSI. 
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5.2.2.2 High energy cytidine phosphates localise in areas of low oxygen 
availability 
The five molecules that discriminated most strongly towards the centre region were 
also identified using the HMDB with sub-1 ppm error. Four of these are related 
metabolites and all contain cytidine, including cytidine diphosphate (CDP) (AUC = 
0.967), cytidine monophosphate (CMP) (AUC = 0.978), CDP-ethanolamine (AUC = 
0.979), and cytidine-2’,3’-cyclic phosphate (cCMP) (AUC = 0.950) (Figure 5.10). 
These distributions were reproducible across independently imaged biological 
replicates (figure 5.11). Cytidine and uridine have a mass difference of 0.98401 Da, 
(UDP: [M-H]- m/z 323.02859; CDP: [M-H]- m/z 322.04458). The high spectral 
resolution offered by FT-ICR allows the resolution of the monoisotopic peak of UDP 
to the first isotope of CDP with ease (figure 5.12).
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Figure 5.10. Discriminatory analysis for the identified five centre discriminatory molecules. Formulae were assigned with a sub-ppm error. For 
each formula identified, the ion density map, ROC, box and whisker plot, and expected isotope pattern are shown. Expected isotope pattern is 
overlaid as a scatter plot on the spectrum.
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Figure 5.11. Biological replicates of the distributions of the discriminatory molecules 
identified in the centre region of an MCF-7 spheroid. 
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Figure 5.12. The high resolution of the FT-ICR MS resolves the sub-1 Da mass 
difference between the monoisotopic peak of UMP (blue) and the first isotope peak 
of CMP (red). 
High-energy cytidine phosphates are utilised in the post-translational modification of 
glycoproteins and glycosylation of glycolipids with N-acetylneuraminic acid 
(NeuNAc). This modification is produced as an end-product of the sialic acid 
pathway (figure 5.13). Interestingly, there is evidence that cancer cells present 
elevated levels of neuraminic acid, which has been suggested to play an important 
role in malignancy and the evasion of the immune system.165 Furthermore, it is 
thought that hypoxia further increases the expression of intracellular NeuNAc.166  
In addition, the sialic acid pathway and the HBP are closely linked, whereby 
NeuNAc can be converted to CMP-NeuNAc for use in the sialic pathway, or 
alternatively isomerised to N-acetylmannosamine (ManNAc), which can be 
converted back into GlcNAc and salvaged back into the HBP (figure 5.13).146 As 
shown in our data, the intermediates of both these pathways have distinct 
distributions in the MTS. The high energy uridine phosphates associated with the 
HBP are localised towards the outer proliferative regions (figure 5.9). In contrast, 
high energy cytidine phosphates distribute towards the oxidative hypoxic conditions 
of the central region (figure 5.10). These distibutions suggest that the 
microenvironments within MTS display distinct metabolic fluxes in these pathways. 
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Figure 5.13. Sialic acid pathway. N-acetyl neuraminic acid (sialic acid) is formed by 
the end product of the HBP. UDP-GlcNAc Uridine N-acetylglucosamine; UDP 
Uridine diphosphate; ATP adenosine triphosphate; ADP adenosine diphosphate; 
ManNAc-6-P N-acetylmannosamine-6-phosphate; PEP Phosphoenol pyruvate; 
Neu9NAc-9-P N-acetylneuraminic acid-9-phosphate; NeuNAc N-acetylneuraminic 
acid; CMP-NeuAc cytidine monophosphate N-acetylneuraminic acid; CMP cytidine 
monophosphate. 
5.3 Conclusions 
Here, high resolution MSI has been used to determine metabolite distributions within 
MTS cell culture models. Metabolite markers have been employed to indicate 
regions of increased oxidative stress and hypoxia. In addition, the information 
obtained using this approach may be informative for investigating the regional flux 
High Spectral Resolution Mass Spectrometry Imaging of Three-Dimensional Cell Culture 
 
Chapter 5. Untargeted metabolite mapping in 3D cell culture models 
using high spectral resolution FT-ICR MSI   89 
through biochemical pathways. Here, an upregulation of metabolic branch pathways 
such as the HBP in the regions of the spheroid with greater access to oxygen was 
observed. Conversely, there is greater glycolytic flux within the regions limited by 
hypoxia. However, the presence of ionisation bias enables the comparison of 
relative intensities, but prevents any definitive quantification of the distributions 
observed. This methodology shows great promise for applications in toxicity studies 
during drug development, whereby the ADME of the drug could be correlated with 
its effects on cellular metabolism.
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Observing the distribution of a hypoxia marker within multicellular tumour 
spheroids 
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6.1 Introduction 
Oxygen is vital for cell survival, as it is the terminal electron acceptor in cellular 
respiration. Under conditions of insufficient oxygen; a phenomenon known as 
hypoxia, cells die by necrosis or apoptosis.167 Many solid tumours experience 
hypoxia and trigger complex responses for adaptation, survival, and metastasis.168 
Therefore, understanding the effects of these hypoxia-induced changes in tumours 
is essential for the development of effective cancer treatments.168 
To detect hypoxic regions in tissues, various probes have been developed. A 
number of these contain a 2-nitroimidazole structure that readily undergoes 
reductive metabolism and uniquely accumulates in hypoxic regions.169 Pimonidazole 
is a 2-nitroimidazole-based marker used for measuring tumour hypoxia in 
pathological research.170,171 Under hypoxic conditions, the nitro group on the 
imidazole ring is reduced in a series of steps to produce highly reactive products, 
which can covalently bind to cellular nucleophiles such as thiol-containing 
proteins.167,168  
Figure 6.1 outlines a suggested metabolism of pimonidazole reduction. First, a two-
electron reduction produces nitroso-pimonidazole (2) through a highly reactive and 
short lived nitrenium intermediate.168,170,172 A second two-electron reduction product 
forms pimonidazole hydroxylamine (3). This product can then covalently bind to 
nucleophilic macromolecules (5), or conjugate with glutathione (6) in cells.170,172,173 
Alternatively, the hydroxylamine can undergo a further reduction to yield an amine 
derivative (4).168,172,174  
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Figure 6.1. Suggested mechanism for the accumulation of pimonidazole in hypoxic 
tissue regions. Under hypoxic conditions, the nitro group on the imidazole ring is 
reduced in a series of steps to produce a product capable of covalently binding to 
proteins, glutathione, and other macromolecules within the cell. 
MSI is advantageous over immunohistochemical techniques, as it provides an 
untargeted approach that does not require a specific label or antibody.170 Because 
of the basic properties of the piperidine side chain, pimonidazole is suitable for mass 
spectral detection.168 MSI has been applied to identify pimonidazole and a number 
of its reduced forms, including the glutathione conjugate, which was found to 
colocalise with the immunohistochemically stained areas corresponding to hypoxic 
tissue.170  
In this chapter, the use of MALDI-MSI to map the distribution of pimonidazole within 
MTS will be discussed. Initially, human prostate cancer (PC3) spheroids were 
cultured over 14 days to approximately 500 µm in diameter. The spheroids were 
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subsequently dosed with pimonidazole for 24 hours, and MALDI ToF and FT-ICR 
MSI were carried out. CASI was employed to lower the limit of detection and 
increase the signal intensity of pimonidazole and its metabolites. Finally, a dosing 
time course was used to assess the time-dependent penetration of the hypoxia 
marker into the spheroids. 
6.2 Results and discussion 
6.2.1 Initial method development 
To establish the ionisation efficiency of pimonidazole, MALDI MS was carried out. 
100 µM pimonidazole was mixed with either DHB or CHCA and 15 spectra were 
averaged using ToF MS (see methods section 3.4.1 for details) (figure 6.2). DHB 
produced a signal 100-fold more intense than CHCA and did not present other 
significant peaks within the region of the monoisotopic peak. Unlike previously 
published literature,168 fragmentation of the parent ion did not occur under the 
experimental conditions employed. 
 
Figure 6.2. MALDI MALDI MS of pimonidazole on steel plates with (top) DHB and 
(bottom) CHCA as the matrix. Expected isotope pattern is overlaid as a scatter plot. 
To establish the correct dosing concentration, 14-day-old PC3 spheroids were 
cultured using the hanging drop method and dosed with a range of pimonidazole 
concentrations from 100 µM to 1 mM for 24 hours. After dosing the spheroid at 
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concentrations below 200 µM, no peaks corresponding to pimonidazole or its 
metabolites were observed by MSI, whereas concentrations greater than 500 µM 
resulted in disintegration of the spheroid during incubation (figure 6.3). Therefore, a 
concentration of 200 µM was selected for further experiments. 
Figure 6.3. Microscope image of a PC3 spheroid dosed with (A) 200 µM (B) 500 µM 
and (C) 1 mM pimonidazole for 24 hours. 
6.2.2 MSI of pimonidazole 
To observe the distribution of pimonidazole and its metabolites after 24 hours, 
MALDI-MSI was employed. 14-day-old PC3 spheroids were dosed with 200 µM 
pimonidazole for 24 hours and prepared for imaging as previously discussed. DHB 
was used as the matrix and the spheroids were imaged in positive mode at 40 µm 
spatial resolution. H&E staining was used to confirm the structural integrity of the 
spheroids after sectioning. 
6.2.2.1 ToF MSI of pimonidazole 
Initially, positive mode MALDI ToF MSI was performed on dosed and untreated PC3 
spheroids. Imaging runs were calibrated using red phosphorus prior to imaging and 
using internal DHB peaks post-imaging (see methods section 3.5.1 and table 3.5 for 
details). Using TIC normalisation, a low intensity peak consistent with pimonidazole 
at m/z 255.145 was observed in the treated spheroid and in the gelatin surrounding 
the control spheroid with a mass error of 1.2 ppm (figure 6.4). An exported pixel 
from the control and treated spheroid shows that the peak corresponding to 
pimonidazole is uniquely present within the dosed spheroids and absent in the 
control. 
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Figure 6.4. MALDI ToF MSI of pimonidazole (m/z 255.145) in (A) control and (B) 
dosed PC3 spheroids. H&E staining was used to confirm the morphology of the 
spheroid. The predicted isotope pattern is plotted over the data as a scatter plot with 
a 1.4 ppm error. 
An advantage of MSI is the global untargeted analysis across the entire mass range 
imaged. This untargeted approach enables the visualisation of pimonidazole and its 
metabolites within the same spheroid (figure 6.5). The ion density maps show that 
all of the metabolites distribute uniformly across the spheroid. Furthermore, both the 
parent ion (1, m/z 255.145) and the nitroso ion (2, m/z 239.150) are present at 
significantly lower intensities than the subsequent reduction species. Whilst MSI is 
currently not a quantitative technique, the relative intensities of the metabolites can 
be observed using a box and whisker plot (figure 6.6). These show that 
pimonidazole and the nitroso ions have low relative intensities, whereas the 
hydroxylamine (3, m/z 241.166) and amine (4, m/z 225.171) derivatives are present 
at much higher relative intensities. Using an exported pixel, the S/N of the parent ion 
and its metabolites were 3, 6, 96 and 122 respectively. As a result of the low S/N for 
the ions observed, the control produces a false positive, however these values are 
all significantly lower than the dosed spheroid. The spectra are normalised using 
TIC, and the box and whisker plots are plotted as a percentage of the most 
abundant metabolite observed. The errors were calculated as 4.4, 4.8, and 1.3 ppm 
for the nitroso (2), hydroxylamine (3), and amine (4) metabolites respectively.  
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Figure 6.5. ToF MSI of pimonidazole-dosed spheroids over 24 hours. Ion density 
maps of pimonidazole (m/z 255.145), nitroso (m/z 239.150), hydroxylamine (m/z 
241.166), and amine (m/z 225.171) derivatives. The box and whisker plots compare 
the intensity of each respective metabolite between the treated and control 
spheroids. The predicted isotope patterns are plotted over the data as scatter plots 
with 1.4, 4.4, 4.8, and 1.3 ppm errors respectively. 
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Figure 6.6. Box and whisker plots showing the intensity of the parent ion and each 
metabolite after 24 hours of dosing compared to an untreated spheroid (control). 
The values are normalised against the highest peak intensity within the regions 
selected. 
Whilst the peaks are absent in the control, the high errors after calibration prevent 
confident assignment of the peaks using m/z values alone. Therefore, MALDI FT-
ICR MSI was employed for confident assignment of the peaks without the 
requirement for MS/MS. 
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6.2.2.2 FT-ICR MSI of pimonidazole 
PC3 spheroids were prepared as previously discussed and imaged at 40 µm 
resolution using the 12T FT-ICR in positive mode. Quadratic calibration of 
representative exported pixels post-imaging was carried out using internal peaks 
(see methods, table 3.2 for details). However, unlike ToF MSI, the pimonidazole 
parent ion was not observed in the ion density maps or an exported pixel (figure 
6.7). 
 
Figure 6.7. FT-ICR for pimonidazole (m/z 255.14517) in (A) control and (B) dosed 
PC3 spheroids. H&E staining was used to confirm the morphology of the spheroid. 
The predicted isotope pattern is plotted as a scatter plot over the data. 
Despite the absence of pimonidazole, all three of the metabolites were observed 
within the spheroid at low intensity and with sub-ppm errors (figure 6.8). 
Furthermore, the distributions of the metabolites were unique from those observed 
by ToF. Whilst the nitroso ion (2, m/z 239.15025) displayed a uniform distribution 
across the spheroid, the other derivatives were localised towards the centre of the 
spheroid. This could be suggestive of the pimonidazole undergoing reduction as a 
result of the hypoxic environment at the centre of the spheroid.  
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Figure 6.8. FT-ICR MSI of pimonidazole-dosed spheroids over 24 hours. Ion density 
maps of pimonidazole (m/z 255.14517), nitroso (m/z 239.15025), hydroxylamine 
(m/z 241.16590), and amine (m/z 225.17099) derivatives. The box and whisker plots 
compare the intensity of each respective metabolite between the treated and control 
spheroids. The predicted isotope patterns are plotted over the data as a scatter 
plots with calculated errors of 0.408, 0.482, and 0.222 ppm for each metabolite 
respectively. 
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The box and whisker plots show that pimonidazole is present at a value equivalent 
to the control, suggesting the peak is the result of the baseline noise, whereas the 
other metabolites are all present at higher intensities. Moreover, the nitroso (2, m/z 
239.15025) and amine (4, m/z 225.17099) metabolites are present at the highest 
relative intensities of the metabolites observed, suggesting that pimonidazole is 
reduced over 24 hours within the spheroid (figure 6.9). The lower intensity of the 
hydroxylamine product could be the result of its reaction with intracellular 
macromolecules. However, due to the variety of proteins it can conjugate to within 
the cell, these are not observed within the mass range imaged.  
 
Figure 6.9. Box and whisker plot showing the intensity of pimonidazole and its 
metabolites after 24 hours. The values are normalised against the highest peak 
intensity. 
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Previous literature suggests that the glutathione conjugate of the hydroxylamine 
reduction product colocalises with regions of hypoxia. However, the glutathione 
conjugate (m/z 530.23914) was not observed by either MALDI ToF or FT-ICR MSI 
(figure 6.10). The ion density map produced a signal that was localised to the 
surrounding regions of the spheroid. However, this was present in both the control 
and the dosed spheroid, suggesting this could be the result of a matrix or gelatin-
related peak. 
 
Figure 6.10. Ion density map showing the distribution of m/z 530.23914 
corresponding to the pimonidazole glutathione conjugate in (A) ToF MSI and (B) FT-
ICR MSI after 24 hours. The predicted isotope pattern is plotted over the data as a 
scatter plot. 
Alternative literature has detected the presence of an additional pimonidazole 
reduction product at m/z 223.15528, which is suggested to colocalise with regions of 
hypoxia identified by immunohistochemical staining.168 The identity of the ion was 
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proposed to have originated from a conjugate that undergoes in-source 
fragmentation to regenerate the nitrenium ion or a structurally related species.167,168 
The distribution of m/z 223.15528 was observed by both ToF and FT-ICR MSI 
(figure 6.11). Similarly to the metabolite products discussed, the distribution of this 
ion is uniformly localised when imaged by MALDI ToF MSI, whereas MALDI FT-ICR 
MSI suggests it is localised to the centre region. The S/N for this ion under ToF MSI 
was 120, whereas for FT-ICR the S/N was 3.8. 
 
Figure 6.11. MALDI (A) ToF and (B) FT-ICR MSI of m/z 223.15528 in dosed 
spheroids over 24 hours. The box and whisker plots compare the intensity of each 
respective metabolite between the treated and control spheroids. The predicted 
isotope patterns are plotted over the data as scatter plots with a calculated error of 
0.4 and 0.158 ppm errors by ToF and FT-ICR respectively. 
6.2.3 CASI for improved signal-to-noise of selected ions 
Whilst all three metabolites were observed using MALDI FT-ICR MSI, the S/N for 
each metabolite is very low. The nitroso (2), hydroxylamine (3), and amine (4) 
reduction products had S/N values of 17.5, 4.3, and 19.4 respectively. Therefore, 
CASI can be used to increase the S/N, achieve better sensitivity, and lower the limit 
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of detection for low abundance analytes without the need for MS/MS. In CASI mode, 
target ions are accumulated and enriched using quadrupoles, increasing the signal 
intensity of the selected ions.33  
Initially, MALDI MS CASI was employed to detect the presence of pimonidazole and 
its metabolites in the spheroids. An average of 15 acquired spectra show that 
pimonidazole and all three reduction metabolites are observed using a Q1 mass of 
m/z 240 and CASI window of m/z 40 (figure 6.12). All four ions were observed at a 
resolution of over 98000. The S/N for each ion was 402.6, 119.1, 470.0, and 550.9 
for pimonidazole (1, m/z 255.14517), nitroso (2, m/z 239.15025), hydroxylamine (3, 
m/z 241.16590) and amine (4, m/z 225.17099) ions respectively. This is an increase 
of over 10-fold for each metabolite. Due to the narrow mass window, single-point 
calibration was carried out using the parent ion (m/z 255.14517). 
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Figure 6.12. (A) MALDI MS of 15 averaged spectra with a CASI window of m/z 40 
ionises pimonidazole and all three of its reduction metabolites. (B) Pimonidazole 
(m/z 255.14517), (C) nitroso (m/z 239.15025), (D) hydroxylamine (m/z 241.16590), 
and (E) amine (m/z 225.17099) derivatives. The predicted isotope patterns are 
plotted over the data as scatter plots with 0.000, 0.084, 0.105, and 0.124 ppm mass 
errors respectively. 
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As previously discussed, the high spectral resolution obtainable by FT-ICR enables 
the observation of IFS of the first isotope peak for each metabolite to increase the 
confidence of the formula assignment. Due to the low signal of the metabolites, the 
success of the analysis was limited. However, there is some evidence for the correct 
isotope ratios between the 13C and 15N (Figure 6.13).  
 
Figure 6.13. The fine structure of the first isotope for (A) pimonidazole and (B–D) its 
metabolites observed by MALDI MS analysis. (B) Nitroso, (C) hydroxylamine, and 
(D) amine. The predicted isotope fine structures are plotted over the data as scatter 
plots. 
Based on the spectra obtained, CASI MSI of spheroids was carried out with a Q1 
mass of m/z 240 and a window of m/z 40. Unlike the MALDI FT-ICR MSI data 
previously, the use of CASI improved the sensitivity and enabled the detection and 
visualisation of the pimonidazole parent ion (1, m/z 255.14517) within the spheroid 
(figure 6.14). 
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Figure 6.14. FT-ICR for pimonidazole in (A) control and (B) dosed PC3 spheroids 
with CASI. H&E staining was used to confirm the morphology of the spheroid. The 
isotope patterns are plotted over the data as scatter plots with a 0 ppm error.  
Due to the window of m/z 40, it was possible to also observe the distribution of the 
reduction metabolites across the PC3 spheroid (figure 6.15). These show that 
pimonidazole and its metabolites all localise to the centre region of the spheroid. 
The ion density maps suggest that the hydroxylamine (3, m/z 241.16590) and amine 
(4, m/z 225.17099) metabolites are present at higher intensities compared to the 
parent ion. The S/N for the parent ion and its metabolites was 71.2, 169.9, 27.3, and 
189.9 respectively.  
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Figure 6.15. FT-ICR MSI of pimonidazole-dosed spheroids over 24 hours with a 
CASI window of m/z 40. Ion density maps of pimonidazole (m/z 255.14517) and its 
nitroso (m/z 239.15025), hydroxylamine (m/z 241.16590), and amine (m/z 
225.17099) derivatives. The box and whisker plots compare the intensity of each 
respective metabolite between the treated and control spheroids. The predicted 
isotope patterns are plotted over the data as scatter plots with 0.000, 0.866, 0.788, 
and 0.666 ppm errors respectively. 
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The CASI window utilised also enabled the observation of the pimonidazole-derived 
reduction product at m/z 223.15528. This ion had a similar distribution to the other 
metabolites and localised towards the centre of the spheroid (figure 6.16). The S/N 
of this ion was 107.6. 
 
Figure 6.16. (A) FT-ICR MSI of pimonidazole-derived ion (m/z 223.15528). The box 
and whisker plot compares the intensity of the m/z 223.15528 peak between the 
dosed spheroid and the control. The predicted isotope pattern is plotted over the 
data as scatter plots with 0.809 ppm error. 
The box and whisker plots of pimonidazole and its metabolites show that each 
successive reduction derivative increases in relative intensity. Furthermore, the 
amine (4) derivative displays the highest intensity compared to the other metabolites 
(figure 6.17). This implies that pimonidazole has undergone reduction into the amine 
(4, m/z 225.17099) derivative within the PC3 spheroids after 24 hours. However, the 
extent of conjugation of the hydroxylamine (3, m/z 241.16590) with other 
macromolecules within the cell is unknown. The average intensity of m/z 223.15528 
is similar to the parent ion, however its point of production within the reduction 
pathway is uncertain. 
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Figure 6.17. Box and whisker plot showing the intensity of pimonidazole and each 
metabolite after 24 hours. The values are normalised against the highest peak 
intensity. 
In order to observe the glutathione conjugate, CASI at m/z 530 with a window of m/z 
15 was employed. Single-point calibration with a DHB matrix peak at m/z 545.07145 
was used for assignment. Whilst MALDI MS analysis produced a peak that 
corresponded to the conjugate with 0.945 ppm error (figure 6.18), the peak was only 
observed in the matrix surrounding the spheroid and was not present within the 
spheroid itself (figure 6.19). This suggests that the peak could be the result of the 
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matrix or gelatin. Furthermore, the large error associated with the peak is suggestive 
that it does not correspond to the glutathione conjugate. 
 
Figure 6.18 MALDI MS analysis of peak corresponding to glutathione conjugate 
(m/z 530.23914) in spheroids. The predicted isotope pattern is plotted over the data 
as a scatter plot. 
 
Figure 6.19. Ion density map corresponding to the pimonidazole glutathione 
conjugate (m/z 530.23914). The predicted isotope pattern is plotted over the data as 
a scatter plot. 
6.2.4 Pimonidazole metabolism time course 
To observe the time-dependent penetration and metabolism of pimonidazole over 
24 hours within a spheroid, 14-day-old PC3 spheroids were dosed with 200 µM 
pimonidazole for six, 18 and 24 hours. Spheroids were sectioned and imaged using 
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MALDI FT-ICR MSI with a Q1 mass of m/z 240 and a CASI window of m/z 40. The 
distribution of the pimonidazole parent ion (1, m/z 255.14517) was observed at the 
first time point of six hours (figure 6.20). The box and whisker plot shows an 
increased uptake until 18 hours at which point the intensity of the peak 
corresponding to pimonidazole remains the same. The ion density maps show that 
pimonidazole is localised towards the centre at six hours but becomes distributed 
throughout the spheroid by 24 hours. This suggests that pimonidazole can penetrate 
and accumulate throughout the spheroid within this period. 
 
Figure 6.20. Box and whisker plot and ion density map showing the intensity of the 
pimonidazole parent ion over a 24-hour time course. 
The distributions of the reduction metabolites over 24 hours were also observed 
(figure 6.21). All three reduction metabolites are present by six hours and become 
distributed throughout the spheroid over the time course, suggesting that 
pimonidazole diffuses into the spheroid and begins to undergo reduction within six 
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hours. Furthermore, the intensities of all three metabolites increase towards the 
central core, suggesting that pimonidazole is undergoing reduction from the centre 
of the spheroid. 
 
Figure 6.21. Ion density maps of pimonidazole (m/z 255.14517), nitroso (m/z 
239.15025), hydroxylamine (m/z 241.16590), and amine (m/z 225.17099) 
derivatives over a 24-hour time course. 
The box and whisker plots of pimonidazole metabolites show that the intensity of the 
nitroso (2, m/z 239.15025) and hydroxylamine (3, m/z 241.16590) derivatives 
increase up until 18 hours, at which point the average intensity plateaus, whereas 
the amine (4, m/z 225.17099) derivative continues to increase in intensity at the 24-
hour timepoint (figure 6.22). This could suggest, that at 24 hours, the uptake of 
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pimonidazole is at an equivalent rate to its reduction (figure 6.22A), resulting in an 
accumulation of the final reduction amine derivative (figure 6.22D). 
 
Figure 6.22. Box and whisker plot showing the intensity of (A) pimonidazole (m/z 
255.14517) (B) nitroso (m/z 239.15025), (C) hydroxylamine (m/z 241.16590) and 
(D) amine (m/z 225.17099) over the 24-hour time course. The values are 
normalised against the highest peak intensity. 
Moreover, by dividing the spheroid into an ‘outer’ and ‘centre’ region based on 50% 
of the radius, the box and whisker plots show that there is a greater accumulation of 
pimonidazole and its derivatives in the centre region compared to the outer region 
(figure 6.23). This further suggests that pimonidazole is becoming more reduced in 
the centre of the spheroid. 
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Figure 6.23. Box and whisker plots showing the intensity of (A) pimonidazole (m/z 
255.14517) (B) nitroso (m/z 239.15025), (C) hydroxylamine (m/z 241.16590) and 
(D) amine (m/z 225.17099) derivatives over the 24-hour time course between the 
outer (O) and centre (C) of the spheroid. Each numerical value corresponds to the 
number of hours the spheroid was dosed. 
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Given that the imidazole ring is only reduced under hypoxic conditions, these results 
suggest that the centre of the spheroid is experiencing hypoxia.167,168 This is in 
agreement with current literature, which indicates that spheroids with radii greater 
than 200 µm surpass oxygen diffusion limits and experience hypoxic conditions.84,115 
However, it has been suggested that MALDI-MSI of pimonidazole and its 
metabolites display a non-specific localisation, and their distributions do not 
correlate with the hypoxic regions of the cell. Therefore, the localisation of the 
reduction products through MALDI-MSI does not definitively identify the oxygen 
deficiency within the spheroid. 
Similarly to the other metabolites, the intensity of the pimonidazole-derived ion (m/z 
223.15528) increases up to 18 hours, at which point it remains the same (figure 
6.24). The ion density maps show that the derivative was observed at the centre of 
the spheroid from six hours and becomes distributed throughout the spheroid over 
the time course. The increasing intensity towards the centre of the spheroid 
suggests that this could be a hypoxic region. Conversely, the localisation of this ion 
was similar to other metabolites within the spheroid, whereas previous literature 
observed a unique distribution.168 
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Figure 6.24. Box and whisker plot and ion density map showing the intensity of the 
m/z 223.15528 over a 24-hour time course. The box and whisker plot compares the 
relative intensity of each respective metabolite between the treated and control 
spheroids. 
6.3 Conclusions 
Here we show MALDI-MSI can be employed to observe the distribution of the 
hypoxia marker pimonidazole using both MALDI ToF and FT-ICR MSI. Furthermore, 
CASI provides an effective tool to improve the sensitivity of detecting both the 
parent ion and its metabolites. Finally, using high spatial resolution MSI, it is 
possible to simultaneously map the time-dependent distribution of pimonidazole and 
its metabolites over a 24-hour time course. Future work could complement this data 
with immunohistochemical to establish which metabolites colocalise with the hypoxic 
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7.1 Introduction 
Sub-optimal matrix application conditions can cause extensive analyte diffusion, 
therefore the selection of the most appropriate matrix and optimisation of its 
application parameters is key to obtaining high quality and biologically relevant 
spectra directly from tissue samples.9 Subtle changes in matrix application rate, 
drying times, matrix composition and thickness have all been demonstrated to affect 
the ionisation efficiency, the propensity to detect low abundance compounds and 
the reproducibility of the results obtained.40,175 
Automated matrix application platforms remove the inter-user variability of manual 
applications by controlling the temperature, solvent flow rate, velocity of the spraying 
nozzle, and the number of passes; however they are generally slower than manual 
alternatives.94 Several automated systems are commercially available, including the 
Bruker ImagePrep, the SunChrom SunCollect, and the HTX-TM-Sprayer, however 
the cost of this equipment limits many research facilities’ accessibility to the 
technique.95 A number of less expensive automated matrix application strategies 
have been developed in academic research laboratories, including an automated 
acoustic spotter,78 the repurposing of an inkjet printer,79 and the use of an pneumatic 
sprayer on top of a pneumatically moveable base (table 7.1).95 After optimisation, 
these systems produced matrix crystals of 5 to 10 µm in diameter, and the mass 
spectra data collected displayed a high signal intensity and reproducibility.95 
Table 7.1. A comparison of the cost of different automated matrix application 
methods as of March 2018. 
Matrix deposition method Company Approximate cost ($) 
HTX sprayer Carrboro 60,000 
ImagePrep Bruker 45,000 
Suncollect SunChrom 20,000 
Langartech CIC EnergiGUNE 3,500 
Inkjet printer University of Florida 200 
3D printer University of Edinburgh 2,600 
In this chapter, method development of matrix application will be discussed. A 
commercial 3D printer ($300) and other parts commonly found in an analytical 
chemistry lab were used to build a cost-effective alternative to commercial sprayers. 
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The extent of diffusion during matrix application was quantified using printed 
rhodamine B microarrays and fluorescence imaging. Optimisation of matrix 
application was carried out using experimental design to vary key experimental 
parameters including bed temperature, gas pressure, and nozzle height, which 
effectively reduced analyte diffusion on the rhodamine B microarrays. Subsequently, 
the home-built sprayer was used to observe metabolite distributions in MCF-7 
spheroid sections with a consistently high spatial and spectral resolution.  
7.2 Results and discussion 
7.2.1 3D printer set-up 
A WANHAO i3 duplicator 3D printer with a temperature-controlled build plate (0–120 
oC) was used in this work. Adaptation of the printer takes approximately half an hour 
and costs a total of ca. $2600. First, the 3D printer was set up using the manual 
instructions provided by the manufacturer. A nebuliser housing block was designed 
using online software and printed in from poly lactic acid (PLA) plastic using the 3D 
printer (figure 7.1). 
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Figure 7.1. Online software was used to design a nebuliser housing block that held 
the nebuliser in place during matrix application. Holes were designed to secure the 
nebuliser above the sample as well as the block onto the converted printer. The file 
was converted into an .STL format and printed by the 3D printer according to the 
instructions provided by the manufacturer. 
Once the block was printed, the 3D printer was converted into a matrix application 
platform. First, the printer’s extruder and fans were removed to leave the empty 
extruder housing. Any remaining low voltage wires were insulated and secured in 
place with electrical tape (figure 7.2). The extruder and fans were stored to enable 
conversion back to the printer if required for future use. 
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Figure 7.2. Outline of the printer set-up. (A) The 3D printer used was the WANHAO 
Duplicator i3. (B) The extruder and fans were removed to leave the empty extruder 
housing. (C) The remaining low voltage wires were insulated and secured in place 
with electrical tape. 
A hex bolt was secured into the printed nebuliser housing block. The block was then 
attached onto the empty extruder housing using M3 Hex bolts on the underside of 
the housing (figure 7.3). 
 
Figure 7.3. Outline of the printer set-up. (A) An M4 hex bolt was secured in the 3D 
printed nebuliser block. (B) The nebuliser block was then secured in place onto the 
empty extruder housing using (C) the M3 hex bolts on the underside of the 3D 
printed block. 
Nitrogen was used as the nebuliser gas for matrix application (70 psi) and the gas 
pressure was set manually with an inline regulator. A Rheodyne C1-2006 6 port 
valve (Valco Instruments, Texas, USA) was attached on top of the printer (figure 
7.4). 
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Figure 7.4. Outline of the printer set-up. (A) On the top side of the printer (B) a 
Rheodyne 6 port valve was attached. (C) A nitrogen gas supply (70 psi) was 
attached with an inline regulator. To prevent the entanglement of wires, a metal 
place was secured onto the printer and the regulator attached onto the plate. 
The Rheodyne 6 port valve was equipped with a 5 mL sample loop, through which 
matrix could be injected and subsequently sprayed onto the slide. A Shimadzu LC-
10ad HPLC pump was connected to the 6 port valve using 100 µm internal diameter 
fused silica tubing at a flow rate of 0.1 mL/min. A waste line was also connected 
(figure 7.5). 
 
Figure 7.5. Outline of the printer set-up. (A) The 6 port valve was connected to a 5 
mL loop. The valve was connected to the HPLC using 100 µm internal diameter 
fused silica tubing. A waste line was also connected to dispose of excess matrix and 
washes through the system. (B) A schematic of a 6 port valve. The matrix was 
injected through the front of the 6 port valve. 
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Matrix deposition was achieved by replacing the printing extruder with a 
commercially available Bruker Daltonics electrospray emitter for nebulisation without 
the addition of a voltage. The nebuliser was placed through the extruder housing 
block and secured in place using the M4 hex bolt. The 6 port valve was connected 
to the nebuliser using 100 µm internal diameter fused silica tubing and the gas line 
was connected from the inline regulator (figure 7.6).  
 
Figure 7.6. Outline of the printer set-up. (A) The nebuliser was placed through the 
3D printed blocked on the printer and held in place using the hex bolt. (B) 100 µm 
internal diameter fused silica tubing was used to attach the 6 port valve to the 
nebuliser. A gas line from the regulator was attached to the nebuliser. 
The x,y,z position and feed rate of the extruder was controlled with G-code 
instructions; a numerical control programme developed by Massachusetts Institute 
of Technology. The x,y range covered the area of a slide, whilst the z height 
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corresponded to the distance between the emitter and the bed height. The z height 
was calibrated to 0 when the nebuliser was 2 mm above the bed (figure 7.7). 
 
Figure 7.7. Outline of the printer set-up. (A) The final printer set-up. (B) The z height 
is calibrated to 0 by adjusting the platform to 2 mm distance from the nebuliser by 
turning the dials underneath the stage platform. 
The matrix solution and application solvent used was 70% ACN. The mass of matrix 
deposited onto a glass slide using an optimised method on the commercial TM-
sprayerTM was 2 mg. Therefore, the velocity of the spray head and the flow rate of 
the solvent were optimised to match this mass change. The velocity was set within 
the G-code as F1000, which created a velocity of 1100 mm/minute. The total time 
taken for eight coats of a glass slide was 20 minutes and produced an area density 
of 0.11 mg/cm2. For consistent performance, regular wash cycles were done with 10 
mL of solvent before and after use. 
7.2.2 Generation, matrix coating and fluorescence imaging of rhodamine B 
microarrays 
To quantify the extent of delocalisation as a result of matrix application, microarrays 
of rhodamine B – a water soluble fluorescent molecule – were used. As metabolites 
are commonly delocalised during matrix application, a water-soluble molecule 
provided a model system to replicate this phenomenon. Furthermore, fluorescence 
provided an efficient technique to assess a large number of conditions without 
requiring extensive sample preparation. 45 individual spots each containing 50 
droplets of 350 pL rhodamine B in water were dispensed onto a SuperFrostTM glass 
slide using a SciFLEXARRAYER S5 microarray printer equipped with a PDC 80 
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dispense capillary with a 50 µm nozzle aperture. HPLC-grade water was used as 
the solvent which was degassed by sonication prior to printing (30 minutes). 45 
spots provided a high number of replicates to improve the validity of the values 
calculated. The fluorescence was measured using a BioAnalyzer 4F/4S 
fluorescence scanner with a Cy5 filter before and after matrix application. The circle 
tool in ImageJ was used to measure the area (mm2) before and after matrix 
application and the percentage change in area was used to quantify the extent of 
diffusion.  
The concentration of rhodamine for the microarrays was chosen by measuring the 
change in fluorescence as a result of 9AA matrix application for a range of 
concentrations (0.001%–0.5% (w/v) in water) (figure 7.8). The sprayer conditions 
were kept consistent at 30 °C bed temperature, 20 mm z height, and 50 psi gas 
pressure. A 50 ms exposure time and a Cy5 filter was used for measuring the 
fluorescence at 540 nm. 0.001% (w/v) produced an average change in area of 44%, 
whilst 0.5% (w/v) produced a 942% area change after matrix application using the 
conditions (table 7.2). 0.5% rhodamine B (w/v) had a high standard deviation across 
the measured area of 45 spots and resulted in self-quenching of the fluorescence, 
whereas 0.001% (w/v) produced a more consistent spot size. However, the low 
concentration would make it difficult to detect smaller area changes that would occur 
after optimisation of the application parameters. As a result, a concentration of 
0.01% (w/v) rhodamine B in water was selected, as it produced consistent spot 
sizes and the area change was large enough to cover a wider range of optimisation 
conditions. 
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Figure 7.8.Fluorescence of printed microarrays at 540 nm wavelength of (A) 0.001% 
(B) 0.01% (C) 0.1% (D) 0.5% (w/v) rhodamine B in water before and after matrix 
application. The conditions used for the home-built sprayer were 30 °C bed 
temperature, 20 mm z height, 50 psi.  
Table 7.2. Concentrations (w/v) of rhodamine B in water were assessed for the 
change in area measured after matrix application using the home-built printer prior 
to optimisation. The area was measured before and after matrix application for 45 
spots and an average and standard deviation were calculated. The parameters used 




before (mm2) SD 
Average area 
after (mm2) SD 
Percentage 
area change 
0.001 0.446 0.036 0.646 0.102 44.803 
0.01 0.675 0.054 1.437 0.371 113.032 
0.1 0.539 0.136 1.760 0.546 226.540 
0.5 0.843 0.059 8.718 1.173 934.378 
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To identify an exposure time that accurately represented the area change of a 
rhodamine B spot, a variety of fluorescence scanner exposure times were tested for 
their effect on the spot area. The area (mm2) of 45 spots was measured using the 
ImageJ circle tool over three exposure times of 30, 60 and 90 ms prior to matrix 
application (figures 7.9 and 7.10). Increasing the exposure increased the measured 
area, however it also results in the saturation of more pixels. 
 
Figure 7.9. Fluorescence at 540 nm wavelength of a representative 0.01% (w/v) 
rhodamine B microarray spot in water imaged at (A) 30 ms (B) 60 ms (C) 90 ms 
exposure time with a Cy5 filter on a fluorescence scanner. The white dotted line 
depicts the initial size of the rhodamine B spot at 30 ms exposure. Note as the 
exposure increases, the size of the rhodamine spot also increases. Scale bar 1 mm. 
 
Figure 7.10. Box and whisker plot showing the effect of increasing exposure time on 
the area of the measured fluorescence at 540 nm wavelength across 45 rhodamine 
B spots. With an increasing exposure time, the area of fluorescence also increases. 
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To select an appropriate exposure time, the effect of the measured pixel area was 
compared to the extent of pixel saturation. To do this, the area and brightness 
across 45 rhodamine B spots were measured over exposure times ranging from 20 
to 220 ms prior to matrix application (figure 7.11). As the exposure time increases, 
both the size and the average grayscale of the pixels increases. However, after 
approximately 120 ms exposure, the increase in area begins to level off. The 
brightness of each pixel also begins to plateau as more pixels become saturated at 
ca. 3000 (arbitrary units). The size of the spot plateaus before all the pixels become 
saturated, therefore the exposure time selected for the fluorescence measurements 
was 70 ms. At this exposure time, approximately 50% of the pixels are saturated 
and it is approximately 50% of the maximum spot size across the exposure times 
investigated. Applying a longer exposure time will result in an overestimation of area 
spot size, so any delocalisation observed will be reduced when applied to MSI of 
tissue samples. 
 
Figure 7.11. The (A) rhodamine area (mm2) and (B) average brightness (arbitrary 
units) with increasing exposure measured by fluorescence at 540 nm wavelength 
across 45 microarray spots of 0.01% (w/v) rhodamine B. The line of best fit is 
plotted based on the average across 45 spots at each exposure increment. 
Three common matrices – 9AA, DHB, and CHCA – were assessed to establish 
which matrix would benefit most from the optimisation using the converted 3D 
printer. Each matrix was applied to the rhodamine B printed microarray slides by 
means of the laboratory’s current standard application protocols using a 
commercially available matrix application platform, the HTX TM-sprayer (Bruker 
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Daltonics, Bremen, Germany). For each matrix, the circle selection tool on ImageJ 
was used to measure the area of observed fluorescence for each rhodamine B spot 
before and after matrix application (figure 7.12). From this, the percentage change 
in area across the 45 spots could be calculated (table 7.3). 
 
Figure 7.12. Measured fluorescence at 540 nm wavelength of 0.01% rhodamine B 
(w/v) microarray spots (left) before and (right) after matrix application using the 
optimised application of three common matrices by the HTXTM automated sprayer. 
(A) 9AA (B) DHB (C) CHCA. Scale bar 1 mm. 
Table 7.3. Average change in fluorescence area at 540 nm wavelength after matrix 
application using an optimised method on the commercial HTX sprayer. Note that 
CHCA can not be calculated as the matrix itself is fluorescent. 
Matrix Average area 
before (mm2) 
SD Average area 
after (mm2) 
SD Average% change 
in area 
9AA 0.713 0.058 0.892 0.076 25.214 
DHB 0.850 0.087 2.119 0.256 150.540 
CHCA 0.763 0.083 N/A N/A N/A 
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All three matrices showed some delocalisation despite using a standard optimised 
method for matrix application. CHCA was fluorescent and therefore fluorescence 
cannot be used to optimise its application. The optimised protocol for DHB 
application produced a 150% increase in rhodamine B area. This extensive 
delocalisation observed could be reduced using the converted 3D printer platform as 
an alternative method of application. However, a number of methods are available 
for DHB matrix application including sublimation, which has been shown to 
significantly reduce delocalisation compared to wet application methods.176 9AA 
produces poor results using sublimation and its optimised method using a 
commercial sprayer presented a 25% increase in spot area based on the changes in 
fluorescence (figure 7.13).176 5 mg/mL 9AA in 70% ACN was selected for 
optimisation of the 3D printer, as this is consistent with the current laboratory 
protocol. 
 
Figure 7.13. A representative rhodamine B spot (A) before and (B) after matrix 
application of 5 mg/mL 9-aminoacridine in 70% ACN imaged using fluorescence at 
70 ms exposure time and 540 nm. Matrix application was carried out using the 
current optimised set-up in the laboratory with the HTX-TM sprayer. The dotted 
circle denotes the original area of the spot. Scale bar 1 mm. 
To optimise the matrix application conditions using the home-built 3D printer, a user 
defined experimental design was compiled using Design Expert 10 (Stat-Ease, 
Minneapolis, USA) with discrete increments of 10 for three matrix application 
variables: nebulising gas pressure (40–60 psi), build-plate temperature (20–40 oC) 
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and nebuliser z height (i.e. height of nebuliser above the sample surface) (10–30 
mm). This process produced a set of 27 discrete conditions for matrix application.  
Microarrays of rhodamine B spots (0.01% w/v) were printed on glass slides (45 
spots per slide) and each slide was coated with 9AA using one of the combinations 
of parameters identified. The fluorescence before and after matrix application was 
recorded using a fluorescence scanner at 70 ms exposure time. The area of each 
spot (mm2) before and after matrix application was measured using imageJ as 
previously described (figure 7.14).  
 
Figure 7.14. A representative rhodamine spot (0.01% w/v) imaged at 70 ms 
exposure using a fluorescence scanner at 540 nm wavelength before and after 
matrix application under various application conditions. (A) 40 oC, 30 mm, 50 psi, (B) 
30 oC, 30 mm, 50 psi, and (C) 20 oC, 10 mm, 60 psi). Scale bar 1 mm. 
The measured area across 45 spots was used to calculate the percentage area 
change for each combination of parameters identified using experimental design 
(figure 7.15 and table 7.4). The combination of a 40 °C build-plate temperature, 30 
mm nebuliser z height and 50 psi gas pressure produced a dry matrix application 
with a 9.44% increase in area. This is smaller than the commercial matrix 
application, which produced a 25% increase in fluorescence area after matrix 
High Spectral Resolution Mass Spectrometry Imaging of Three-Dimensional Cell Culture 
 
Chapter 7. MALDI matrix application utilising a modified 3D printer for 
accessible high-resolution mass spectrometry imaging  132 
application. In contrast, the worst conditions were identified as 20 °C, 10 mm z 
height and 60 psi gas pressure, producing a 403% increase in area of rhodamine B 
with visible smearing of the rhodamine B spots after matrix application.  
 
Figure 7.15. 45 Rhodamine B spots (0.01% w/v) were spotted using a microarray 
printer, and the fluorescence imaged at 70 ms exposure and 540 nm wavelength. 
The change in spot area after matrix application was measured for all 27 conditions 
identified using experimental design. Shown are the images of the optimised (A, 40 
oC, 30 mm, 50 psi), intermediate (B, 30 oC, 30 mm, 50 psi) and worst (C, 20 oC, 10 
mm, 60 psi) conditions before and after matrix application are shown. Scale bar 1 
mm. 
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Table 7.4. Experimental design using a user defined method with discrete 
increments of 10 for three parameters: temperature (20–40 oC), z height (10–30 
mm) and gas pressure (40–60 psi). This produced 27 different conditions for matrix 
application. The area of rhodamine fluorescence at 540 nm wavelength across 45 
individual spots was measured before and after matrix application and the average 













40 30 50 0.0016 9.4445 5.5831 
40 20 40 0.0022 14.0961 8.4560 
30 30 40 0.0017 15.4110 6.4115 
40 30 60 0.0016 16.5411 8.4517 
20 30 50 0.0015 25.8315 5.8350 
30 30 60 0.0015 28.0233 13.1018 
40 30 40 0.0014 31.2360 9.1229 
30 30 50 0.0008 48.1635 9.8320 
30 20 60 0.0018 54.1213 15.5157 
20 20 50 0.0015 55.0061 14.3394 
20 30 40 0.0015 56.5612 10.2006 
40 20 50 0.0016 59.6784 18.8256 
20 20 40 0.0017 60.7045 12.6046 
30 20 40 0.0018 75.2751 26.9346 
20 20 60 0.0020 88.5743 19.8371 
40 10 60 0.0014 101.3613 25.0613 
30 10 60 0.0022 150.3883 50.7967 
20 30 60 0.0018 152.2325 14.7132 
40 10 50 0.0014 180.3564 65.7270 
20 10 50 0.0021 190.4001 26.6111 
30 20 50 0.0020 207.4699 65.9244 
40 10 40 0.0019 210.5439 60.6413 
30 10 50 0.0026 271.8757 59.0557 
20 10 40 0.0025 289.0410 78.5388 
40 20 60 0.0019 346.0704 84.7562 
30 10 40 0.0025 401.5536 95.6569 
20 10 60 0.0020 403.3202 67.4806 
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A bubble plot was used to observe how changing each parameter affected the 
average area change of rhodamine B spots after matrix application (figure 7.16). At 
low temperatures and z heights there was a large change in area, however as both 
the z height and temperature increased, there was a smaller change after matrix 
application. In contrast, varying the gas pressure had a lesser effect on the extent of 
observed delocalisation, and at the highest z height and temperature, the gas 
pressure’s effect on the area change was negligible. 
 
Figure 7.16. A bubble plot showing how the 27 matrix application conditions affect 
the change in area of rhodamine B fluorescence. The dark to pale blue colour scale 
is increasing gas pressure and the size of the circle is the percentage area change 
of after matrix application (diffusion). Note that as the temperature and z height 
increase, there is a smaller area change of the rhodamine B spot after matrix 
application under those combination of conditions. 
7.2.3 Imaging the MALDI matrix crystal size using scanning electron 
microscopy (SEM) 
The crystal size produced during matrix application defines the spatial resolution 
and the extent of analyte diffusion, thus reducing the crystal size achieves a greater 
spatial resolution.1,40 SEM was used to assess the size of the matrix crystals 
produced for both the optimised and worst parameters using the modified 3D printer 
platform, as well as for the laboratory’s standard application protocol using a 
commercially available system (the HTX TM-sprayer) (figure 7.17). SEM images 
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revealed that the sub-optimal conditions produced a non-uniform coverage of large 
inhomogeneous crystals. In contrast, the optimised conditions produced a more 
homogenous uniform coating of small regularly-sized crystals than those observed 
using the commercial printer. 
Figure 7.17. Scanning electron microscope images of the crystals produced under 
the (A) worst 3D printer conditions (B) optimised 3D printer conditions and (C) 
optimised commercial HTX-TM spraying conditions. The worst conditions produced 
large inhomogeneous crystals whilst the optimised method produced small crystals 
with a uniform coverage that were similar to those observed using the commercial 
sprayer. 
7.2.4 MALDI imaging of metabolite distributions in 3D cell culture models 
The optimised conditions identified corresponded to a 40 °C bed temperature, a 30 
mm z height and a 50 psi gas pressure. Matrix application aims to extract the 
maximum amount of analyte whilst reducing analyte delocalisation.40 Whilst the 
crystals were similar to the commercial sprayer, if the crystallisation occurs too 
quickly, there will be poor analyte incorporation and thus a poor ion signal.  
As a result, it was important to apply the optimised conditions to an imaging run with 
a high spatial resolution. Sectioned MCF-7 spheroid samples were selected for this 
process due to their small size, as any delocalisation caused by matrix application 
can greatly affect the biological validity of the results obtained.  
Eight-day-old MCF-7 spheroids were sectioned and coated with 9AA in 70% ACN 
using the optimised and worst conditions identified by experimental design of 
rhodamine B microarrays. The coated sections were imaged using MALDI FT-ICR 
MS at 40 µm imaging resolution in negative mode. The resulting MSI data achieved 
using the optimised and non-optimal 3D printer matrix application conditions were 
compared to the current laboratory standard protocol using an HTX-TM sprayer. 
High Spectral Resolution Mass Spectrometry Imaging of Three-Dimensional Cell Culture 
 
Chapter 7. MALDI matrix application utilising a modified 3D printer for 
accessible high-resolution mass spectrometry imaging  136 
The spatial localisation of a number of metabolites including glutathione, ATP and 
AMP throughout the spheroid were observed, and an optical image of an adjoining 
H&E stained section validated the spheroid morphology after cryo-sectioning (figure 
7.18).  
Figure 7.18. Eight-day MCF-7 spheroids were imaged at 40 µm lateral laser 
resolution using the FT-ICR. Distributions of molecules were observed and 
compared between the non-optimised and optimised parameters of the 3D printer 
compared to that of the current protocol using a commercially available sprayer. The 
H&E stain confirms the structural integrity of the sample. ATP adenosine 
triphosphate; AMP adenosine monophosphate; F-1-P fructose-1-phoshate. 
ATP distributed to the outer region of the spheroid under all spraying conditions, 
however ATP was observed to localise in the embedding medium prior to 
optimisation. Furthermore, this distribution was reproducible across multiple 
spheroids using both the 3D printer and the optimised method (figure 7.19). 
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Figure 7.19. Distribution of ATP across three different spheroids imaged in negative 
mode at 40 µm resolution using FT-ICR MS. ATP uniformly localises to the outer 
region of the spheroids and is reproducible across three different spheroids using 
both (top) the commercial sprayer and (bottom) the optimised application using the 
home-built sprayer.  
Prior to optimisation of the home-built sprayer, AMP localised outside of the 
spheroid in the embedding medium with a similar distribution to ATP. However, after 
optimisation, it localised uniformly throughout the spheroid with a similar distribution 
to the commercial sprayer. Fructose-1-phosphate (F-1-P) was uniformly distributed 
throughout the spheroid under sub-optimal conditions and using the commercial 
sprayer. However, the optimised conditions produced a unique distribution of F-1-P 
that was localised towards the centre of the spheroid. F-1-P is an intermediate in 
glycolysis and is likely localised to this central region as a result of the hypoxic 
conditions experienced at the centre of the spheroid.  
Prior to optimisation, both reduced and oxidised glutathione had extensively 
delocalised out of the spheroid and diffused into the embedding medium. However, 
after optimisation, both the reduced and oxidised forms had a similar distribution 
towards the centre of the spheroid that was similar to the optimal matrix application 
using the commercial sprayer.  
Under sub-optimal conditions, the converted 3D printer sprayer produced extensive 
diffusion of various molecules as discussed. These metabolites diffused out of the 
tissue and into the embedding medium, producing a biologically inaccurate 
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distribution. Under these spraying conditions, the nebuliser was located near the 
sample at a high gas pressure without the addition of a heated bed. At lower 
temperatures, matrix crystals form more slowly and therefore produce a 
heterogeneous distribution, incorporating analytes across larger regions with a poor 
S/N for the analytes observed.40 However, after optimisation, these metabolites had 
distributions similar to those observed after matrix application using the 
commercially available sprayer. Furthermore, a number of molecules became more 
localised to the central region using the 3D printer, suggesting that there was some 
diffusion using the commercial sprayer that was altering the distribution of 
metabolites.  
7.3 Conclusions 
Here we have shown that a 3D printer can be converted into an effective automated 
MALDI matrix application platform and operates with minimal analyte diffusion 
during matrix application. Using fluorescent microarrays and experimental design, 
the conditions for 9AA matrix application were optimised. Incorporating a heated 
bed and increasing the z height of the sprayer minimised sample wetting and 
therefore reduced analyte diffusion. These optimised conditions were then used to 
reproducibly image MCF-7 spheroids at 40 µm resolution and identify numerous 
metabolites with reduced analyte delocalisation. The images had comparable 
distributions to those observed using a commercially available printer at a fraction of 
the set-up cost compared to commercially available systems. 
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8.1 Conclusions 
Here, we have developed a method for high spectral and spatial resolution MALDI-
MSI of MCF-7 and PC3 spheroids. By preparing the gelatin at 37 °C and embedding 
the spheroids on the petri dish lid, this effectively reduced the handling of spheroids 
and minimised damage during sample preparation. For each matrix, FT-ICR MS 
MALDI MS analysis was used to compile tentative formula assignment lists at sub-
ppm errors. Whilst formulae can be tentatively assigned, MS/MS is required to 
provide confidence on the metabolite isoforms. Furthermore, to improve the 
confidence of the assignments, the IFS for each metabolite should be investigated.  
Using the developed protocol, we have shown the application of high resolution MSI 
to determine metabolite distributions within MTS cell culture models. Initially, ATP 
and glutathione were employed as targeted metabolite markers to indicate regions 
of increased oxidative stress and hypoxia. Subsequently, untargeted discriminatory 
analysis was used to investigate how these microenvironments affect the regional 
flux through metabolic branch pathways. Here we have shown that there is an 
upregulation of the HBP in regions of the spheroid with greater access to oxygen; 
whereas there is greater glycolytic flux within the regions limited by hypoxia. 
Nevertheless, whilst it is possible to compare the relative intensities of these 
metabolites in the different microenvironments, ionisation bias prevents any 
definitive quantification of the distributions observed. 
MALDI-MSI has also been employed to observe the distribution of pimonidazole and 
its metabolites within PC3 MTS over a 24-hour time course. CASI effectively 
increased the S/N and achieved better sensitivity of the hypoxia marker and its 
reduction products. We have shown that pimonidazole accumulated at the centre of 
the spheroid by six hours and underwent reduction over the time course. However, 
due to the various conjugates the hydroxylamine derivative can form, it was not 
possible to observe all of the reaction products. In addition, previous MSI literature 
has suggested that pimonidazole displays a non-specific localisation to regions of 
hypoxia. Therefore, future work could complement this data with 
immunohistochemical staining to establish which metabolites colocalise with the 
hypoxic regions of the spheroid.  
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Finally, we have shown that a 3D printer can be converted into an effective 
automated MALDI matrix application platform. Using fluorescent microarrays and 
experimental design, the conditions for 9AA matrix application were optimised. 
Incorporating a heated bed and increasing the z height of the sprayer minimised 
sample wetting and reduced analyte diffusion. These optimised conditions were 
then used to reproducibly image MCF-7 spheroids and observe numerous 
metabolites with reduced analyte delocalisation. The images had comparable 
distributions to those observed using a commercially available printer at a fraction of 
the set-up cost. 
MSI using FT-ICR provides unparalleled spectral resolution for confident elemental 
assignment. By increasing the transient recording time, FT-ICR produces an 
approximately linear improvement of mass resolution.177 However, this results in an 
inherently slow acquisition time, as the high mass resolving power requires long 
transients to be acquired for each pixel.34 Given that a typical MS image can consist 
of tens of thousands of pixels, acquisition time may become a constraining factor. 
This can result in a trade-off between spectral resolution and data aquisition time. 
Notwithstanding, in comparison to animal tissue samples, the small size of MTS 
mitigates this disadvantage somewhat, allowing multiple biological replicates to be 
analysed on realistic timescales. 
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Appendices 
CHCA mass list positive mode 
Observed m/z Expected m/z Error (ppm) Tentative neutral formula Adduct 
272.12560 272.12571 0.41892 C14H19NO3 [M+Na]+ 
275.13877 275.13902 0.90500 C15H18N2O3 [M+H]+ 
280.09184 280.09205 0.73190 C8H20NO6P [M+Na]+ 
282.09704 282.09721 0.61681 C13H15NO6 [M+H]+ 
282.27888 282.27914 0.92462 C18H35NO [M+H]+ 
283.01872 283.01894 0.77380 C6H13O9P [M+Na]+ 
285.24224 285.24242 0.63455 C17H32O3 [M+H]+ 
286.31024 286.31044 0.70204 C18H39NO [M+H]+ 
294.10987 294.11006 0.65962 C16H17NO3 [M+Na]+ 
296.06579 296.06598 0.64850 C8H20NO6P [M+K]+ 
298.08980 298.08972 -0.25831 C11H17NO7 [M+Na]+ 
299.25791 299.25807 0.53800 C18H34O3 [M+H]+ 
308.06572 308.06552 -0.65246 C16H13O5 [M+Na]+ 
311.25792 311.25807 0.48513 C19H34O3 [M+H]+ 
317.24504 317.24510 0.19228 C19H34O2 [M+Na]+ 
331.13750 331.13740 -0.31407 C6H7N5O [2M+H]+ 
341.30500 341.30502 0.06446 C21H40O3 [M+H]+ 
344.11297 344.11286 -0.30804 C18H17NO6 [M+H]+ 
365.10534 365.10543 0.25198 C12H22O11 [M+Na]+ 
370.12878 370.12851 -0.71867 C20H19NO6 [M+H]+ 
374.14331 374.14349 0.47843 C15H21N5O5 [M+Na]+ 
376.35746 376.35739 -0.18068 C25H45NO [M+H]+ 
379.09244 379.09246 0.06067 C10H7NO3 [2M+H]+ 
388.12151 388.12142 -0.23962 C14H23NO10 [M+Na]+ 
390.37319 390.37304 -0.37912 C26H47NO [M+H]+ 
391.22443 391.22452 0.22493 C21H36O4 [M+K]+ 
391.28432 391.28429 -0.08689 C24H38O4 [M+H]+ 
393.30004 393.29994 -0.26443 C24H40O4 [M+H]+ 
405.24011 405.24002 -0.23196 C25H34O3 [M+Na]+ 
406.16966 406.16970 0.10833 C16H25N5O6 [M+Na]+ 
408.32381 408.32369 -0.30368 C26H43NO [M+Na]+ 
411.06290 411.06293 0.07785 C23H16O5 [M+K]+ 
413.04209 413.04220 0.25663 C22H14O6 [M+K]+ 
413.09587 413.09554 -0.80853 C18H18N2O8 [M+Na]+ 
413.26618 413.26623 0.12099 C24H38O4 [M+Na]+ 
415.22206 415.22200 -0.15413 C19H37O6P [M+Na]+ 
417.24012 417.24017 0.11504 C23H38O4 [M+K]+ 
419.25572 419.25570 -0.04293 C21H39O6P [M+H]+ 
419.31578 419.31559 -0.46266 C26H42O4 [M+H]+ 
422.33921 422.33934 0.29834 C27H45NO [M+Na]+ 
429.24049 429.24017 -0.75016 C24H38O4 [M+K]+ 
431.21717 431.21691 -0.60063 C19H37O7P [M+Na]+ 
433.27142 433.27132 -0.24003 C27H38O3 [M+Na]+ 
436.28225 436.28222 -0.08022 C26H39NO3 [M+K]+ 
436.35502 436.35514 0.27042 C25H51NO2 [M+K]+ 
439.22219 439.22200 -0.44169 C21H37O6P [M+Na]+ 
441.23782 441.23765 -0.39435 C21H39O6P [M+Na]+ 
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441.29772 441.29753 -0.42828 C26H42O4 [M+Na]+ 
443.25303 443.25330 0.60011 C21H41O6P [M+Na]+ 
445.27156 445.27147 -0.20662 C25H42O4 [M+K]+ 
448.28247 448.28237 -0.22977 C24H43NO4 [M+K]+ 
448.35524 448.35514 -0.22750 C26H51NO2 [M+K]+ 
450.29799 450.29802 0.05996 C24H45NO4 [M+K]+ 
457.23287 457.23256 -0.67580 C21H39O7P [M+Na]+ 
457.27179 457.27147 -0.70418 C26H42O4 [M+K]+ 
459.24848 459.24821 -0.58574 C21H41O7P [M+Na]+ 
461.26421 461.26386 -0.75662 C21H43O7P [M+Na]+ 
464.31377 464.31367 -0.22183 C25H47NO4 [M+K]+ 
468.30856 468.30847 -0.20072 C22H46NO7P [M+H]+ 
473.19740 473.19720 -0.41843 C15H12N2O [2M+H]+ 
473.30281 473.30277 -0.08874 C27H46O4 [M+K]+ 
476.21724 476.21740 0.32968 C20H40NO7P [M+K]+ 
482.32425 482.32412 -0.27782 C23H48NO7P [M+K]+ 
485.26400 485.26386 -0.28644 C23H43O7P [M+Na]+ 
489.17720 489.17686 -0.69300 C13H12N2O3 [2M+H]+ 
490.29063 490.29041 -0.44871 C22H46NO7P [M+Na]+ 
490.32936 490.32932 -0.08770 C27H49NO4 [M+K]+ 
492.34498 492.34497 -0.02640 C27H51NO4 [M+K]+ 
494.32426 494.32412 -0.29131 C24H48NO7P [M+H]+ 
495.44090 495.44079 -0.22808 C31H58O4 [M+H]+ 
496.33991 496.33977 -0.29012 C24H50NO7P [M+H]+ 
501.31451 501.31436 -0.30520 C21H40N8O6 [M+H]+ 
506.36056 506.36050 -0.11652 C26H52NO6P [M+H]+ 
508.21917 508.21869 -0.94841 C20H39NO10S [M+Na]+ 
508.34018 508.33977 -0.81442 C25H50NO7P [M+H]+ 
509.45657 509.45644 -0.26106 C32H60O4 [M+H]+ 
510.35568 510.35542 -0.51729 C25H52NO7P [M+H]+ 
516.30642 516.30606 -0.69726 C24H48NO7P [M+Na]+ 
517.42295 517.42273 -0.42325 C31H58O4 [M+Na]+ 
518.32200 518.32171 -0.55950 C24H50NO7P [M+Na]+ 
518.36059 518.36050 -0.17170 C27H52NO6P [M+H]+ 
519.36423 519.36399 -0.45633 C13H25NO4 [2M+H]+ 
520.34002 520.33977 -0.48814 C26H50NO7P [M+H]+ 
520.37642 520.37627 -0.29402 C29H55NO4 [M+K]+ 
521.45671 521.45644 -0.52353 C33H60O4 [M+H]+ 
522.35554 522.35542 -0.23739 C26H52NO7P [M+H]+ 
522.52473 522.52446 -0.52246 C34H67NO2 [M+H]+ 
523.47229 523.47209 -0.38780 C33H62O4 [M+H]+ 
524.37118 524.37107 -0.21740 C26H54NO7P [M+H]+ 
530.27019 530.27009 -0.19235 C28H45NO4S [M+K]+ 
531.43877 531.43838 -0.73198 C32H60O4 [M+Na]+ 
532.07190 532.07218 0.52812 C23H17NO14 [M+H]+ 
532.33757 532.33736 -0.39449 C25H52NO7P [M+Na]+ 
535.29064 535.29016 -0.89858 C29H42O9 [M+H]+ 
536.37155 536.37107 -0.90236 C27H54NO7P [M+H]+ 
536.37155 536.37107 -0.90236 C27H54NO7P [M+H]+ 
537.48797 537.48774 -0.43350 C34H64O4 [M+H]+ 
538.35071 538.35033 -0.70400 C26H52NO8P [M+H]+ 
538.38682 538.38672 -0.19317 C27H56NO7P [M+H]+ 
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539.13380 539.13366 -0.26153 C31H22O9 [M+H]+ 
543.43863 543.43838 -0.45819 C33H60O4 [M+Na]+ 
544.33762 544.33736 -0.47764 C26H52NO7P [M+Na]+ 
544.50674 544.50640 -0.62258 C34H67NO2 [M+Na]+ 
545.45424 545.45403 -0.38317 C33H62O4 [M+Na]+ 
547.47237 547.47209 -0.51692 C35H62O4 [M+H]+ 
550.38687 550.38672 -0.27980 C28H56NO7P [M+H]+ 
551.50362 551.50339 -0.42248 C35H66O4 [M+H]+ 
559.47015 559.46968 -0.83829 C34H64O4 [M+Na]+ 
560.40764 560.40745 -0.33547 C30H58NO6P [M+H]+ 
563.50357 563.50339 -0.32475 C36H66O4 [M+H]+ 
564.40185 564.40237 0.91424 C29H58NO7P [M+H]+ 
565.51931 565.51904 -0.48274 C36H68O4 [M+H]+ 
572.36895 572.36866 -0.50667 C28H56NO7P [M+Na]+ 
575.50370 575.50339 -0.54387 C37H66O4 [M+H]+ 
577.51926 577.51904 -0.38613 C37H68O4 [M+H]+ 
578.38216 578.38163 -0.91462 C29H56NO8P [M+H]+ 
578.41841 578.41802 -0.68117 C30H60NO7P [M+H]+ 
581.19566 581.19587 0.35272 C19H14O3 [2M+H]+ 
585.48570 585.48533 -0.63025 C36H66O4 [M+Na]+ 
588.43904 588.43875 -0.48943 C32H62NO6P [M+H]+ 
589.26976 589.27021 0.76705 C12H22O8 [2M+H]+ 
589.51919 589.51904 -0.25953 C19H34O2 [2M+H]+ 
591.53496 591.53469 -0.46151 C38H70O4 [M+H]+ 
592.39773 592.39728 -0.75794 C30H58NO8P [M+H]+ 
593.12668 593.12671 0.05732 C25H30O14 [M+K]+ 
595.33934 595.33955 0.34770 C34H52O6 [M+K]+ 
600.36322 600.36358 0.59131 C29H56NO8P [M+Na]+ 
601.51919 601.51904 -0.25436 C39H68O4 [M+H]+ 
603.53481 603.53469 -0.20380 C39H70O4 [M+H]+ 
605.23543 605.23587 0.72699 C29H42O11 [M+K]+ 
606.41291 606.41293 0.03463 C31H60NO8P [M+H]+ 
606.44935 606.44932 -0.05606 C32H64NO7P [M+H]+ 
613.34785 613.34759 -0.42227 C30H55O9P [M+Na]+ 
614.37974 614.37923 -0.83824 C30H58NO8P [M+Na]+ 
617.55061 617.55034 -0.44207 C20H36O2 [2M+H]+ 
619.56627 619.56599 -0.45677 C40H74O4 [M+H]+ 
620.42898 620.42858 -0.64310 C32H62NO8P [M+H]+ 
622.40807 622.40785 -0.35989 C31H60NO9P [M+H]+ 
627.53457 627.53469 0.18644 C41H70O4 [M+H]+ 
628.39523 628.39488 -0.56493 C31H60NO8P [M+Na]+ 
629.55074 629.55034 -0.64014 C41H72O4 [M+H]+ 
631.56627 631.56599 -0.44809 C41H74O4 [M+H]+ 
632.42878 632.42858 -0.31466 C33H62NO8P [M+H]+ 
634.44423 634.44423 0.00158 C33H64NO8P [M+H]+ 
636.42372 636.42350 -0.35197 C32H62NO9P [M+H]+ 
638.45197 638.45200 0.04072 C34H66NO6P [M+Na]+ 
639.36319 639.36324 0.07977 C32H57O9P [M+Na]+ 
640.46815 640.46765 -0.78692 C34H68NO6P [M+Na]+ 
641.41555 641.41528 -0.42718 C33H63O8P [M+Na]+ 
646.44449 646.44423 -0.40065 C34H64NO8P [M+H]+ 
647.37865 647.37897 0.50048 C36H54O10 [M+H]+ 
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648.42414 648.42350 -0.99318 C33H62NO9P [M+H]+ 
648.46009 648.45988 -0.32230 C34H66NO8P [M+H]+ 
648.62904 648.62892 -0.18192 C42H81NO3 [M+H]+ 
650.43935 650.43915 -0.31363 C33H64NO9P [M+H]+ 
653.55044 653.55034 -0.15760 C43H72O4 [M+H]+ 
655.43110 655.43093 -0.26547 C34H65O8P [M+Na]+ 
659.59747 659.59729 -0.27744 C43H78O4 [M+H]+ 
664.45524 664.45480 -0.66822 C34H66NO9P [M+H]+ 
664.49172 664.49118 -0.81115 C35H70NO8P [M+H]+ 
666.43441 666.43406 -0.52518 C33H64NO10P [M+H]+ 
666.48328 666.48330 0.02401 C36H70NO6P [M+Na]+ 
667.43078 667.43093 0.21875 C35H65O8P [M+Na]+ 
668.49926 668.49895 -0.46971 C36H72NO6P [M+Na]+ 
669.44684 669.44658 -0.39436 C35H67O8P [M+Na]+ 
670.61100 670.61087 -0.19982 C42H81NO3 [M+Na]+ 
672.42104 672.42109 0.07436 C33H64NO9P [M+Na]+ 
675.54410 675.54355 -0.81268 C37H75N2O6P [M+H]+ 
676.45486 676.45480 -0.09461 C35H66NO9P [M+H]+ 
676.49117 676.49118 0.01626 C36H70NO8P [M+H]+ 
678.50696 678.50683 -0.19012 C36H72NO8P [M+H]+ 
681.44643 681.44658 0.21425 C36H67O8P [M+Na]+ 
683.46238 683.46223 -0.22386 C36H69O8P [M+Na]+ 
685.46805 685.46813 0.12109 C35H71N2O6P [M+K]+ 
688.41594 688.41601 0.09442 C33H64NO10P [M+Na]+ 
690.50691 690.50683 -0.11441 C37H72NO8P [M+H]+ 
692.52258 692.52248 -0.14296 C37H74NO8P [M+H]+ 
693.44664 693.44658 -0.09229 C37H67O8P [M+Na]+ 
695.46226 695.46223 -0.04745 C37H69O8P [M+Na]+ 
698.43855 698.43915 0.85333 C37H64NO9P [M+H]+ 
699.54138 699.54115 -0.33450 C37H77N2O6P [M+Na]+ 
700.48869 700.48878 0.12277 C36H72NO8P [M+Na]+ 
703.57481 703.57485 0.05827 C39H79N2O6P [M+H]+ 
704.52254 704.52248 -0.08374 C38H74NO8P [M+H]+ 
705.59098 705.59050 -0.67886 C39H81N2O6P [M+H]+ 
706.53831 706.53813 -0.25335 C38H76NO8P [M+H]+ 
709.47768 709.47788 0.27767 C38H71O8P [M+Na]+ 
711.43721 711.43676 -0.62690 C22H29NO3 [2M+H]+ 
714.50443 714.50443 -0.00560 C37H74NO8P [M+Na]+ 
716.46290 716.46271 -0.26100 C36H72NO8P [M+K]+ 
718.53820 718.53813 -0.09603 C39H76NO8P [M+H]+ 
719.54146 719.54162 0.22653 C19H37NO5 [2M+H]+ 
720.55405 720.55378 -0.37194 C39H78NO8P [M+H]+ 
721.47778 721.47788 0.13445 C39H71O8P [M+Na]+ 
721.53770 721.53780 0.13444 C39H77O9P [M+H]+ 
723.49365 723.49353 -0.17001 C39H73O8P [M+Na]+ 
725.45352 725.45418 0.91391 C45H66O5 [M+K]+ 
725.55654 725.55680 0.35283 C39H79N2O6P [M+Na]+ 
726.50399 726.50443 0.60013 C38H74NO8P [M+Na]+ 
727.52744 727.52723 -0.28590 C41H75O8P [M+H]+ 
728.52003 728.52008 0.06314 C38H76NO8P [M+Na]+ 
732.55382 732.55378 -0.05187 C40H78NO8P [M+H]+ 
735.55348 735.55345 -0.04486 C40H79O9P [M+H]+ 
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737.50912 737.50918 0.07729 C40H75O8P [M+Na]+ 
740.49951 740.49910 -0.55503 C39H76NO7P [M+K]+ 
740.52003 740.52008 0.06212 C39H76NO8P [M+Na]+ 
742.51527 742.51475 -0.70167 C39H78NO7P [M+K]+ 
742.53573 742.53573 -0.00539 C39H78NO8P [M+Na]+ 
743.55902 743.55850 -0.70472 C47H76O5 [M+Na]+ 
744.49433 744.49401 -0.42579 C38H76NO8P [M+K]+ 
746.56950 746.56943 -0.09108 C41H80NO8P [M+H]+ 
747.49367 747.49353 -0.19131 C41H73O8P [M+Na]+ 
747.57276 747.57292 0.21804 C20H39NO5 [2M+H]+ 
749.50910 749.50918 0.10273 C41H75O8P [M+Na]+ 
753.48599 753.48548 -0.67287 C47H70O5 [M+K]+ 
754.51439 754.51475 0.47580 C40H78NO7P [M+K]+ 
754.53583 754.53573 -0.13783 C40H78NO8P [M+Na]+ 
756.49420 756.49401 -0.24719 C39H76NO8P [M+K]+ 
758.51029 758.50966 -0.82662 C39H78NO8P [M+K]+ 
758.56964 758.56943 -0.27420 C42H80NO8P [M+H]+ 
759.55123 759.55104 -0.24751 C40H81O9P [M+Na]+ 
760.58509 760.58508 -0.01052 C42H82NO8P [M+H]+ 
766.48705 766.48649 -0.73061 C38H72NO12P [M+H]+ 
766.53515 766.53573 0.75143 C41H78NO8P [M+Na]+ 
767.53819 767.53752 -0.87422 C49H76O4 [M+K]+ 
768.55132 768.55138 0.07286 C41H80NO8P [M+Na]+ 
770.50951 770.50951 0.00130 C43H74NO7P [M+Na]+ 
772.58550 772.58508 -0.54104 C43H82NO8P [M+H]+ 
774.60053 774.60073 0.26078 C43H84NO8P [M+H]+ 
777.54077 777.54048 -0.37683 C43H79O8P [M+Na]+ 
777.59534 777.59464 -0.90021 C52H82O2 [M+K]+ 
778.53603 778.53573 -0.39048 C42H78NO8P [M+Na]+ 
780.55114 780.55138 0.30235 C42H80NO8P [M+Na]+ 
782.56715 782.56703 -0.15845 C42H82NO8P [M+Na]+ 
784.52533 784.52531 -0.02167 C41H80NO8P [M+K]+ 
784.56924 784.56994 0.89348 C42H83NO9 [M+K]+ 
785.56868 785.56910 0.53083 C44H81O9P [M+H]+ 
786.57719 786.57735 0.20214 C42H86NO7P [M+K]+ 
786.60061 786.60073 0.15510 C44H84NO8P [M+H]+ 
794.56663 794.56703 0.49838 C43H82NO8P [M+Na]+ 
796.52578 796.52531 -0.58630 C42H80NO8P [M+K]+ 
796.58284 796.58268 -0.20588 C43H84NO8P [M+Na]+ 
798.54126 798.54096 -0.37193 C42H82NO8P [M+K]+ 
800.61617 800.61638 0.26480 C45H86NO8P [M+H]+ 
801.54082 801.54048 -0.42793 C45H79O8P [M+Na]+ 
802.63279 802.63203 -0.94439 C45H88NO8P [M+H]+ 
802.63279 802.63203 -0.94439 C45H88NO8P [M+H]+ 
804.55136 804.55138 0.01989 C44H80NO8P [M+Na]+ 
807.63569 807.63505 -0.79739 C45H89N2O6P [M+Na]+ 
808.58290 808.58268 -0.27703 C44H84NO8P [M+Na]+ 
810.60017 810.60073 0.69331 C46H84NO8P [M+H]+ 
813.56168 813.56161 -0.09096 C43H83O10P [M+Na]+ 
813.68453 813.68440 -0.15731 C47H93N2O6P [M+H]+ 
814.63225 814.63203 -0.26761 C46H88NO8P [M+H]+ 
815.70058 815.70005 -0.64730 C47H95N2O6P [M+H]+ 
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824.55699 824.55661 -0.45722 C44H84NO8P [M+K]+ 
824.61472 824.61398 -0.90224 C45H88NO8P [M+Na]+ 
827.57718 827.57726 0.09183 C44H85O10P [M+Na]+ 
827.70063 827.70005 -0.69832 C48H95N2O6P [M+H]+ 
828.55137 828.55138 0.00724 C46H80NO8P [M+Na]+ 
828.64794 828.64768 -0.31135 C47H90NO8P [M+H]+ 
830.56755 830.56703 -0.63089 C46H82NO8P [M+Na]+ 
832.58451 832.58508 0.68702 C48H82NO8P [M+H]+ 
834.60117 834.60073 -0.52480 C48H84NO8P [M+H]+ 
835.64183 835.64223 0.47389 C51H88O7 [M+Na]+ 
835.66681 835.66635 -0.55525 C47H93N2O6P [M+Na]+ 
837.68283 837.68200 -0.99560 C47H95N2O6P [M+Na]+ 
838.63271 838.63203 -0.80846 C48H88NO8P [M+H]+ 
839.68869 839.68882 0.15244 C50H95O7P [M+H]+ 
841.71562 841.71570 0.09742 C49H97N2O6P [M+H]+ 
842.66363 842.66333 -0.35364 C48H92NO8P [M+H]+ 
851.64026 851.64028 0.02701 C47H93N2O6P [M+K]+ 
852.58849 852.58791 -0.67559 C46H88NO8P [M+K]+ 
852.64476 852.64528 0.60518 C47H92NO8P [M+Na]+ 
854.66075 854.66093 0.20593 C47H94NO8P [M+Na]+ 
858.59895 858.59833 -0.72677 C48H86NO8P [M+Na]+ 
859.60325 859.60347 0.25710 C45H89O11P [M+Na]+ 
862.63262 862.63203 -0.68163 C50H88NO8P [M+H]+ 
863.63652 863.63718 0.76074 C47H91O11P [M+H]+ 
864.64706 864.64768 0.71937 C50H90NO8P [M+H]+ 
 
  
High Spectral Resolution Mass Spectrometry Imaging of Three-Dimensional Cell Culture 
 
Appendices   159 
DHB mass list positive mode 
Observed m/z Expected m/z Error (ppm) Tentative neutral formula Adduct 
155.03387 155.03389 0.09675 C7H6O4 [M+H]+ 
198.08894 198.08909 0.74209 C8H17NO2 [M+K]+ 
203.22295 203.22302 0.35921 C10H26N4 [M+H]+ 
204.12294 204.12303 0.46051 C9H17NO4 [M+H]+ 
211.06007 211.06010 0.14214 C10H10O5 [M+H]+ 
217.04950 217.04954 0.16125 C12H8O4 [M+H]+ 
218.13869 218.13869 -0.02292 C10H19NO4 [M+H]+ 
222.08889 222.08909 0.88703 C10H17NO2 [M+K]+ 
224.10459 224.10459 -0.02231 C13H15NO [M+Na]+ 
226.08389 226.08385 -0.18135 C12H13NO2 [M+Na]+ 
229.04948 229.04954 0.24012 C13H8O4 [M+H]+ 
229.07063 229.07067 0.15279 C10H12O6 [M+H]+ 
230.24781 230.24784 0.13464 C14H31NO [M+H]+ 
232.15433 232.15434 0.02154 C11H21NO4 [M+H]+ 
240.09950 240.09950 -0.00416 C13H15NO2 [M+Na]+ 
245.04441 245.04445 0.16324 C13H8O5 [M+H]+ 
251.05265 251.05261 -0.16331 C10H12O6 [M+Na]+ 
256.09440 256.09457 0.64820 C10H19NO4 [M+K]+ 
256.26349 256.26349 0.00390 C16H33NO [M+H]+ 
258.11009 258.11010 0.03874 C8H20NO6P [M+H]+ 
258.27912 258.27914 0.08131 C16H35NO [M+H]+ 
263.14619 263.14623 0.15201 C4H9N3O2 [2M+H]+ 
264.09953 264.09950 -0.11738 C15H15NO2 [M+Na]+ 
265.25254 265.25259 0.19604 C18H32O [M+H]+ 
270.31553 270.31553 -0.01110 C18H39N [M+H]+ 
273.00465 273.00481 0.59706 C9H14O2S3 [M+Na]+ 
280.09203 280.09205 0.05355 C8H20NO6P [M+Na]+ 
280.26118 280.26109 -0.33897 C16H35NO [M+Na]+ 
282.11010 282.11022 0.41119 C12H21NO4 [M+K]+ 
282.27910 282.27914 0.14525 C18H35NO [M+H]+ 
283.01894 283.01894 -0.00353 C6H13O9P [M+Na]+ 
284.29478 284.29479 0.03869 C18H37NO [M+H]+ 
285.03927 285.03936 0.32978 C15H8O6 [M+H]+ 
285.24247 285.24242 -0.17178 C17H32O3 [M+H]+ 
286.31043 286.31044 0.03842 C18H39NO [M+H]+ 
294.11011 294.11006 -0.15640 C16H17NO3 [M+Na]+ 
296.06593 296.06598 0.17564 C8H20NO6P [M+K]+ 
296.12591 296.12587 -0.14859 C13H23NO4 [M+K]+ 
296.23496 296.23502 0.21267 C16H35NO [M+K]+ 
298.09678 298.09684 0.19121 C11H15N5O3S [M+H]+ 
298.10512 298.10498 -0.47299 C15H17NO4 [M+Na]+ 
299.25802 299.25807 0.17042 C18H34O3 [M+H]+ 
302.07879 302.07876 -0.08607 C17H13NO3 [M+Na]+ 
308.06577 308.06552 -0.81476 C16H13O5 [M+Na]+ 
310.31027 310.31044 0.55106 C20H39NO [M+H]+ 
311.25812 311.25807 -0.15743 C19H34O3 [M+H]+ 
312.12068 312.12063 -0.16340 C16H19NO4 [M+Na]+ 
319.00628 319.00621 -0.23511 C9H12O10 [M+K]+ 
320.08932 320.08933 0.02812 C17H15NO4 [M+Na]+ 
322.14132 322.14136 0.13659 C18H21NO3 [M+Na]+ 
330.07296 330.07303 0.20299 C10H17N3O6S [M+Na]+ 
336.15701 336.15701 0.01190 C19H23NO3 [M+Na]+ 
341.30502 341.30502 0.00586 C21H40O3 [M+H]+ 
348.07037 348.07036 -0.02586 C10H14N5O7P [M+H]+ 
349.19103 349.19105 0.06873 C22H24N2O2 [M+H]+ 
350.17267 350.17266 -0.01713 C20H25NO3 [M+Na]+ 
353.26863 353.26864 0.01698 C21H36O4 [M+H]+ 
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354.13117 354.13119 0.06495 C18H21NO5 [M+Na]+ 
355.28459 355.28429 -0.85565 C21H38O4 [M+H]+ 
360.06928 360.06899 -0.81373 C15H15NO8 [M+Na]+ 
364.18833 364.18831 -0.04393 C21H27NO3 [M+Na]+ 
365.10540 365.10543 0.08765 C12H22O11 [M+Na]+ 
365.11044 365.11079 0.96409 C18H18N2O5 [M+Na]+ 
366.20394 366.20396 0.06554 C21H29NO3 [M+Na]+ 
376.32096 376.32101 0.12224 C24H41NO2 [M+H]+ 
376.35734 376.35739 0.13817 C25H45NO [M+H]+ 
378.20416 378.20396 -0.51824 C22H29NO3 [M+Na]+ 
381.29993 381.29994 0.01574 C23H40O4 [M+H]+ 
388.12132 388.12142 0.24992 C14H23NO10 [M+Na]+ 
391.22434 391.22452 0.45498 C21H36O4 [M+K]+ 
392.21985 392.21962 -0.59915 C23H31NO3 [M+Na]+ 
393.30000 393.29994 -0.16273 C24H40O4 [M+H]+ 
394.12599 394.12611 0.29940 C20H21NO6 [M+Na]+ 
395.06071 395.06089 0.45056 C17H14O11 [M+H]+ 
396.17802 396.17814 0.31299 C21H27NO5 [M+Na]+ 
399.14473 399.14452 -0.53865 C15H22N6O5S [M+H]+ 
400.10061 400.10044 -0.42739 C15H23NO9 [M+K]+ 
404.35215 404.35231 0.38580 C26H45NO2 [M+H]+ 
405.24010 405.24002 -0.20728 C25H34O3 [M+Na]+ 
408.32372 408.32384 0.28899 C23H47NO2 [M+K]+ 
413.26611 413.26623 0.29037 C24H38O4 [M+Na]+ 
415.22198 415.22200 0.03853 C19H37O6P [M+Na]+ 
416.35204 416.35231 0.63888 C27H45NO2 [M+H]+ 
417.23994 417.24005 0.26843 C21H37O6P [M+H]+ 
419.25565 419.25582 0.40071 C23H40O4 [M+K]+ 
421.33102 421.33124 0.51266 C13H22O2 [2M+H]+ 
422.23022 422.23033 0.26289 C21H37NO5 [M+K]+ 
422.33927 422.33949 0.51617 C24H49NO2 [M+K]+ 
428.03672 428.03669 -0.06775 C10H15N5O10P2 [M+H]+ 
431.21688 431.21691 0.07189 C19H37O7P [M+Na]+ 
433.27137 433.27132 -0.12463 C27H38O3 [M+Na]+ 
436.28224 436.28237 0.29110 C23H43NO4 [M+K]+ 
436.35499 436.35514 0.33917 C25H51NO2 [M+K]+ 
439.22206 439.22200 -0.14571 C21H37O6P [M+Na]+ 
439.34190 439.34180 -0.22534 C26H46O5 [M+H]+ 
439.37793 439.37819 0.58492 C27H50O4 [M+H]+ 
441.23764 441.23765 0.01360 C21H39O6P [M+Na]+ 
441.29789 441.29753 -0.81351 C26H42O4 [M+Na]+ 
443.25302 443.25330 0.62267 C21H41O6P [M+Na]+ 
445.23265 445.23256 -0.19990 C20H39O7P [M+Na]+ 
445.27133 445.27147 0.30992 C25H42O4 [M+K]+ 
448.28223 448.28237 0.30561 C24H43NO4 [M+K]+ 
448.35513 448.35514 0.01784 C26H51NO2 [M+K]+ 
450.29784 450.29802 0.39307 C24H45NO4 [M+K]+ 
457.23260 457.23256 -0.08530 C21H39O7P [M+Na]+ 
457.27150 457.27147 -0.06998 C26H42O4 [M+K]+ 
459.24821 459.24821 0.00218 C21H41O7P [M+Na]+ 
461.26371 461.26386 0.32736 C21H43O7P [M+Na]+ 
462.29805 462.29802 -0.07138 C25H45NO4 [M+K]+ 
462.37069 462.37079 0.21195 C27H53NO2 [M+K]+ 
464.31353 464.31367 0.29506 C25H47NO4 [M+K]+ 
465.35770 465.35745 -0.53507 C28H48O5 [M+H]+ 
465.39396 465.39384 -0.26429 C29H52O4 [M+H]+ 
466.29300 466.29282 -0.39460 C22H44NO7P [M+H]+ 
467.40978 467.40949 -0.62686 C29H54O4 [M+H]+ 
468.30841 468.30847 0.11958 C22H46NO7P [M+H]+ 
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469.09753 469.09767 0.29205 C20H20O13 [M+H]+ 
477.39383 477.39384 0.01466 C15H26O2 [2M+H]+ 
480.30845 480.30847 0.03331 C23H46NO7P [M+H]+ 
482.32405 482.32412 0.13684 C23H48NO7P [M+H]+ 
485.26385 485.26386 0.02267 C23H43O7P [M+Na]+ 
487.27968 487.27951 -0.34682 C23H45O7P [M+Na]+ 
490.29032 490.29041 0.18356 C22H46NO7P [M+Na]+ 
490.32917 490.32932 0.29980 C27H49NO4 [M+K]+ 
490.40163 490.40209 0.93393 C29H57NO2 [M+K]+ 
491.33254 491.33269 0.31140 C12H23NO4 [2M+H]+ 
492.34480 492.34497 0.33919 C27H51NO4 [M+K]+ 
493.42531 493.42514 -0.35061 C31H56O4 [M+H]+ 
494.32404 494.32412 0.15375 C24H48NO7P [M+H]+ 
494.49290 494.49316 0.51972 C32H63NO2 [M+H]+ 
495.40450 495.40440 -0.19984 C30H54O5 [M+H]+ 
496.33971 496.33977 0.11283 C24H50NO7P [M+H]+ 
501.31437 501.31436 -0.02593 C21H40N8O6 [M+H]+ 
504.30618 504.30606 -0.23795 C23H48NO7P [M+Na]+ 
504.34484 504.34485 0.02181 C26H50NO6P [M+H]+ 
506.26418 506.26435 0.33184 C22H46NO7P [M+K]+ 
506.36035 506.36050 0.29821 C26H52NO6P [M+H]+ 
507.44103 507.44079 -0.47887 C32H58O4 [M+H]+ 
508.00268 508.00302 0.67322 C10H16N5O13P3 [M+H]+ 
508.33981 508.33977 -0.08656 C25H50NO7P [M+H]+ 
509.12901 509.12897 -0.08446 C23H24O13 [M+H]+ 
509.45637 509.45644 0.13151 C32H60O4 [M+H]+ 
510.35539 510.35542 0.05094 C25H52NO7P [M+H]+ 
511.09621 511.09655 0.66915 C14H26N4O11P2 [M+Na]+ 
513.29503 513.29516 0.25521 C25H47O7P [M+Na]+ 
516.28393 516.28369 -0.45711 C22H45NO10S [M+H]+ 
516.30594 516.30606 0.23242 C24H48NO7P [M+Na]+ 
517.38614 517.38635 0.39816 C30H54O5 [M+Na]+ 
517.42287 517.42273 -0.26864 C31H58O4 [M+Na]+ 
518.32168 518.32171 0.05788 C24H50NO7P [M+Na]+ 
518.36024 518.36050 0.50351 C27H52NO6P [M+H]+ 
519.36405 519.36399 -0.10975 C13H25NO4 [2M+H]+ 
520.27952 520.28000 0.91874 C23H48NO7P [M+K]+ 
520.33966 520.33977 0.20371 C26H50NO7P [M+H]+ 
521.45637 521.45644 0.12849 C33H60O4 [M+H]+ 
522.35531 522.35542 0.20293 C26H52NO7P [M+H]+ 
522.52446 522.52446 -0.00574 C34H67NO2 [M+H]+ 
523.32239 523.32252 0.25223 C12H23NO5 [2M+H]+ 
523.47202 523.47209 0.12799 C33H62O4 [M+H]+ 
524.37097 524.37107 0.18308 C26H54NO7P [M+H]+ 
525.47821 525.47784 -0.70222 C35H60N2O [M+H]+ 
531.43835 531.43838 0.05833 C32H60O4 [M+Na]+ 
532.33698 532.33736 0.71383 C25H52NO7P [M+Na]+ 
532.37615 532.37615 0.00376 C28H54NO6P [M+H]+ 
534.29535 534.29565 0.55774 C24H50NO7P [M+K]+ 
536.37108 536.37107 -0.02610 C27H54NO7P [M+H]+ 
537.48768 537.48774 0.10605 C34H64O4 [M+H]+ 
538.35030 538.35033 0.05758 C26H52NO8P [M+H]+ 
538.38658 538.38672 0.25261 C27H56NO7P [M+H]+ 
538.38658 538.38672 0.25261 C27H56NO7P [M+H]+ 
543.43847 543.43838 -0.16377 C33H60O4 [M+Na]+ 
544.33739 544.33736 -0.05511 C26H52NO7P [M+Na]+ 
544.50681 544.50640 -0.75114 C34H67NO2 [M+Na]+ 
545.45407 545.45403 -0.07150 C33H62O4 [M+Na]+ 
546.35299 546.35301 0.03661 C26H54NO7P [M+Na]+ 
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547.47206 547.47209 0.04932 C35H62O4 [M+H]+ 
549.48763 549.48774 0.19473 C35H64O4 [M+H]+ 
550.35027 550.35029 0.04361 C32H49NO5 [M+Na]+ 
550.38662 550.38672 0.17442 C28H56NO7P [M+H]+ 
551.35371 551.35382 0.20314 C13H25NO5 [2M+H]+ 
551.50330 551.50339 0.15775 C35H66O4 [M+H]+ 
552.32943 552.32960 0.29873 C26H50NO9P [M+H]+ 
552.36623 552.36598 -0.45079 C27H54NO8P [M+H]+ 
559.46966 559.46968 0.03754 C34H64O4 [M+Na]+ 
560.31122 560.31130 0.13921 C26H52NO7P [M+K]+ 
560.33218 560.33228 0.16954 C26H52NO8P [M+Na]+ 
560.40745 560.40745 0.00357 C30H58NO6P [M+H]+ 
561.48730 561.48774 0.77829 C18H32O2 [2M+H]+ 
563.50330 563.50339 0.15439 C36H66O4 [M+H]+ 
564.40215 564.40237 0.38271 C29H58NO7P [M+H]+ 
565.51897 565.51904 0.11848 C36H68O4 [M+H]+ 
566.38189 566.38163 -0.45729 C28H56NO8P [M+H]+ 
571.46956 571.46968 0.21173 C35H64O4 [M+Na]+ 
572.36839 572.36866 0.47172 C28H56NO7P [M+Na]+ 
575.50330 575.50339 0.15117 C37H66O4 [M+H]+ 
577.51895 577.51904 0.15064 C37H68O4 [M+H]+ 
578.38165 578.38163 -0.03285 C29H56NO8P [M+H]+ 
578.41764 578.41802 0.65005 C30H60NO7P [M+H]+ 
579.38531 579.38512 -0.32448 C14H27NO5 [2M+H]+ 
580.36098 580.36090 -0.14646 C28H54NO9P [M+H]+ 
582.27281 582.27295 0.23357 C21H39N7O12 [M+H]+ 
585.35326 585.35268 -0.99769 C29H55O8P [M+Na]+ 
585.48562 585.48533 -0.49361 C36H66O4 [M+Na]+ 
589.51896 589.51904 0.13061 C19H34O2 [2M+H]+ 
591.53461 591.53469 0.13017 C38H70O4 [M+H]+ 
592.39719 592.39728 0.15361 C30H58NO8P [M+H]+ 
594.37635 594.37655 0.32807 C29H56NO9P [M+H]+ 
594.41308 594.41293 -0.25067 C30H60NO8P [M+H]+ 
597.35320 597.35268 -0.87720 C30H55O8P [M+Na]+ 
597.48526 597.48533 0.11883 C37H66O4 [M+Na]+ 
598.38652 598.38672 0.32755 C32H56NO7P [M+H]+ 
599.50142 599.50098 -0.73228 C37H68O4 [M+Na]+ 
600.36309 600.36358 0.80784 C29H56NO8P [M+Na]+ 
601.51882 601.51904 0.36075 C39H68O4 [M+H]+ 
603.53453 603.53469 0.26013 C39H70O4 [M+H]+ 
604.25508 604.25489 -0.31444 C21H39N7O12 [M+Na]+ 
605.55038 605.55034 -0.07101 C39H72O4 [M+H]+ 
606.41285 606.41293 0.13357 C31H60NO8P [M+H]+ 
606.44921 606.44932 0.17479 C32H64NO7P [M+H]+ 
607.41610 607.41642 0.53176 C15H29NO5 [2M+H]+ 
608.39184 608.39220 0.58515 C30H58NO9P [M+H]+ 
611.36793 611.36833 0.64773 C31H57O8P [M+Na]+ 
613.34748 613.34759 0.18097 C30H55O9P [M+Na]+ 
614.37897 614.37923 0.41505 C30H58NO8P [M+Na]+ 
616.35812 616.35849 0.60030 C29H56NO9P [M+Na]+ 
618.41298 618.41293 -0.07924 C32H60NO8P [M+H]+ 
619.56641 619.56599 -0.68274 C40H74O4 [M+H]+ 
620.42850 620.42858 0.13055 C32H62NO8P [M+H]+ 
622.40773 622.40785 0.18637 C31H60NO9P [M+H]+ 
622.44413 622.44423 0.16226 C32H64NO8P [M+H]+ 
627.36270 627.36324 0.86234 C31H57O9P [M+Na]+ 
628.39466 628.39488 0.34214 C31H60NO8P [M+Na]+ 
631.56611 631.56599 -0.19475 C41H74O4 [M+H]+ 
632.42837 632.42858 0.33363 C33H62NO8P [M+H]+ 
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633.58207 633.58164 -0.68342 C41H76O4 [M+H]+ 
634.40781 634.40785 0.05675 C32H60NO9P [M+H]+ 
634.44437 634.44423 -0.21909 C33H64NO8P [M+H]+ 
635.44789 635.44772 -0.26281 C16H31NO5 [2M+H]+ 
636.42322 636.42350 0.43367 C32H62NO9P [M+H]+ 
636.45974 636.45988 0.22154 C33H66NO8P [M+H]+ 
638.40222 638.40276 0.84586 C31H60NO10P [M+H]+ 
639.36300 639.36324 0.37694 C32H57O9P [M+Na]+ 
640.46749 640.46765 0.24357 C34H68NO6P [M+Na]+ 
641.37936 641.37889 -0.73124 C32H59O9P [M+Na]+ 
641.41494 641.41528 0.52384 C33H63O8P [M+Na]+ 
644.38949 644.38979 0.46556 C31H60NO9P [M+Na]+ 
644.42622 644.42618 -0.06983 C32H64NO8P [M+Na]+ 
645.42854 645.42797 -0.88468 C40H62O4 [M+K]+ 
646.44434 646.44423 -0.16861 C34H64NO8P [M+H]+ 
648.42323 648.42350 0.41023 C33H62NO9P [M+H]+ 
648.45962 648.45988 0.40249 C34H66NO8P [M+H]+ 
648.62920 648.62892 -0.42860 C42H81NO3 [M+H]+ 
650.43884 650.43915 0.47045 C33H64NO9P [M+H]+ 
651.45784 651.45789 0.08136 C18H31NO4 [2M+H]+ 
652.41821 652.41841 0.30655 C32H62NO10P [M+H]+ 
653.55032 653.55034 0.02601 C43H72O4 [M+H]+ 
654.41012 654.41053 0.61888 C33H62NO8P [M+Na]+ 
655.43053 655.43093 0.60418 C34H65O8P [M+Na]+ 
657.38863 657.38921 0.88836 C33H63O8P [M+K]+ 
658.40491 658.40544 0.80498 C32H62NO9P [M+Na]+ 
658.44191 658.44183 -0.12909 C33H66NO8P [M+Na]+ 
659.59707 659.59729 0.32899 C43H78O4 [M+H]+ 
660.36348 660.36373 0.37404 C31H60NO9P [M+K]+ 
662.43849 662.43915 0.99028 C34H64NO9P [M+H]+ 
662.47593 662.47553 -0.60229 C35H68NO8P [M+H]+ 
664.41815 664.41841 0.39132 C33H62NO10P [M+H]+ 
664.45437 664.45480 0.64113 C34H66NO9P [M+H]+ 
664.49082 664.49118 0.54327 C35H70NO8P [M+H]+ 
666.43376 666.43406 0.45016 C33H64NO10P [M+H]+ 
666.48269 666.48330 0.90925 C36H70NO6P [M+Na]+ 
666.63932 666.63949 0.25051 C42H83NO4 [M+H]+ 
667.39438 667.39454 0.24124 C34H61O9P [M+Na]+ 
668.49865 668.49895 0.44278 C36H72NO6P [M+Na]+ 
669.44632 669.44658 0.38241 C35H67O8P [M+Na]+ 
670.40480 670.40544 0.95465 C33H62NO9P [M+Na]+ 
670.61047 670.61087 0.59051 C42H81NO3 [M+Na]+ 
671.40482 671.40486 0.06553 C34H65O8P [M+K]+ 
672.42071 672.42109 0.56512 C33H64NO9P [M+Na]+ 
672.45714 672.45748 0.49817 C34H68NO8P [M+Na]+ 
674.43969 674.43915 -0.80660 C35H64NO9P [M+H]+ 
674.47487 674.47553 0.98002 C36H68NO8P [M+H]+ 
675.54313 675.54355 0.62320 C37H75N2O6P [M+H]+ 
676.45436 676.45480 0.64454 C35H66NO9P [M+H]+ 
676.49183 676.49118 -0.95936 C36H70NO8P [M+H]+ 
677.55903 677.55920 0.25238 C37H77N2O6P [M+H]+ 
678.47014 678.47045 0.45101 C35H68NO9P [M+H]+ 
678.50641 678.50683 0.62048 C36H72NO8P [M+H]+ 
680.44994 680.44971 -0.33801 C34H66NO10P [M+H]+ 
683.40473 683.40486 0.19608 C35H65O8P [M+K]+ 
683.46191 683.46223 0.46382 C36H69O8P [M+Na]+ 
685.42034 685.42051 0.25386 C35H67O8P [M+K]+ 
686.43616 686.43674 0.84494 C34H66NO9P [M+Na]+ 
686.47279 686.47313 0.48946 C35H70NO8P [M+Na]+ 
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688.39463 688.39503 0.57670 C33H64NO9P [M+K]+ 
688.41573 688.41601 0.39947 C33H64NO10P [M+Na]+ 
688.49126 688.49118 -0.11474 C37H70NO8P [M+H]+ 
690.47015 690.47045 0.42869 C36H68NO9P [M+H]+ 
690.50625 690.50683 0.84141 C37H72NO8P [M+H]+ 
692.52206 692.52248 0.60792 C37H74NO8P [M+H]+ 
694.46499 694.46536 0.53278 C35H68NO10P [M+H]+ 
695.46161 695.46223 0.88718 C37H69O8P [M+Na]+ 
697.47803 697.47788 -0.21936 C37H71O8P [M+Na]+ 
697.52502 697.52550 0.68098 C37H75N2O6P [M+Na]+ 
698.43645 698.43674 0.41521 C35H66NO9P [M+Na]+ 
699.43659 699.43616 -0.60906 C36H69O8P [M+K]+ 
699.54126 699.54115 -0.16296 C37H77N2O6P [M+Na]+ 
700.45308 700.45239 -0.98508 C35H68NO9P [M+Na]+ 
700.48823 700.48878 0.77946 C36H72NO8P [M+Na]+ 
703.57444 703.57485 0.58416 C39H79N2O6P [M+H]+ 
704.48624 704.48610 -0.20440 C37H70NO9P [M+H]+ 
704.52199 704.52248 0.69693 C38H74NO8P [M+H]+ 
705.59044 705.59050 0.08645 C39H81N2O6P [M+H]+ 
706.53773 706.53813 0.56756 C38H76NO8P [M+H]+ 
709.47725 709.47788 0.88375 C38H71O8P [M+Na]+ 
711.43579 711.43616 0.52570 C37H69O8P [M+K]+ 
711.49379 711.49353 -0.36964 C38H73O8P [M+Na]+ 
712.43998 712.43954 -0.61760 C34H66NO12P [M+H]+ 
713.45214 713.45181 -0.45693 C37H71O8P [M+K]+ 
714.50390 714.50443 0.73618 C37H74NO8P [M+Na]+ 
716.46215 716.46256 0.57365 C39H68NO7P [M+Na]+ 
718.53761 718.53813 0.72508 C39H76NO8P [M+H]+ 
719.54112 719.54162 0.69906 C19H37NO5 [2M+H]+ 
719.56023 719.56090 0.93390 C47H74O5 [M+H]+ 
720.55344 720.55378 0.47464 C39H78NO8P [M+H]+ 
721.47727 721.47788 0.84133 C39H71O8P [M+Na]+ 
723.49323 723.49353 0.41051 C39H73O8P [M+Na]+ 
725.45244 725.45181 -0.86291 C38H71O8P [M+K]+ 
725.49600 725.49633 0.44935 C37H73O11P [M+H]+ 
725.55616 725.55680 0.87657 C39H79N2O6P [M+Na]+ 
727.57233 727.57245 0.15943 C39H81N2O6P [M+Na]+ 
728.51962 728.52008 0.62593 C38H76NO8P [M+Na]+ 
730.47847 730.47836 -0.14648 C37H74NO8P [M+K]+ 
731.52272 731.52215 -0.78330 C40H75O9P [M+H]+ 
732.55330 732.55378 0.65797 C40H78NO8P [M+H]+ 
734.56972 734.56943 -0.39207 C40H80NO8P [M+H]+ 
737.45166 737.45181 0.20883 C39H71O8P [M+K]+ 
737.50875 737.50918 0.57898 C40H75O8P [M+Na]+ 
738.45508 738.45519 0.14896 C36H68NO12P [M+H]+ 
739.46745 739.46746 0.01893 C39H73O8P [M+K]+ 
740.51959 740.52008 0.65630 C39H76NO8P [M+Na]+ 
742.47868 742.47836 -0.42695 C38H74NO8P [M+K]+ 
742.53535 742.53573 0.50637 C39H78NO8P [M+Na]+ 
744.49379 744.49386 0.09537 C41H72NO7P [M+Na]+ 
746.56902 746.56943 0.55186 C41H80NO8P [M+H]+ 
747.49355 747.49353 -0.03077 C41H73O8P [M+Na]+ 
747.57244 747.57292 0.64609 C20H39NO5 [2M+H]+ 
749.50881 749.50918 0.48965 C41H75O8P [M+Na]+ 
753.48522 753.48548 0.34904 C47H70O5 [M+K]+ 
754.53544 754.53573 0.37904 C40H78NO8P [M+Na]+ 
756.55193 756.55138 -0.73227 C40H80NO8P [M+Na]+ 
758.50981 758.50966 -0.19380 C39H78NO8P [M+K]+ 
758.56930 758.56943 0.17401 C42H80NO8P [M+H]+ 
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760.58491 760.58508 0.22614 C42H82NO8P [M+H]+ 
765.48358 765.48311 -0.60877 C41H75O8P [M+K]+ 
766.48618 766.48649 0.40444 C38H72NO12P [M+H]+ 
766.53569 766.53573 0.04696 C41H78NO8P [M+Na]+ 
768.55118 768.55138 0.25503 C41H80NO8P [M+Na]+ 
770.50946 770.50951 0.06619 C43H74NO7P [M+Na]+ 
770.54647 770.54605 -0.54637 C41H82NO7P [M+K]+ 
772.58551 772.58508 -0.55398 C43H82NO8P [M+H]+ 
774.60049 774.60073 0.31242 C43H84NO8P [M+H]+ 
775.60395 775.60422 0.35198 C21H41NO5 [2M+H]+ 
777.54028 777.54048 0.25336 C43H79O8P [M+Na]+ 
778.53627 778.53573 -0.69875 C42H78NO8P [M+Na]+ 
780.55148 780.55138 -0.13324 C42H80NO8P [M+Na]+ 
782.56715 782.56703 -0.15845 C42H82NO8P [M+Na]+ 
784.52557 784.52531 -0.32759 C41H80NO8P [M+K]+ 
785.56683 785.56669 -0.17567 C42H83O9P [M+Na]+ 
786.60055 786.60073 0.23138 C44H84NO8P [M+H]+ 
788.51963 788.52008 0.56562 C43H76NO8P [M+Na]+ 
794.56721 794.56703 -0.23157 C43H82NO8P [M+Na]+ 
796.52562 796.52531 -0.38542 C42H80NO8P [M+K]+ 
796.58273 796.58268 -0.06779 C43H84NO8P [M+Na]+ 
798.54125 798.54096 -0.35941 C42H82NO8P [M+K]+ 
800.54439 800.54361 -0.97309 C43H78NO10P [M+H]+ 
800.61597 800.61638 0.51460 C45H86NO8P [M+H]+ 
804.55154 804.55138 -0.20384 C44H80NO8P [M+Na]+ 
808.58346 808.58268 -0.96960 C44H84NO8P [M+Na]+ 
809.65141 809.65070 -0.88186 C45H91N2O6P [M+Na]+ 
810.60050 810.60073 0.28621 C46H84NO8P [M+H]+ 
811.66849 811.66875 0.32279 C47H91N2O6P [M+H]+ 
813.56149 813.56161 0.14258 C43H83O10P [M+Na]+ 
813.68483 813.68440 -0.52600 C47H93N2O6P [M+H]+ 
814.63249 814.63203 -0.56222 C46H88NO8P [M+H]+ 
815.70049 815.70005 -0.53696 C47H95N2O6P [M+H]+ 
822.60028 822.60073 0.54948 C47H84NO8P [M+H]+ 
824.55704 824.55661 -0.51785 C44H84NO8P [M+K]+ 
828.64806 828.64768 -0.45616 C47H90NO8P [M+H]+ 
830.56911 830.56943 0.38769 C48H80NO8P [M+H]+ 
835.66708 835.66635 -0.87834 C47H93N2O6P [M+Na]+ 
836.61573 836.61638 0.77933 C48H86NO8P [M+H]+ 
838.63027 838.62963 -0.76792 C46H90NO8P [M+Na]+ 
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DHB mass list negative mode 
Observed m/z Expected m/z Error (ppm) Tentative neutral formula Adduct 
153.01930 153.01933 0.20912 C7H6O4 [M-H]- 
187.04010 187.04007 -0.17109 C11H8O3 [M-H]- 
201.07692 201.07685 -0.36305 C9H14O5 [M-H]- 
214.97518 214.97521 0.15816 C9H6O4 [M+K-2H]- 
215.03498 215.03498 0.00930 C12H8O4 [M-H]- 
216.04289 216.04308 0.88871 C13H9NO [M+Na-2H]- 
217.05075 217.05063 -0.54365 C12H10O4 [M-H]- 
227.03513 227.03498 -0.65188 C13H8O4 [M-H]- 
232.97623 232.97615 -0.35626 C7H6O7S [M-H]- 
241.01196 241.01188 -0.34438 C6H11O8P [M-H]- 
243.03007 243.02990 -0.71185 C13H8O5 [M-H]- 
244.95345 244.95363 0.74708 C7H12OS3 [M+K-2H]- 
245.04560 245.04555 -0.21629 C13H10O5 [M-H]- 
259.02487 259.02481 -0.22392 C13H8O6 [M-H]- 
260.03280 260.03295 0.56531 C9H12NO6P [M-H]- 
261.04066 261.04046 -0.75850 C13H10O6 [M-H]- 
273.04061 273.04046 -0.54204 C14H10O6 [M-H]- 
281.24862 281.24860 -0.05689 C18H34O2 [M-H]- 
288.02778 288.02798 0.68743 C12H13NO5 [M+K-2H]- 
289.03557 289.03538 -0.67120 C14H10O7 [M-H]- 
299.99526 299.99496 -0.99002 C9H13NO6S [M+K-2H]- 
305.03050 305.03029 -0.68518 C14H10O8 [M-H]- 
321.04066 321.04046 -0.61674 C18H10O6 [M-H]- 
323.05634 323.05611 -0.70576 C18H12O6 [M-H]- 
327.01230 327.01224 -0.19877 C14H10O8 [M+Na-2H]- 
329.01547 329.01562 0.45591 C9H13N2O8P [M+Na-2H]- 
329.02790 329.02804 0.41638 C11H16O9 [M+K-2H]- 
334.04854 334.04871 0.51789 C17H15NO4 [M+K-2H]- 
335.05642 335.05611 -0.91925 C19H12O6 [M-H]- 
335.07728 335.07724 -0.11639 C16H16O8 [M-H]- 
348.05278 348.05248 -0.86768 C11H21NO7S [M+K-2H]- 
350.04331 350.04363 0.90846 C17H15NO5 [M+K-2H]- 
351.05114 351.05103 -0.32474 C19H12O7 [M-H]- 
351.07245 351.07216 -0.83743 C16H16O9 [M-H]- 
353.06674 353.06668 -0.18127 C19H14O7 [M-H]- 
355.17354 355.17382 0.79116 C16H30O7 [M+Na-2H]- 
369.06173 369.06159 -0.37663 C19H14O8 [M-H]- 
379.04605 379.04594 -0.28756 C10H6O4 [2M-H]- 
381.06168 381.06159 -0.23356 C20H14O8 [M-H]- 
382.17352 382.17321 -0.81900 C16H25N5O6 [M-H]- 
395.20498 395.20512 0.35678 C19H34O7 [M+Na-2H]- 
397.05674 397.05651 -0.58934 C20H14O9 [M-H]- 
397.18446 397.18411 -0.89127 C8H13N3O3 [2M-H]- 
403.05241 403.05268 0.67733 C8H10O4S [2M-H]- 
409.18414 409.18439 0.60120 C19H32O8 [M+Na-2H]- 
409.22064 409.22077 0.32012 C20H36O7 [M+Na-2H]- 
411.19980 411.20004 0.57393 C19H34O8 [M+Na-2H]- 
417.24108 417.24115 0.16537 C21H39O6P [M-H]- 
419.25687 419.25692 0.10733 C23H42O4 [M+K-2H]- 
423.19981 423.20004 0.53403 C20H34O8 [M+Na-2H]- 
425.05132 425.05142 0.23527 C21H14O10 [M-H]- 
426.05474 426.05475 0.02112 C15H17N5O6S2 [M-H]- 
435.19998 435.20004 0.12868 C21H34O8 [M+Na-2H]- 
438.04375 438.04352 -0.53648 C17H17N3O7S2 [M-H]- 
439.02586 439.02593 0.15717 C20H18O7S [M+K-2H]- 
447.03348 447.03352 0.08277 C18H18O11 [M+K-2H]- 
453.21029 453.21060 0.68622 C21H36O9 [M+Na-2H]- 
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455.00648 455.00621 -0.59779 C13H8S2 [2M-H]- 
465.04429 465.04408 -0.44942 C18H20O12 [M+K-2H]- 
466.99754 466.99729 -0.52677 C16H12N4O9S2 [M-H]- 
481.20546 481.20524 -0.46758 C10H15N3O4 [2M-H]- 
483.03373 483.03352 -0.44096 C21H18O11 [M+K-2H]- 
483.04226 483.04251 0.52169 C10H10O5S [2M-H]- 
500.02260 500.02265 0.09600 C14H18N5O11P [M+K-2H]- 
505.01761 505.01787 0.50889 C23H16O11 [M+K-2H]- 
519.15246 519.15214 -0.62217 C13H12N2O4 [2M-H]- 
523.26328 523.26295 -0.62875 C11H22N2O3S [2M-H]- 
523.29952 523.29981 0.54462 C23H40N8O6 [M-H]- 
543.04501 543.04501 0.00737 C21H20O15S [M-H]- 
551.01383 551.01371 -0.21052 C22H16O15S [M-H]- 
551.25654 551.25692 0.68026 C34H42O4 [M+K-2H]- 
553.27866 553.27829 -0.67597 C30H44O8 [M+Na-2H]- 
561.03535 561.03554 0.33153 C9H15NO3S3 [2M-H]- 
571.28916 571.28889 -0.47787 C25H49O12P [M-H]- 
577.94956 577.94983 0.46717 C10H18N5O15P3 [M+K-2H]- 
582.31260 582.31311 0.88269 C26H49NO13 [M-H]- 
595.00151 595.00114 -0.62521 C21H18O17S [M+Na-2H]- 
597.30396 597.30454 0.96601 C27H51O12P [M-H]- 
599.32004 599.32019 0.24528 C27H53O12P [M-H]- 
602.98949 602.98917 -0.53566 C4H6N4O12 [2M-H]- 
640.96050 640.96114 0.99694 C28H12O16 [M+K-2H]- 
673.48127 673.48138 0.16185 C37H71O8P [M-H]- 
699.49709 699.49703 -0.08721 C39H73O8P [M-H]- 
790.80237 790.80217 -0.25291 C52H105NO3 [M-H]- 
809.51885 809.51855 -0.36688 C41H79O13P [M-H]- 
833.51784 833.51855 0.85541 C43H79O13P [M-H]- 
835.53341 835.53420 0.94909 C43H81O13P [M-H]- 
863.56481 863.56550 0.80249 C45H85O13P [M-H]- 
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9AA mass list negative mode 
Observed m/z Expected m/z Error (ppm) Tentative neutral formula Adduct 
152.99581 152.99580 -0.08497 C8H4O2 [M+Na-2H]- 
171.00637 171.00640 0.16374 C3H9O6P [M+Na-2H]- 
176.93594 176.93595 0.05087 H4O7P2 [M-H]- 
188.03532 188.03532 -0.01595 C10H7NO3 [M-H]- 
191.01971 191.01973 0.08376 C6H8O7 [M-H]- 
194.06114 194.06114 -0.01546 C13H9NO [M-H]- 
195.07749 195.07752 0.13328 C9H12N2O3 [M-H]- 
195.08241 195.08250 0.48185 C9H18OS [M+Na-2H]- 
196.03799 196.03800 0.03061 C10H9NO2 [M+Na-2H]- 
204.98122 204.98123 0.05854 C6H6O6S [M-H]- 
207.04453 207.04450 -0.14007 C6H12N2O4S [M-H]- 
210.08834 210.08842 0.35699 C9H13N3O3 [M-H]- 
211.00131 211.00128 -0.16114 C10H6O4 [M+Na-2H]- 
214.04859 214.04860 0.03270 C5H14NO6P [M-H]- 
226.08334 226.08333 -0.04865 C9H13N3O4 [M-H]- 
227.03818 227.03835 0.76199 C10H12O4S [M-H]- 
228.09900 228.09898 -0.08768 C9H15N3O4 [M-H]- 
235.03945 235.03942 -0.14466 C7H12N2O5S [M-H]- 
237.09150 237.09145 -0.20245 C8H18N2O4S [M-H]- 
238.89177 238.89172 -0.23023 H3O9P3 [M-H]- 
241.01193 241.01188 -0.21991 C6H11O8P [M-H]- 
241.21734 241.21730 -0.14924 C15H30O2 [M-H]- 
242.07833 242.07824 -0.35526 C9H13N3O5 [M-H]- 
249.05512 249.05507 -0.21682 C8H14N2O5S [M-H]- 
253.05000 253.04998 -0.07508 C7H14N2O6S [M-H]- 
253.21738 253.21730 -0.30014 C16H30O2 [M-H]- 
255.23298 255.23295 -0.10187 C16H32O2 [M-H]- 
256.90243 256.90228 -0.58388 H5O10P3 [M-H]- 
259.01304 259.01293 -0.43627 C6H12O9S [M-H]- 
259.02248 259.02244 -0.14671 C6H13O9P [M-H]- 
260.02346 260.02343 -0.10768 C9H11NO6S [M-H]- 
260.08878 260.08881 0.11150 C9H15N3O6 [M-H]- 
260.87358 260.87366 0.30283 H3O9P3 [M+Na-2H]- 
262.01222 262.01230 0.30533 C10H11NO5 [M+K-2H]- 
262.08682 262.08670 -0.45405 C9H17N3O4S [M-H]- 
267.23297 267.23295 -0.05987 C17H32O2 [M-H]- 
269.24867 269.24860 -0.24513 C17H34O2 [M-H]- 
273.09214 273.09210 -0.13549 C19H14O2 [M-H]- 
274.10428 274.10446 0.65304 C10H17N3O6 [M-H]- 
275.01747 275.01736 -0.41088 C6H13O10P [M-H]- 
279.23294 279.23295 0.05014 C18H32O2 [M-H]- 
281.24866 281.24860 -0.19911 C18H34O2 [M-H]- 
283.26430 283.26425 -0.16239 C18H36O2 [M-H]- 
295.05882 295.05879 -0.09829 C15H14O5 [M+Na-2H]- 
295.22794 295.22787 -0.24388 C18H32O3 [M-H]- 
295.26442 295.26425 -0.56221 C19H36O2 [M-H]- 
297.03811 297.03806 -0.18179 C14H12O6 [M+Na-2H]- 
297.24347 297.24352 0.16148 C18H34O3 [M-H]- 
297.27967 297.27990 0.78714 C19H38O2 [M-H]- 
300.03960 300.03948 -0.41328 C8H15NO9S [M-H]- 
300.04905 300.04899 -0.19663 C8H16NO9P [M-H]- 
303.23300 303.23295 -0.15170 C10H16O [2M-H]- 
304.03403 304.03401 -0.06578 C9H12N3O7P [M-H]- 
305.01806 305.01803 -0.11475 C9H11N2O8P [M-H]- 
305.06414 305.06427 0.42942 C13H16O7 [M+Na-2H]- 
306.07658 306.07653 -0.16336 C10H17N3O6S [M-H]- 
307.07994 307.07992 -0.06187 C13H18O7 [M+Na-2H]- 
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309.05920 309.05919 -0.04853 C12H16O8 [M+Na-2H]- 
309.27997 309.27990 -0.21340 C20H38O2 [M-H]- 
311.07463 311.07484 0.65901 C12H18O8 [M+Na-2H]- 
315.04864 315.04877 0.42216 C11H18O8 [M+K-2H]- 
322.04456 322.04458 0.04658 C9H14N3O8P [M-H]- 
323.02866 323.02859 -0.21670 C9H13N2O9P [M-H]- 
323.09013 323.09009 -0.12071 C17H18O5 [M+Na-2H]- 
325.03873 325.03875 0.05230 C14H14O7S [M-H]- 
327.03068 327.03086 0.55652 C15H14O5S [M+Na-2H]- 
327.23300 327.23295 -0.14057 C22H32O2 [M-H]- 
328.04546 328.04524 -0.66149 C10H12N5O6P [M-H]- 
328.05849 328.05847 -0.04877 C10H17N3O6S [M+Na-2H]- 
329.04912 329.04902 -0.31910 C11H16O10 [M+Na-2H]- 
333.05924 333.05922 -0.05404 C9H19O11P [M-H]- 
334.07143 334.07144 0.04191 C11H17N3O7S [M-H]- 
336.08697 336.08710 0.37193 C11H19N3O7S [M-H]- 
337.05419 337.05410 -0.26702 C13H16O9 [M+Na-2H]- 
338.98882 338.98877 -0.13865 C6H14O12P2 [M-H]- 
340.99451 340.994643 0.184753 C10H13N2O7P [M+K-2H]- 
342.11124 342.11116 -0.23092 C20H19NO3 [M+Na-2H]- 
344.03238 344.03241 0.09011 C10H17N3O6S [M+K-2H]- 
344.03983 344.04016 0.95338 C10H12N5O7P [M-H]- 
346.05587 346.05581 -0.17916 C10H14N5O7P [M-H]- 
350.13733 350.13738 0.13138 C19H23NO4 [M+Na-2H]- 
360.97101 360.97072 -0.81170 C6H14O12P2 [M+Na-2H]- 
362.05090 362.05072 -0.48888 C10H14N5O8P [M-H]- 
363.19403 363.19416 0.36620 C22H30O3 [M+Na-2H]- 
364.08208 364.08201 -0.19501 C12H19N3O8S [M-H]- 
371.05933 371.05958 0.67105 C13H18O11 [M+Na-2H]- 
371.07486 371.07484 -0.06737 C17H18O8 [M+Na-2H]- 
371.13012 371.12985 -0.73290 C19H26O4S [M+Na-2H]- 
372.13332 372.13296 -0.97008 C20H21N3O3 [M+Na-2H]- 
375.01157 375.01136 -0.57332 C9H15N4O8P [M+K-2H]- 
376.03101 376.03102 0.02393 C16H11NO10 [M-H]- 
377.20989 377.20981 -0.20413 C23H32O3 [M+Na-2H]- 
387.15269 387.15254 -0.39261 C8H18OS2 [2M-H]- 
388.25259 388.25270 0.29105 C20H39NO4S [M-H]- 
389.20987 389.20997 0.24408 C21H36O4 [M+K-2H]- 
391.22556 391.22562 0.14058 C21H38O4 [M+K-2H]- 
395.20503 395.20512 0.23026 C19H34O7 [M+Na-2H]- 
401.01541 401.01566 0.61344 C10H16N2O11P2 [M-H]- 
401.14058 401.14041 -0.41631 C20H28O5S [M+Na-2H]- 
402.01091 402.01091 -0.01244 C9H15N3O11P2 [M-H]- 
402.99499 402.99492 -0.17122 C9H14N2O12P2 [M-H]- 
403.22546 403.22546 0.00744 C25H34O3 [M+Na-2H]- 
405.00481 405.00519 0.94814 C16H16O8S [M+K-2H]- 
405.24124 405.24127 0.06169 C22H40O4 [M+K-2H]- 
407.22045 407.22041 -0.08840 C19H37O7P [M-H]- 
409.23602 409.23606 0.10752 C19H39O7P [M-H]- 
415.22565 415.22562 -0.08429 C23H38O4 [M+K-2H]- 
417.24121 417.24127 0.13182 C23H40O4 [M+K-2H]- 
418.95506 418.95510 0.10264 C6H15O15P3 [M-H]- 
419.25685 419.25680 -0.12164 C21H41O6P [M-H]- 
420.26023 420.26029 0.14515 C20H39NO8 [M-H]- 
421.06576 421.06575 -0.02375 C12H22O14S [M-H]- 
421.23609 421.23606 -0.06172 C20H39O7P [M-H]- 
423.25171 423.25171 0.00945 C20H41O7P [M-H]- 
424.97684 424.97687 0.05883 C9H14N2O12P2 [M+Na-2H]- 
426.02221 426.02214 -0.16666 C10H15N5O10P2 [M-H]- 
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427.02555 427.02593 0.88753 C19H18O7S [M+K-2H]- 
429.05825 429.05819 -0.13984 C11H20N4O10P2 [M-H]- 
431.22062 431.22041 -0.47771 C21H37O7P [M-H]- 
431.25698 431.25676 -0.50318 C27H38O3 [M+Na-2H]- 
432.25244 432.25216 -0.63852 C23H41NO4 [M+K-2H]- 
433.23617 433.23606 -0.24467 C21H39O7P [M-H]- 
433.27243 433.27241 -0.03924 C27H40O3 [M+Na-2H]- 
435.25178 435.25171 -0.15164 C21H41O7P [M-H]- 
437.26746 437.26736 -0.21955 C21H43O7P [M-H]- 
440.95058 440.95080 0.50346 C9H14N2O12P2 [M+K-2H]- 
441.04120 441.04158 0.85933 C20H20O7S [M+K-2H]- 
442.01713 442.01705 -0.17420 C10H15N5O11P2 [M-H]- 
443.25700 443.25692 -0.19176 C25H42O4 [M+K-2H]- 
445.05317 445.05310 -0.14830 C11H20N4O11P2 [M-H]- 
448.00409 448.00408 -0.01562 C10H15N5O10P2 [M+Na-2H]- 
449.23126 449.23094 -0.70788 C26H36O5 [M+Na-2H]- 
452.27840 452.27826 -0.30291 C21H44NO7P [M-H]- 
455.05724 455.05723 -0.02417 C21H22O7S [M+K-2H]- 
455.11667 455.11709 0.93163 C18H26O12 [M+Na-2H]- 
455.12427 455.12421 -0.13623 C18H24N4O8S [M-H]- 
459.06851 459.068718 0.278825 C17H19N4O8P [M+Na-2H]- 
460.28325 460.28346 0.46493 C25H45NO4 [M+K-2H]- 
462.29898 462.29911 0.28986 C25H47NO4 [M+K-2H]- 
463.97817 463.97802 -0.32329 C10H15N5O10P2 [M+K-2H]- 
465.30447 465.30441 -0.13969 C27H46O4S [M-H]- 
466.30785 466.30752 -0.71627 C28H41N3O3 [M-H]- 
473.28257 473.28274 0.35074 C30H44O2 [M+K-2H]- 
476.27856 476.27826 -0.62358 C23H44NO7P [M-H]- 
478.29400 478.29391 -0.18190 C23H46NO7P [M-H]- 
479.29295 479.29330 0.73233 C29H46O3 [M+K-2H]- 
480.11230 480.11234 0.08956 C19H25NO12 [M+Na-2H]- 
480.27345 480.27318 -0.56634 C22H44NO8P [M-H]- 
480.30944 480.30956 0.25608 C23H48NO7P [M-H]- 
481.25675 481.25719 0.92051 C22H43O9P [M-H]- 
481.97734 481.97724 -0.21578 C9H16N3O14P3 [M-H]- 
482.11939 482.11959 0.40861 C19H23N7O6 [M+K-2H]- 
482.96131 482.96125 -0.12216 C9H15N2O15P3 [M-H]- 
488.27860 488.27823 -0.76391 C29H41NO4 [M+Na-2H]- 
491.27825 491.27804 -0.41931 C26H46O6 [M+K-2H]- 
501.12973 501.12969 -0.08381 C19H26N4O10S [M-H]- 
505.98854 505.98847 -0.14032 C10H16N5O13P3 [M-H]- 
508.30455 508.30448 -0.14165 C24H48NO8P [M-H]- 
509.28860 509.28849 -0.21010 C24H47O9P [M-H]- 
520.91746 520.91713 -0.62774 C9H15N2O15P3 [M+K-2H]- 
521.98360 521.98338 -0.41381 C10H16N5O14P3 [M-H]- 
527.11142 527.11137 -0.08917 C28H26O8 [M+K-2H]- 
527.97043 527.97041 -0.03220 C10H16N5O13P3 [M+Na-2H]- 
535.03711 535.03718 0.12896 C14H22N2O16P2 [M-H]- 
543.94417 543.94435 0.33275 C10H16N5O13P3 [M+K-2H]- 
551.26284 551.26264 -0.37006 C30H42O8 [M+Na-2H]- 
553.27836 553.27829 -0.13375 C30H44O8 [M+Na-2H]- 
558.06435 558.06440 0.08422 C15H23N5O14P2 [M-H]- 
561.31995 561.32022 0.48101 C26H55NO7P [M+K-2H]- 
563.06857 563.06848 -0.15984 C16H26N2O16P2 [M-H]- 
565.04772 565.04774 0.04247 C15H24N2O17P2 [M-H]- 
569.27329 569.27324 -0.09310 C25H47O12P [M-H]- 
571.28897 571.28889 -0.14529 C25H49O12P [M-H]- 
575.19899 575.19901 0.03999 C13H20O5S [2M-H]- 
579.02685 579.02701 0.27460 C15H22N2O18P2 [M-H]- 
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579.29404 579.29394 -0.17953 C32H46O8 [M+Na-2H]- 
581.30964 581.30959 -0.09289 C32H48O8 [M+Na-2H]- 
582.31288 582.31311 0.40185 C26H49NO13 [M-H]- 
585.95521 585.95480 -0.69971 C10H17N5O16P4 [M-H]- 
597.30440 597.30454 0.22936 C27H51O12P [M-H]- 
599.32004 599.32019 0.24528 C27H53O12P [M-H]- 
601.02464 601.02436 -0.46421 C16H26N2O16P2 [M+K-2H]- 
606.07412 606.07429 0.28544 C17H27N3O17P2 [M-H]- 
607.36149 607.36166 0.27661 C30H57O10P [M-H]- 
611.14454 611.14469 0.23890 C20H32N6O12S2 [M-H]- 
613.13951 613.13999 0.78449 C20H31N4O16P [M-H]- 
616.47111 616.47115 0.06326 C34H68NO6P [M-H]- 
617.41878 617.41878 -0.00162 C33H63O8P [M-H]- 
620.02021 620.02016 -0.07580 C15H22N5O16P3 [M-H]- 
628.05599 628.05624 0.39328 C17H27N3O17P2 [M+Na]- 
631.43499 631.43443 -0.88845 C34H65O8P [M-H]- 
635.10988 635.11012 0.37316 C12H14O10 [2M-H]- 
642.48686 642.48680 -0.09494 C36H70NO6P [M-H]- 
643.43435 643.43443 0.12278 C35H65O8P [M-H]- 
644.03011 644.03018 0.10093 C17H27N3O17P2 [M+K-2H]- 
645.45015 645.45008 -0.11000 C35H67O8P [M-H]- 
649.10053 649.10057 0.05854 C20H32N6O12S2 [M+K-2H]- 
657.44955 657.45008 0.80462 C36H67O8P [M-H]- 
659.46536 659.46573 0.55954 C36H69O8P [M-H]- 
662.10215 662.10185 -0.46065 C21H27N7O14P2 [M-H]- 
664.11723 664.11750 0.39903 C21H29N7O14P2 [M-H]- 
669.45021 669.450079 -0.19568 C37H67O8P [M-H]- 
671.46565 671.46573 0.11765 C37H69O8P [M-H]- 
673.48154 673.48138 -0.23906 C37H71O8P [M-H]- 
687.49711 687.49703 -0.11782 C38H73O8P [M-H]- 
693.10728 693.10747 0.27269 C28H32O18 [M+K-2H]- 
699.49689 699.49703 0.19871 C39H73O8P [M-H]- 
701.51280 701.51268 -0.17106 C39H75O8P [M-H]- 
714.50741 714.50793 0.72637 C39H74NO8P [M-H]- 
727.52770 727.52833 0.86595 C41H77O8P [M-H]- 
730.50219 730.50284 0.89391 C39H74NO9P [M-H]- 
742.53889 742.53923 0.45654 C41H78NO8P [M-H]- 
744.51790 744.51849 0.79649 C40H76NO9P [M-H]- 
745.50313 745.50251 -0.83299 C40H75O10P [M-H]- 
753.41954 753.41957 0.03584 C36H67O14P [M-H]- 
758.53466 758.53414 -0.68158 C41H78NO9P [M-H]- 
788.54460 788.54471 0.13696 C42H80NO10P [M-H]- 
807.50231 807.50290 0.73436 C41H77O13P [M-H]- 
809.51891 809.518553 -0.44100 C41H79O13P [M-H]- 
833.51830 833.51855 0.30353 C43H79O13P [M-H]- 
835.53392 835.53420 0.33871 C43H81O13P [M-H]- 
863.56507 863.56550 0.50141 C45H85O13P [M-H]- 
 
